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Abstract 
Musculoskeletal disorders are a leading cause of disease burden worldwide. 
Alarmingly, the prevalence and socioeconomic impact of these conditions is rising. 
Pain is a common and disabling feature of many musculoskeletal disorders. While 
significant individual burden is evident at all stages of pain, socioeconomic costs 
increase dramatically when pain becomes chronic (> 3 months). Therapies that 
reduce the duration and severity of chronic pain are needed to lessen the individual 
and socioeconomic burden of these conditions. However, current interventions 
achieve limited success. The lack of effective therapies is hypothesised to be caused, 
in part, by a limited understanding of the neurophysiology of chronic musculoskeletal 
pain and the mechanisms driving the transition to chronicity. 
Recent advances in technology provide evidence of structural and functional changes 
in brain regions, including the primary motor cortex (M1), in response to 
musculoskeletal pain. Lasting changes in the excitability, topography and 
organisation of M1 have been hypothesized to underpin symptom chronicity in 
musculoskeletal disorders, however the mechanisms underlying these changes 
remain unclear. Inhibitory intracortical networks modulate the excitability, 
organisation and output of extrinsically projecting M1 neurons, and are well 
positioned to influence the cortical response to pain. Yet, the effect of acute and 
chronic muscle pain on inhibitory intracortical networks has not been fully 
elucidated. Thus, the overall aim of this thesis was to contribute to the body of 
knowledge on the intracortical response to musculoskeletal pain using i) acute 
 xvi 
experimental pain models in healthy individuals and ii) clinical populations living with 
chronic pain.   
This aim was addressed via one secondary and three primary research studies. First, 
a systematic review and meta-analyses was performed to establish the effect of 
experimental muscle pain on the primary motor (M1) and somatosensory cortices 
(S1). Following a detailed and reproducible systematic search of the literature, 25 
studies (15 neuroimaging and 10 electrophysiological studies) were included. 
Systematic evaluation of functional magnetic resonance imaging (fMRI) data revealed 
consistent evidence of increased S1 activation in response to acute muscle pain. As 
meta-analyses of electrophysiological recordings at S1 (n = 3) revealed strong 
evidence of reduced intracortical processing during pain [1.99 (0.64, 3.34)] and 
moderate evidence following the resolution of pain [0.65 (0.15, 1.16)], increased 
activity in cortical networks with inhibitory functionality may underpin increased S1 
activation. The systematic review also identified evidence of increased M1 activation 
using fMRI during muscle pain. However, this effect was not consistent across studies. 
These inconsistencies may relate to the temporal profile of the M1 response since 
meta-analyses of transcranial magnetic stimulation data (TMS; n = 10) revealed 
strong evidence of reduced M1 excitability post pain [0.97 (0.59, 1.35)], and 
moderate evidence during pain [0.52 (-0.01, 1.06)]. Evidence of reduced intracortical 
facilitation and increased intracortical inhibition was also noted in M1. However, this 
finding was derived from a single study, such that no definitive conclusion could be 
made as to whether these mechanisms underpin the M1 response to pain. Thus, 
 xvii 
three primary research studies were performed to further evaluate the effect of 
muscle pain on intracortical activity.  
In studies 2, 3 and 4, TMS was used to evaluate forms of intracortical inhibition 
previously unexplored in: healthy persons with acute experimental muscle pain 
(study 2) and persons with specific chronic musculoskeletal pain conditions (study 3 
and 4). The results of study 2 confirmed the findings of study 1, while also providing 
the first description of the temporal effect of muscle pain on intracortical networks 
engaged in sensorimotor integration. Consistent with the findings of the systematic 
review, corticomotor output (M1 excitability) was reduced during (p = 0.001) and 
following an episode of acute experimental muscle pain (p = 0.003). Concurrent 
measurements of intracortical inhibition in these participants revealed that this 
effect was accompanied by reduced short- and long latency afferent inhibition in the 
post pain period (p = 0.039, p = 0.035). These mechanisms reflect the integration of 
somatosensory afferent input at M1, thus, this response may reflect altered 
intracortical activity within S1, M1, or both regions. As an additional form of 
inhibition, long interval intracortical inhibition, was unaffected by acute muscle pain, 
this study also provides evidence of a differential effect of acute muscle pain on 
distinct inhibitory intracortical networks.  
Study 3 provides the first description of intracortical activity in persons experiencing 
chronic musculoskeletal pain due to lateral epicondylalgia (LE, ‘tennis elbow’). 
Participants with LE (n = 14) displayed reduced short interval intracortical inhibition 
(p = 0.005), long interval intracortical inhibition (p = 0.046) and intracortical 
 xviii 
facilitation (p = 0.026), compared to pain-free controls. There was no direct 
relationship between reduced intracortical activity and pain or disability in LE (p > 
0.16). These findings support previous observations of reduced intracortical 
inhibition in other musculoskeletal conditions and suggest a shift towards cortical 
disinhibition in response to chronic pain.  
Study 4 provides the first description of the depth and magnitude of cortical 
disinhibition in chronic musculoskeletal pain. The temporal and spatial profile of post-
silent period electromyographic (EMG) bursting in persons with low back pain (LBP; 
n = 11) was significantly different to that observed in pain-free controls. In these 
individuals, EMG bursts were smaller (p = 0.050) and occurred earlier (p = 0.009) 
implying reduced corticomotor disinhibition in this condition. Similar to the findings 
of study 3, no direct relationship was found between burst characteristics and pain 
severity (p > 0.24). 
The findings from the four studies conducted in this thesis provide novel insight into 
the intracortical response to acute and chronic musculoskeletal pain. As each of the 
mechanisms investigated are thought to be mediated by distinct neuronal 
populations, these findings suggest that the intracortical response to musculoskeletal 
pain is extensive and diverse.  Observations of opposing changes in short- and long 
interval intracortical inhibition in the acute (increased inhibition) and chronic 
(decreased inhibition) stages of pain suggest that these forms of inhibition could play 
a role in the transition to chronicity. However, study 3 and 4 did not detect a 
correlation between intracortical inhibition and measures of pain and disability in LE 
 xix 
and LBP, respectively. While this suggest that changes in intracortical activity may not 
contribute directly to symptoms of chronic pain and motor dysfunction, there is the 
possibility of a non-linear relationship between these variables.  
When the findings are taken together, changes in intracortical inhibition in pain 
suggest the enactment of a cortically driven motor strategy to protect painful tissues 
from further insult. While beneficial in the short term when the need to protect the 
tissues is high, failure to return to normal intracortical function in the long-term could 
lead to pain persistence through altered tissue loading. Large, longitudinal trials 
examining the transition from acute to chronic pain are necessary to confirm these 
hypotheses. If confirmed, future therapies which target maladaptive intracortical 
change could lead to greater improvements in pain and function for individuals 
experiencing chronic musculoskeletal pain. 
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Thesis overview 
Chronic musculoskeletal pain is a leading cause of disease burden worldwide (Vos et 
al. 2012). Despite the enormity of the problem, most therapies have moderate effect 
sizes at best (Moulin 2001, Nielson et al. 2001, Menke 2014). This is not surprising 
given that many treatments, such as pharmacotherapy, target generic symptoms not 
underlying mechanisms (Moulin 2001). An area of increasing research and 
therapeutic interest is the effect that pain, both acute and chronic, has on the brain. 
Transient and lasting changes in cortical organisation and function have been 
documented in the primary motor cortex (M1) using methodologies including 
functional magnetic resonance imaging (fMRI) and transcranial magnetic stimulation 
(TMS). This body of work has led to the suggestion that structural and functional 
changes within M1 contribute to symptom chronicity in musculoskeletal pain 
conditions (Wand et al. 2011, Moseley et al. 2012). However, while observations of 
altered M1 excitability, topography and organisation have been demonstrated, the 
physiological processes driving these effects remain unclear (Tsao et al. 2008, Tsao et 
al. 2011b, Schabrun et al. 2014, Schabrun et al. 2015a, Schabrun et al. 2015b, Te et 
al. 2017). As inhibitory interneuronal activity is a key determinant of cortical plasticity 
(Liepert et al. 1998a, Murakami et al. 2012), it is possible that evaluation of 
intracortical networks could provide valuable insight into the mechanisms 
underpinning short and long-term M1 adaptation to musculoskeletal pain. Thus, the 
overarching objective of this thesis was to explore the effect of musculoskeletal pain 
on intracortical networks acting within M1.  
 xxi 
To answer this objective, one secondary research study and three primary research 
studies were conducted. Specific study aims and hypotheses were as follows: 
Study 1 
Aim: To examine current evidence regarding the effect (direction, strength, duration) 
of acute experimental muscle pain on the excitability of the primary motor (M1) and 
primary somatosensory cortices (S1). 
Hypothesis: That M1 and S1 excitability is reduced during and following the 
resolution of, acute muscle pain.  
Study 2 
Aim: To determine the effect of acute experimental muscle pain on corticomotor 
output, long interval intracortical inhibition, short latency afferent inhibition and long 
latency afferent inhibition.  
Hypothesis: That corticomotor output is decreased and intracortical/afferent 
inhibition are increased in response to acute experimental muscle pain.  
Study 3 
Aim: To investigate short interval intracortical inhibition, long interval intracortical 
inhibition and intracortical facilitation in persons with and without chronic 
musculoskeletal pain due to lateral epicondylalgia (‘tennis elbow’).  
 xxii 
Hypothesis: That intracortical inhibition is reduced and intracortical facilitation is 
increased in persons with lateral epicondylalgia compared to pain free controls.   
Study 4 
Aim: To investigate the temporal and spatial characteristics of post silent period 
electromyographic bursting in persons with and without chronic low back pain.  
Hypothesis: That post silent period electromyographic bursting is both decreased 
and widespread in persons with low back pain compared to pain free controls.  
Each research study included in this thesis has been published as a stand-alone article 
in a peer reviewed journal: European Journal of Pain (Study 1 and 3), Pain Medicine 
(Study 2) and the International Journal of Neuroscience (Study 4). These journal 
articles are presented (subject to minor editorial changes) in Chapters 2 to 5.  The 
findings from the four studies are then synthesized and discussed ‘in toto’ in Chapter 
6 to provide an overarching theory on the role of cortical inhibition in musculoskeletal 
pain. In this final chapter, the limitations, clinical implications and future directions 
of the research are also discussed.    
The next chapter (Chapter 1) establishes a framework for the research undertaken 
by providing a detailed, focused review of the literature surrounding M1 adaptations 
in musculoskeletal pain conditions. The contribution of cortical inhibition is discussed 
and avenues available to study intracortical mechanisms are described. The chapter 
then concludes with a detailed summary of the research rationale behind each study.  
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Chapter 1: General Introduction 
 
This chapter provides an overview of the literature surrounding musculoskeletal pain 
and cortical inhibition. The chapter focuses on the role of the brain in acute and 
chronic musculoskeletal pain and the methodologies available to study inhibitory 
cortical mechanisms in the primary motor cortex (M1). Critical review of specific 
literature relevant to each research study is provided in the Introduction and 
Discussion sections of Chapters 2 to 5. 
 
Chapter 1 
2 
 
1.1 Musculoskeletal pain is a significant health problem 
Pain is a normal physiological response to noxious stimuli. In the period following 
injury, pain supports the healing process by encouraging rest and recovery. However, 
pain that persists beyond the normal scope of healing (typically three months or 
longer) neither protects nor supports this process and may reflect an underlying 
pathology (Peyron 2013).  Persistent or ‘chronic’ musculoskeletal pain states (i.e. pain 
arising from muscles, tendons, ligaments, bones, joints and associated tissues) have 
been estimated to affect 1.3 billion people worldwide (Vos et al. 2016). Chronic low 
back pain (LBP) is the most prevalent form of musculoskeletal pain and has been the 
leading cause of disability globally since 1990 (Vos et al. 2012, Vos et al. 2016).  
Musculoskeletal pain conditions have, and continue to be, a costly problem for 
Australia. While significant burden is evident at all stages of pain, many costs 
associated with these conditions increase dramatically when pain becomes chronic. 
In 2012, the direct cost of caring for persons with chronic musculoskeletal pain, 
combined with indirect costs associated with loss of worker participation and 
productivity, totaled 55.1 billion Australian dollars (Arthritis and Osteoporosis 
Victoria 2013). Since back complaints remain the eighth most common reason for 
presenting to a general practitioner and up to 75% of these presentations require 
ongoing care and management (i.e. are chronic), the cost of care is expected to 
remain high well into the future (Britt et al. 2015). Alarmingly, epidemiological studies 
suggest this may be the reality for nearly all populations around the world (Murray 
et al. 2012, Vos et al. 2016).   
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Findings from the most recent Global Burden of Disease Study indicate that the global 
burden of painful musculoskeletal disorders (measured as ‘years lived with disability’- 
a disability weighted measure of prevalence) rose by 18.6-20.5% in the last decade 
(Vos et al. 2016). The rate of burden also increased over this time. However, this was 
modest (4.9-6.6%) and suggests that the majority of increase in burden could be 
explained by an increase in the severity or duration of these conditions, rather than 
the emergence of a significant number of new cases. Recent data from the Australian 
Institute of Health and Welfare (AIHW) indicate that the health impact of chronic 
musculoskeletal pain is considerable. For example, in an AIHW 2016 bulletin, it was 
noted that a significant proportion of individuals with chronic back problems suffered 
high levels of disability and poor quality of life due to reductions in mobility, selfcare, 
employment and social participation (AIHW 2016). Of these individuals, 13% 
reported their pain as ‘severe’, and 3.7%, ‘very severe’. The level of pain and disability 
experienced by persons with chronic musculoskeletal conditions is perhaps 
unsurprising given that many treatments are only moderately efficacious (Moulin 
2001, Nielson et al. 2001, Menke 2014). The lack of effective therapies may be 
caused, in part, by a limited understanding of the neurophysiology of chronic 
musculoskeletal pain. Prioritization of research into musculoskeletal pain is therefore 
essential to lessen the burden of these conditions on the individual, community and 
economy.  
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1.2 Musculoskeletal pain in the laboratory 
1.2.1 Acute muscle pain 
Research into the impact of acute musculoskeletal pain on cortical plasticity in clinical 
populations is challenging due to the narrow window in which participants must be 
identified and recruited. Additionally, in these situations there is likely to be a lack of 
baseline data prior to the pain incident. This has led researchers to develop a number 
of experimental models to study muscle pain in otherwise pain-free volunteers. 
Endogenous and exogenous methods of inducing acute muscle pain are detailed in 
Table 1.1. Endogenous methods based on ischemia or exercise are suitable for 
studying general pain states as these interventions typically induce pain in entire 
muscle groups or body segments, whereas exogenous methods based on thermal, 
electrical or chemical stimulation are more appropriate for investigations of local 
and/or referred pains (Arendt-Nielsen et al. 2001). 
Experimental pain models have advantages and disadvantages. An advantage shared 
by all is that they permit investigation of the temporal effects of acute pain in a 
controlled environment, without the threat of lasting tissue damage and 
independent of comorbidities which often accompany clinical pain (Graven-Nielsen 
2006). However, a common disadvantage is their lack of specificity. For example, 
although mechanical models have a large array of research applications (e.g. 
assessment of hyperalgesia, pain thresholds and pain tolerance) and can be used to 
target individual muscles, in actuality this methodology is not muscle specific as skin 
and deeper structures are also impacted upon by mechanical pressure. Furthermore, 
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models which do demonstrate tissue specificity do not always demonstrate 
nociceptive specificity. This is best evidenced by chemical models of acute pain, 
which, despite being considered muscle specific, have been shown to activate both 
low (non-nociceptive) and high threshold (nociceptive) mechanosensitive group IV 
afferents (Cairns et al. 2003, Hoheisel et al. 2004).  
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Table 1.1 Experimental models of acute musculoskeletal pain. 
MODE 
 
METHODOLOGY 
 
STIMULUS 
DURATION 
TISSUE 
SPECIFIC? 
NOCICEPTOR  
SPECIFIC? 
PAIN  
DISTRIBUTION 
PROPOSED MECHANISM 
 OF ACTION 
TECHNICAL 
REFERENCES 
Ischemic 
Tourniquet is applied to limb 
to restrict blood flow at rest 
or during volitional 
contraction 
≤2 hours No No Diffuse 
Restricted blood flow leads to the 
accumulation of endogenous 
substances which activate 
nociceptive afferents 
Mills et al. (1982), 
Graven-Nielsen et al. 
(2003), Segerdahl et 
al. (2004) 
Exercise 
Participant performs 
concentric muscle 
contractions usually to 
fatigue 
Minutes No No Diffuse 
Restricted blood flow leads to the 
accumulation of endogenous 
substances which activate 
nociceptive afferents 
Vecchiet et al. 
(1983), Cook et al. 
(1997), O'Connor et 
al. (2001) 
Mechanical 
A hand-held or automated 
pressure algometer is 
applied over muscle tissue 
Seconds - 
minutes 
No No Local 
Downward pressure activates 
group III and IV nociceptive 
afferents 
Kosek et al. (1999), 
Schubert et al. 
(2004), Finocchietti 
et al. (2011) 
Thermal 
Intramuscular injection of 
heated (48°C) or cooled (8°C) 
isotonic saline 
Bolus Yes Yes Local 
Activation of heat-sensitive 
nociceptors 
(Graven-Nielsen et 
al. 2002a) 
Electrical 
Current delivered to muscle 
tissue via needle electrodes 
with uninsulated tips 
Milliseconds Yes No 
Local and 
referred 
Intensities corresponding to pain 
threshold activate group III 
nociceptive afferents 
Svensson et al. 
(1997b, 1997a), 
Niddam et al. (2001) 
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Chemical 
Intramuscular 
infusion/injection of 
hypertonic saline  
Bolus - 30 
minutes 
Yes No Local and 
referred 
Increased intramuscular sodium 
activates group III and IV 
nociceptive afferents 
Jensen et al. (1992), 
Graven-Nielsen et al. 
(1997a), Coppieters 
et al. (2006) 
Intramuscular injection of 
glutamate 
Bolus Yes No 
Local and 
referred 
Activation of peripheral NMDA 
receptors on group III and IV 
afferents 
Cairns et al. (2003), 
Svensson et al. 
(2003b) 
Intramuscular 
injection/infusion of 
capsaicin 
Bolus - 13 
minutes 
Yes No 
Local and 
referred 
Activation of vanilloid receptor 1 
on group III and IV afferents 
Arima et al. (2000), 
Witting et al. (2000) 
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The most common method of inducing acute muscle pain is via hypertonic saline 
(Graven-Nielsen 2006). This model induces pain of clinical quality (deep, sharp ache, 
local and referred) by artificially raising intramuscular sodium to a concentration 
capable of triggering nociceptive afferents in muscle tissue (Graven-Nielsen et al. 
1997c). Two variations of the model exist, the original model consisting of a manual 
bolus dosage, and the contemporary model, a prolonged computer-controlled 
infusion (Graven-Nielsen et al. 1997a, Coppieters et al. 2006). Compared to bolus 
delivery, infusion protocols can induce pain of consistent intensity and predictable 
duration (Figure 1.1). As these variables can be carefully managed by altering the 
rate, volume and timespan of infusion (Graven-Nielsen et al. 1997a), this technique 
is particularly advantageous for experiments featuring lengthy protocols. 
 
A 
B 
Figure 1.1 Hypertonic saline 
induced muscle pain. Typical 
muscle pain intensity profiles after 
A) bolus injection of 5% hypertonic 
saline (0.2ml over 20s) and B) 
continuous infusion of 5% 
hypertonic saline (0.2ml over 20s, 
then 6-9mL/hr).  
A) Reprinted from Clinical Neurophysiology, 
112 /9, Domenica Le Pera, Thomas Graven-
Nielsen, Massimiliano Valeriani, Antonio 
Oliviero, Vincenzo Di Lazzaro, Pietro Attilio 
Tonali, Lars Arendt-Nielsen, Inhibition of motor 
system excitability at cortical and spinal level 
by tonic muscle pain, 1633-1641, Copyright 
(2001), with permission from Elsevier 
 B) Reprinted from Archives of Physical 
Medicine and Rehabilitation, 87 /10, Michel W. 
Coppieters, Ali M. Alshami, Paul W. Hodges, An 
experimental pain model to investigate the 
specificity of the neurodynamic test for the 
median verve in the differential diagnosis of 
hand symptoms, 1412-1417, Copyright (2006), 
with permission from Elsevier 
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The typical experimental set up for infusion involves sterile preparation of 4-6% saline 
solution. Concentrations within this range are most common as they show no 
evidence of in vitro or in vivo toxicity and have been demonstrated to be safe for 
human use (Graven-Nielsen et al. 1997b, Graven-Nielsen et al. 1997a, Graven-Nielsen 
et al. 1997c, Svendsen et al. 2005).  Once loaded into a syringe, the solution is 
delivered via a computer controlled syringe pump through a small gauge stainless 
steel needle inserted into muscle tissue at a volume/rate appropriate for the 
experimental conditions (e.g. 6ml/hour for 10 minutes) (Schabrun et al. 2012). 
Additions to this protocol can include anaesthetization of cutaneous tissue 
surrounding the injection site (to negate any local skin pain arising from needle 
insertion) or a small (0.2ml) bolus injection prior to infusion (to accelerate pain 
onset)(Graven-Nielsen et al. 1997a, Coppieters et al. 2006). Although infusion 
parameters can be varied to accommodate different study designs, it is rare for 
infusion time to extend beyond 30 minutes (Graven-Nielsen 2006). 
1.2.2 Transitional muscle pain 
Until recently, avenues for studying acute muscle pain beyond the 30-minute 
timeframe were limited to models of ischemia-induced pain which are neither tissue 
specific, long-lasting or well understood (Graven-Nielsen 2006). However, there is 
now increasing use of Recombinant Human β-nerve Growth Factor (NGF), a 
neuropeptide involved in the development and reconstruction of nerves, as a proxy 
for studying muscle pain of moderate duration (i.e. between the acute and chronic 
stages) (Schabrun et al. 2016). Unlike hypertonic saline, intramuscular injection of 
NGF does not result in spontaneous pain, but rather a progressively developing 
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muscle soreness that spreads from the site of injection into surrounding tissues 
(Svensson et al. 2003a, Andersen et al. 2008). Although symptoms are not typically 
present at rest, muscle ache and discomfort may be provoked by palpation and 
functional tasks (Nie et al. 2009, Hayashi et al. 2013). As these effects have been 
demonstrated to last around 14 days (Svensson et al. 2003a, Andersen et al. 2008), 
the NGF model of muscle pain is thought to be a valuable method of investigating 
cortical responses to acute muscle pain for up to two weeks. 
1.2.3 Chronic muscle pain 
Investigations of muscle pain beyond two weeks duration is confined mainly to 
clinical studies of chronic pain as an experimental model for human use has yet to be 
developed. While animal models of chronic musculoskeletal pain are available, they 
are limited, imperfect and somewhat controversial due to ethical concerns 
associated with inflicting long-term pain and suffering (Coderre et al. 1987, Kehl et 
al. 2000, Nagakura et al. 2009, Sharma et al. 2010). Hence, muscle pain of longer 
duration is usually studied using cross-sectional study designs where individuals with 
chronic pain are compared with healthy, pain free controls (Schabrun et al. 2015a, 
Schabrun et al. 2015b). Although persons with chronic musculoskeletal pain are 
easier to access than those experiencing an acute episode, subjective and 
quantitative assessments in these individuals may be confounded by the presence of 
other comorbid symptoms (physical and psychological), treatment history and 
medication use. While quality studies attempt to control these confounders, either 
via rigorous pre-screening and exclusion or post-hoc subgroup analyses, this can 
restrict the generalisability of findings. Differences in pain severity, symptom 
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duration and movement dysfunction between individuals can also make it difficult to 
draw definitive conclusions. In summary, despite the limitations of clinical pain 
populations and acute experimental models, both are used widely to generate 
valuable information on motor adaptation and cortical responses to muscle pain. 
1.3 Movement dysfunction in pain 
Movement dysfunction is a key symptom of acute and chronic musculoskeletal pain. 
While some motor consequences are outwardly obvious (i.e. altered gait and 
posture), less obvious effects such as diminished proprioception, reduced fine motor 
performance, altered muscle activation and disturbed muscle synergies are also a 
frequent occurrence (Graven-Nielsen et al. 1997d, Radebold et al. 2000, Graven-
Nielsen et al. 2002b, Matre et al. 2002, Rossi et al. 2003, Slater et al. 2003, Hortobagyi 
et al. 2004, Alizadehkhaiyat et al. 2007, Skinner et al. 2007, Juul-Kristensen et al. 
2008, Henriksen et al. 2011). Although traditional hypotheses advocate a uniform 
effect of muscle pain on motor physiology (i.e. increased or decreased muscle 
activity; Travell et al. 1942, Lund et al. 1991), current opinion is that the motor 
adaptation selected by any one individual is likely to be unique, and dependent upon 
the anatomical and functional complexity of the body part involved (Peck et al. 2008, 
Hodges et al. 2011). 
Contemporary theories of motor changes in pain are supported by a wealth of 
evidence demonstrating variable patterns of adaptation to musculoskeletal pain 
(Hodges et al. 2011). For example, EMG responses of an acutely painful muscle have 
been demonstrated to increase or decrease depending on the individual being 
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examined, even under identical experimental conditions (Hodges et al. 2013, van den 
Hoorn et al. 2015). Acute muscle pain has also been demonstrated to differentially 
affect the activity of distal (increased) and proximal (decreased) muscles within the 
same body segment (Del Santo et al. 2007), as well as the movement characteristics 
of simple and complex multi joint systems (e.g. decreased vs. increased variability re 
joint excursions) (Madeleine et al. 2008, Bergin et al. 2014). There is also evidence of 
variable responses in chronic pain, as muscle activity has been demonstrated to be 
increased (Kaigle et al. 1998, Ambroz et al. 2000), decreased  (Ahern et al. 1988, 
Watson et al. 1997) and unchanged  (Ahern et al. 1988, Watson et al. 1997) in 
individuals with  LBP, compared to pain-free controls. The wide range of adaptations 
evident between individuals and within conditions is testament to the flexible nature 
of the motor system at both the micro and macro level.  
The ultimate goal of motor adaptation to pain is thought to be that of protecting 
injured tissues from further pain or insult. While this concept is not new (Travell et 
al. 1942, Lund et al. 1991), the idea that this can be achieved regardless of the type 
of adaptation or direction of change is a fairly recent development (Hodges et al. 
2011). According to Hodges et al. (2011),  seemingly contrary adaptations such as 
those described above are hypothesised to be equally as effective at providing 
protection to an injured body part. For instance, decreased EMG at the site of pain 
may prevent symptom aggravation by restricting the movement capabilities of the 
affected body part, while increased EMG may act to splint the affected body part, 
thus unloading painful tissues and structures. While these adaptations may be 
beneficial in the short term, Hodges et al. (2011) hypothesised that such changes 
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could be detrimental if maintained long term. There has also been the suggestion 
that variable responses between individuals could explain why some develop chronic 
pain and others do not (van den Hoorn et al. 2015). Although the physiological basis 
of motor adaptations to muscle pain is not fully understood, a growing body of 
evidence points towards altered central nervous system function (Coderre et al. 
1993, Hodges et al. 2011, Bank et al. 2013, Pelletier et al. 2015). As the source of 
movement planning and execution is the motor cortex, changes to the structure and 
function of the primary motor cortex (M1) provides a likely substrate.  
1.4 Primary motor cortex anatomy and physiology 
The primary motor cortex (Brodmann’s area 4) is a subdivision of the greater cerebral 
motor area located in the dorsal portion of the frontal lobe, between the premotor 
cortex (anterior) and primary somatosensory cortex (posterior). Direct electrical 
stimulation of M1 in humans indicates that this region is concerned primarily with 
coordinating and directing physical movement (Penfield et al. 1950). The cortical 
surface of M1 is arranged medial-lateral to depict anatomical divisions of the body, 
with the amount of cortex devoted to each body region being reflective of the 
movement capabilities of that part, rather than the physical size  (Figure 1.2; Penfield 
et al. 1937). In this way, muscles required for fine motor control (e.g. intrinsic hand 
muscles) occupy a disproportionately larger area of the cortex than those necessary 
for gross motor activities (e.g. leg muscles) (Rasmussen et al. 1947). Importantly, 
brain imaging studies demonstrate that these divisions demonstrate considerable 
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overlap and plasticity, especially in response to pain and injury (Roricht et al. 1999, 
Sanes et al. 2000, Karl et al. 2001, Schwenkreis et al. 2001, Meier et al. 2008).  
 
Below the cortical surface exists a complex cytoarchitecture. Here, neurons 
demonstrate a vertical columnar arrangement subdivided into six distinct horizontal 
layers, the most distinctive of which is the descending output layer five. This layer is 
characterized by the presence of a small but significant population (~10%) of giant 
pyramidal neurons known as Betz cells (Rivara et al. 2003). These excitatory long 
Figure 1.2 Somatotopic representation of movement in the human brain. This 
surface map represents hemodynamic responses identified by high resolution 
fMRI during a range of motor tasks (tongue protrusion, squinting, finger 
flexion/extension, wrist flexion/extension [A], wrist adduction/abduction [B], 
forearm pronation/supination, elbow flexion/extension, curl/uncurl of toes 
and rapid eye movement [saccade]). Movement of different body parts is 
shown to activate overlapping areas of the cortex in both M1 (left of central 
sulcus, indicated by the dashed line) and primary somatosensory cortex (S1; 
right of the central sulcus). Source: Michael Graziano [CC BY-SA 1.0 
(http://creativecommons.org/licenses/by-sa/1.0)], via Wikimedia Commons. 
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projection neurons, together with other layer five pyramidal cells, project 
extrinsically from the cortex to form 30% of the corticospinal tract (Hall 2015). 
Pyramidal neurons of the corticospinal pathway are the main means by which M1 
controls the force, direction, extent and speed of movement (Byrne et al. 1997). 
The functional properties of pyramidal neurons are modulated by local circuit 
neurons. These ‘interneurons’ project exclusively within the cortex and are 
morphologically and electrophysiologically diverse (Markram et al. 2004). Up to 50 
subtypes of interneuron have been described, the majority of which are classed as 
inhibitory (Markram et al. 2004). While most inhibitory cells use gamma-amino-
butyric-acid (GABA) as their main neurotransmitter, cholinergic 
(excitatory/inhibitory) and glutamatergic (excitatory) interneurons have also been 
described (Okhotin et al. 1999). GABAergic neurons can be broadly defined based on 
receptor subtype; type A mediate fast inhibitory post synaptic potentials (~2.5ms), 
while type B demonstrate slower temporal characteristics (~45ms) (Benardo 1994). 
Although it remains to be confirmed whether these responses are due to 
independent interneuron populations or differential receptor positioning on the 
same cell (i.e. GABAB receptors situated external from the synapse), there is 
increasing evidence to suggest that separate classes of interneuron may be involved 
(Benardo 1994, Sanger et al. 2001). In addition to interactions with excitatory 
pyramidal neurons, there is also evidence that interneuronal networks are 
interconnected (Tamas et al. 1998), and that interactions between different 
inhibitory populations may be complementary or competitive (Sanger et al. 2001, 
Sailer et al. 2002, Stefan et al. 2002, Sailer et al. 2003, Alle et al. 2009). 
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GABAergic interneurons contribute to motor output through extensive connections 
with M1 pyramidal neurons. Findings in animal and human studies suggest that 
subtle modifications to the strength of inhibitory networks function to regulate the 
excitatory drive to muscles as well as excitatory connections within and between 
cortical motor representations (Jacobs et al. 1991, Liepert et al. 1998a).  For example, 
there is evidence in humans that GABAergic inhibition is decreased in actively 
contracting muscles, but increased for muscles not immediately engaged in a motor 
task, presumably to prevent unwanted movements, muscle overflow and co-
contraction (Ridding et al. 1995, Liepert et al. 1998a, Zoghi et al. 2003, Hammond et 
al. 2007, McNeil et al. 2009). In a seminal study by Jacobs et al. (1991), 
pharmacological blockade of GABAergic inhibition in the rodent brain led to an 
expansion of motor maps, presumably due to the unmasking of existing, but latent, 
excitatory connections between adjacent cortical representations. Since then, 
altered intracortical inhibition has also been proposed as a substrate for altered 
corticomotor output and M1 reorganisation in humans experiencing musculoskeletal 
pain (Schabrun et al. 2012, Schabrun et al. 2015b). 
1.5 The corticomotor response to musculoskeletal pain 
Musculoskeletal pain has been demonstrated to affect the haemodynamic 
(Henderson et al. 2006, Nash et al. 2010b, Takahashi et al. 2011, Loggia et al. 2012), 
metabolic (Svensson et al. 1997c, Kupers et al. 2004), and neuroelectric properties 
(Del Santo et al. 2007, Hoeger Bement et al. 2009, Tsao et al. 2011c, Schabrun et al. 
2012, Rittig-Rasmussen et al. 2014) of M1. While haemodynamic and metabolic 
responses can be examined via brain imaging technologies such as functional 
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magnetic resonance imaging (fMRI) and positron emission tomography (PET), the 
most accessible method of assessing the neuroelectric properties of M1 is via 
transcranial magnetic stimulation (TMS). 
1.5.1 Transcranial magnetic stimulation 
Transcranial magnetic stimulation is a safe, and non-invasive technique used widely 
to examine the corticomotor pathway in conscious humans (Rossini et al. 1998, Chen 
2000). When applied to the scalp overlying M1, TMS produces a corticomotor effect 
(motor evoked potential: MEP; Figure 1.3) via electromagnetic induction of currents 
in the underlying neural tissue (Barker et al. 1985). The strength of this effect is 
dependent upon methodological factors such as coil orientation and stimulation 
intensity, as well as intrinsic factors such as the excitability of cortical, spinal and 
peripheral components of the pathway  (Edgley et al. 1997, Di Lazzaro et al. 1998a, 
Di Lazzaro et al. 2004, Di Lazzaro et al. 2007b, Groppa et al. 2012).  
Responses evoked by TMS have been demonstrated to be due to the direct and/or 
indirect (i.e. interneuronal) activation of pyramidal neurons (Edgley et al. 1997). 
Direct epidural recordings in conscious humans show that the resultant descending 
activity is comprised of a series of high frequency waves (Di Lazzaro et al. 1998b, Di 
Lazzaro et al. 2001a, Di Lazzaro et al. 2001b, Di Lazzaro et al. 2002b). These findings 
indicate that TMS preferentially activates “I” (indirect) waves. However, “D” (direct) 
waves can also be recruited when higher stimulus intensities are used (Di Lazzaro et 
al. 1998b). Since similar patterns of activity have never been recorded during natural 
movement, it is important to recognise that TMS is a means of artificially activating 
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the motor system and that the evoked responses do not necessarily reflect natural 
motor physiology (Lazzaro et al. 2008).  
 
Figure 1.3 TMS of the motor cortex. TMS is performed using a stimulation 
device consisting of an electromagnetic coil attached to a high-voltage 
discharge system. TMS capacitors discharge a large electric pulse which 
causes current flow in the coil. The resultant brief (≤ 1ms) and powerful (1 - 
2.5 Tesla) magnetic field can, if sufficiently intense, penetrate the scalp and 
skull and induce eddy currents within the underlying neural tissue causing 
depolarisation of cell membranes. TMS evoked volleys from M1 (red), 
descend via the corticospinal tract and peripheral motor nerve, producing a 
motor response from skeletal muscle known as a motor evoked potential 
(MEP). 
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Quantification of MEPs in the periphery via electromyography provides information 
on the excitability and conductivity of the corticomotor pathway. Basic outcome 
measures of single pulse TMS include MEP peak-to-peak amplitude (reflective of 
excitability), MEP latency (reflective of signal conduction time from cortex to 
periphery) and ‘motor threshold’. Motor threshold provides a relative measure of the 
resting membrane potential of pyramidal neurons and is defined as the average 
stimulation intensity required to generate a small MEP in a target muscle (typically 
between 50-200uV peak-to-peak amplitude)(Rossini et al. 1994, Pascual-Leone et al. 
2002). As responses to TMS are highly variable, it is common practice to report 
average values for such outcomes. Trials consisting of five stimuli demonstrate 
excellent within-session reliability for measures of MEP amplitude (trials of ten 
stimuli are ideal between-session) (Cavaleri et al. 2017b), however under certain 
conditions as little as two stimuli may be required (Cavaleri et al. 2017a).  
A scan of electronic databases (PubMed, MEDLINE) indicates that over 1000 TMS 
studies are now published each year. Despite this popularity, there are still a number 
of concerns regarding the reliability of TMS generated data. Of most concern is the 
variable nature of the MEP response. Exploratory investigations of normative data 
indicate that this variability may have biological and technical sources (Boroojerdi et 
al. 2000, Wassermann 2002, Cueva et al. 2016). Between subject factors are thought 
to be the main source of variation, accounting for as much as 67% of the total 
variability of MEP measurements (Boroojerdi et al. 2000). Indeed, in addition to 
individual differences in the excitability of the corticomotor pathway, evidence 
suggests that inter-subject factors such as participant age, sex and handedness may 
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also influence study outcomes (Wassermann 2002, Cahn et al. 2003, Pitcher et al. 
2003, Cueva et al. 2016). Although the precise impact of these factors remains 
unclear, it is now expected that these variables are reported and controlled in TMS 
studies (Chipchase et al. 2012). Within subject factors such as menstrual phase, 
caffeine use and time of day are also demonstrated to negatively impact the 
reliability of TMS data, and thus are also increasingly accounted for in TMS study 
designs (Smith et al. 1999, Smith et al. 2002, Cerqueira et al. 2006, Sale et al. 2007).  
Another determinant of the quality and reliability of TMS data is the proficiency of 
the examiner. Alarmingly, in 2002 it was estimated that up to 50% of the between 
subject variability for motor threshold measurements could be due to experimental 
error caused by incorrect electrode/coil placement and inappropriate trial frequency 
(Wassermann 2002). However, results from a more recent study of inter- and intra-
examiner variability provide a more conservative estimate, especially for single pulse 
measures of cortical excitability (Cueva et al. 2016). Improvements in examiner 
reliability over time may reflect increased methodological quality of studies using 
TMS and/or advances in technical competency due to the advent of computer guided 
neuronavigation systems. However, despite this progress, the impact of biological 
and technical factors on TMS evoked responses still remains a significant concern. 
This has led an international panel of experts to develop a TMS methodological 
checklist to inform researchers as to which factors should be reported and/or 
controlled in TMS studies (Chipchase et al. 2012). Adoption of the recommendations 
outlined by this checklist will hopefully lead to improvements in the quality and 
transparency of TMS research. 
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1.5.2 Corticomotor adaptations to acute pain 
Studies using TMS provide evidence of altered corticomotor output during and 
following short lasting experimentally induced muscle pain. Although these effects 
generally manifest as reduced MEP amplitudes (decreased corticomotor excitability) 
(Le Pera et al. 2001, Svensson et al. 2003c, Martin et al. 2008, Schabrun et al. 2012, 
Schabrun et al. 2013, Rittig-Rasmussen et al. 2014), the occasional instance of 
increased (Del Santo et al. 2007) or unchanged excitability (Romaniello et al. 2000) 
indicates a degree of variability in this response. As previously discussed, it is possible 
that inter-subject (and potentially inter-investigator) variability may account for 
differences between technically similar studies. However, as the method for 
threshold determination, coil position, trial frequency and stimulation parameters 
differ between most studies (Appendix A.4), there is a high likelihood that much of 
this variability is due to methodological factors. For example, the same muscle can 
display evidence of increased or decreased excitability depending on whether it is 
examined at rest or during active contraction (Le Pera et al. 2001, Del Santo et al. 
2007). It is also possible that variable responses to pain reflect differences in 
anatomical location since MEPs are consistently reduced in painful muscles of the 
hand, forearm and arm (Le Pera et al. 2001, Svensson et al. 2003c, Martin et al. 2008, 
Schabrun et al. 2012, Schabrun et al. 2013), but increased in superficial abdominal 
and low back muscles (Tsao et al. 2011c). However, as opposing responses have also 
been demonstrated between muscles within a body segment under similar 
experimental conditions (Tsao et al. 2011c), a comprehensive review of these data is 
necessary to clarify the effect of acute muscle pain on corticomotor output, as well 
as the methodological quality of these studies.  
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As mentioned in section 1.3.1, when reviewing TMS data, it is important to recognize 
that the MEP is an aggregate measure of corticospinal excitability, rather than a direct 
reflection of M1 output. Thus, it also remains unclear whether the findings described 
above specifically reflect altered cortical output or simply a net change in the 
excitability of the corticomotor pathway. Although a small number of TMS studies 
have endeavored to control for changes occurring downstream from the cortex by 
including measures of spinal excitability, these investigations remain inconclusive 
since reductions in MEPs were accompanied by decreased spinal excitability in some 
studies (Le Pera et al. 2001, Svensson et al. 2003c), but increased excitability in others 
(Martin et al. 2008).  In contrast, joint investigations of MEPs and peripheral nerve 
excitability (M-waves) demonstrate stability of the peripheral element over time 
(Svensson et al. 2003c, Schabrun et al. 2013), thus ruling out any contribution of 
peripheral mechanisms to the MEP response. As peripheral changes have also been 
excluded by non-TMS studies (Svensson et al. 1998, Graven-Nielsen et al. 2002b, 
Farina et al. 2004, Farina et al. 2005), future work should focus on discerning the 
relative contribution of cortical and spinal mechanisms to the corticomotor response 
to acute muscle pain.  
1.5.3 Corticomotor adaptations in chronic pain 
1.5.3.1 Corticomotor excitability 
A variety of corticomotor adaptations have also been documented for chronic 
musculoskeletal pain, however, as this is a relatively new area of research, the range 
of conditions investigated, as well as data available, is limited.  Despite this, 
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preliminary evidence indicates that corticomotor excitability is altered in persons 
with chronic musculoskeletal pain originating from various anatomical regions and 
structures (Table 1.2). For example, compared to pain-free controls,  motor threshold 
is increased (indicative of decreased excitability) in painful muscles at the site of LBP 
(Strutton et al. 2005), the infraspinatus muscle in chronic shoulder pain (Bradnam et 
al. 2016) and in muscles of the hand and leg in persons with diffuse pain due to 
fibromyalgia (Salerno et al. 2000, Mhalla et al. 2010). A lack of change in spinal 
excitability in fibromyalgia (Salerno et al. 2000) indicates that this response may be 
of cortical origin, although this remains to be confirmed for other conditions. 
However, observations of increased motor threshold are directly contrasted by 
evidence of hyperexcitability (increased MEP amplitudes) in persons with chronic 
pain due to rotator cuff injury (Berth et al. 2009), osteoarthritis (Caumo et al. 2016), 
myofascial pain syndrome (Caumo et al. 2016), lateral epicondylalgia (Schabrun et al. 
2015b) and patellofemoral pain (On et al. 2004). Interestingly, numerous studies have 
failed to detect significant differences in motor threshold or corticomotor output 
between individuals with chronic musculoskeletal pain and pain free controls (Tsao 
et al. 2008, Schwenkreis et al. 2010, Schwenkreis et al. 2011, Masse-Alarie et al. 2012, 
Kittelson et al. 2014, Marker et al. 2014, Vidor et al. 2014, Masse-Alarie et al. 2016, 
Parker et al. 2017). However, as many chronic conditions have only been examined 
on a single occasion and in a sub-set of individuals with chronic pain (those with co-
morbidities or taking medications are usually excluded), it is difficult to draw 
definitive conclusions regarding the effect of chronic pain on corticomotor 
excitability. 
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The generalisability of these findings is also uncertain since the majority of data 
regarding corticomotor excitability in chronic musculoskeletal pain is drawn from 
investigations involving small cohorts of participants (Table 1.2). The main issue with 
small studies like these is that they are typically underpowered and thus predisposed 
to type I (false positive) and type II (false negative) errors (Button et al. 2013). Indeed, 
since the ability of a study to detect an association between a predictor/outcome 
variable is dependent upon the magnitude of association being investigated 
(Banerjee et al. 2009), it is quite possible that a lack of adequate power precluded 
the detection of subtle differences in corticomotor excitability between some 
patient/control groups (Tsao et al. 2008, Schwenkreis et al. 2010, Schwenkreis et al. 
2011, Masse-Alarie et al. 2012, Kittelson et al. 2014, Marker et al. 2014, Vidor et al. 
2014, Masse-Alarie et al. 2016, Parker et al. 2017). However, as few authors provide 
sample size calculations or effect size estimates in text, it remains unclear whether 
inadequate power contributed to these null observations. Furthermore, in the rare 
instance that such details are provided (Schabrun et al. 2015b, Parker et al. 2017), it 
is evident that sample sizes were based on effects described in other small (and 
potentially underpowered) studies (Schwenkreis et al. 2010, Tsao et al. 2011b). 
Although technically correct, this practice is less than ideal as it has to potential to 
lead to the generation of an unreliable body of literature (Button et al. 2013).  
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Table 1.2 Description of studies examining corticomotor excitability in chronic musculoskeletal pain 
STUDY (year) 
N 
(patient, control) 
CONDITION TARGET MUSCLE MEASURE 
 
RESULT 
(patient vs. control) 
Berth (2009) 10, 13 Chronic rotator cuff tear Deltoid 
CMO (rest) 
CMO (active) 
↑ 
↓ 
Berth (2010) 10, 11 Chronic rotator cuff tear FDI RMT ↓ 
Bradnam (2016) 8, 18 Shoulder pain Infraspinatus 
AMT 
CMO 
↑ 
• 
Caumo (2016) 
19, 14 
27, 14 
54, 14 
Fibromyalgia 
Osteoarthritis 
Myofascial pain 
FDI CMO 
↑ 
↑ 
↑ 
Kittelson (2014) 17, 20 Osteoarthritis VL RMT • 
 
Marker (2014) 9,8 Neck pain Trapezius 
RMT 
AMT 
CMO 
• 
• 
• 
Masse-alarie (2012) 13, 9 Low back pain TRA/IO 
AMT 
CMO 
• 
• 
Masse-Alarie (2016) 11, 13 Low back pain Multifidus 
AMT 
CMO 
• 
• 
Mhalla (2010) 46, 21 Fibromyalgia FDI 
RMT 
CMO 
↑ 
↓ 
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On (2004) 13, 13 Patellofemoral pain 
VMO, VL 
EDB 
CMO 
↑ 
• 
Parker (2017) 23, 20 Arthritis FDI 
RMT 
CMO 
• 
• 
Salerno (2000) 13, 13 Fibromyalgia FDI, TA 
RMT 
CMO 
↑ 
• 
Schabrun (2015) 11, 11 Lateral epicondylalgia ECRB, ED 
RMT 
CMO 
• 
↑ 
Schwenkreis (2010) 20, 14 Hand osteoarthritis FDI RMT • 
Schwenkreis (2011) 16, 23 Fibromyalgia Superficial flexor of forearm 
RMT 
CMO 
• 
• 
Strutton (2005) 24, 11 Low back pain LES 
AMT 
CMO 
↑ 
• 
Tsao (2008) 11, 11 Low back pain TrA 
RMT 
AMT 
• 
• 
Vidor (2014) 47, 11 Myofascial pain FDI CMO • 
 
Tabulated results refer to the hemisphere contralateral to the side of pain. RMT, resting motor threshold; AMT, active motor threshold; CMO, corticomotor output; ↓ 
decrease MT/CME; ↑ increase RMT/CME; • no difference RMT/CME; FDI, first dorsal interosseous; VL, vastus lateralis; TrA/IO, transverse abdominus/internal obliques; VM, 
vastus medialis oblique; EDB, extensor digitorum brevis; TA, tibialis anterior; ECRB, extensor carpi radialis brevis; ED, extensor digitorum; LES; longissimus erector spinae; TrA, 
transverse abdominus
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1.5.3.2 M1 organisation 
A small number of studies also provide evidence of cortical reorganisation in chronic 
musculoskeletal conditions (Tsao et al. 2008, Tsao et al. 2011b, Schabrun et al. 2015a, 
Schabrun et al. 2015b, Te et al. 2017). These studies used TMS mapping protocols to 
construct a visual representation of the excitability and organisation of neurons 
projecting to painful muscles and/or muscles within the vicinity of a painful joint 
(Wassermann et al. 1992). This technique, which involves recording the MEP over a 
range of scalp sites (Figure 1.4), is a common and reliable method of studying the 
topographical plasticity of M1 (Uy et al. 2002). 
Similar to observations of motor threshold and corticomotor output, the effect of 
chronic pain on map excitability varies between studies and muscles (Table 1.3). For 
example, map volume (the sum of the MEP amplitude at all map sites) is reduced for 
deep paraspinal muscles in LBP  (Tsao et al. 2011b) and quadriceps muscles in 
patellofemoral pain (indicative of decreased excitability) (Te et al. 2017), but 
increased for wrist extensor muscles in lateral epicondylalgia (increased excitability) 
and deep abdominal muscles in LBP (Tsao et al. 2008), compared to pain free controls 
(Schabrun et al. 2015b). There is also evidence of both reduced and unchanged map 
volume for superficial paraspinal muscles, however these discrepancies may be 
attributable to methodological differences between studies (surface vs. fine wire 
EMG) (Tsao et al. 2011b, Schabrun et al. 2015a). Taken together, data for map volume 
in chronic musculoskeletal conditions imply a differential effect of pain on superficial 
and deep musculature of the trunk, and opposing effects in muscles of the upper and 
lower limb. However, as these data are derived from small cohorts of participants, 
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further work is needed to confirm these findings. It is also important to note that 
changes in map volume, although informative, are not necessarily evidence of M1 
reorganisation. Instead, reorganisation can be inferred based on variations in the 
amplitude weighted centre of the map, or centre of gravity (CoG). As CoG is located 
close to the motor hotspot of the target muscle (Wilson et al. 1993, Thickbroom et 
al. 1998), changes in its location are interpreted to reflect reorganisation of the 
spatial territory and location of the most excitable projections corresponding to a 
given muscle. 
Figure 1.4 Mapping the excitability and topography of M1 with TMS. Single pulse TMS 
can be used to construct a representation of the excitability and organisation of 
neurons that project to a target muscle. TMS is delivered to each site on a grid 
orientated to the vertex (Cz) with the target muscle at rest or during low-level 
contraction (left). The average amplitude of MEPs evoked at each site is used to create 
a map of the cortical representation of the target muscle. The example provided here 
was constructed from MEP responses recorded from the left vastus medialis oblique 
muscle of a healthy individual. Starting at the vertex, five magnetic stimuli were 
delivered at 1cm intervals on a 6 x 7cm grid with the aid of a neuronavigation 
instrument. Stimuli were applied at 100% TMS output at 6s intervals during low-level 
volitional contraction. Note: This map is generated from data that has been 
normalised to maximal MEP amplitude (1mV). Colour scale denotes increments of 
0.02mV. 
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In contrast to map excitability changes, observations of CoG in chronic 
musculoskeletal pain conditions are remarkably similar. For example, both 
individuals with LBP and patellofemoral pain demonstrate significant relocation of 
the CoG compared to pain-free controls (Tsao et al. 2008, Tsao et al. 2011b, Schabrun 
et al. 2015a, Te et al. 2017). Although the direction of change differed in studies of 
LBP (posterior-lateral shift vs. anterior shift), it is possible that this variability may be 
due to differences in the spatial resolution of fine wire and surface recordings (Tsao 
et al. 2011b, Schabrun et al. 2015a). A reduction in the distance between CoGs of 
muscles at the site of pain was also consistent across conditions (Tsao et al. 2011b, 
Schabrun et al. 2015b, Te et al. 2017). Reduced CoG distance between discrete 
muscles suggest that their cortical territories exhibit disproportionate overlap. This 
may indicate that there are fewer discrete corticospinal projections and a greater 
sharing of neural resources between the muscles investigated. Although it has been 
hypothesised that such changes have the potential to negatively impact coordination 
and independent muscle control (Schabrun et al. 2007, Schabrun et al. 2015b), the 
mechanisms underpinning M1 reorganisation remain unclear.  
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Table 1.3 Description of studies examining the excitability and topography of M1 in chronic musculoskeletal pain 
Tabulated results refer to the hemisphere contralateral to the side of pain. COG, centre of gravity; ↓ decrease volume/COG; ↑ increase volume/COG; • no difference 
volume/COG; NR, not reported; NA, not assessed; VL, vastus lateralis; TrA, transverse abdominus; VM, vastus medialis; ED, extensor digitorum; ECRB, extensor carpi radialis 
brevis; LES; longissimus erector spinae; RF, rectus femoris
STUDY 
(year) 
N 
(patient, control) 
CONDITION 
 
TARGET MUSCLE(s) 
 
MAP VOLUME 
(patient vs. control) 
COG LOCATION 
(patient vs. control) 
 
COG DISTANCE BETWEEN MUSCLES 
(patient vs. control) 
 
Schabrun (2015) 11, 11 Lateral epicondylalgia 
ECRB 
ED 
↑ 
↑ 
• 
• 
↓ 
Schabrun (2015) 27, 23 Low back pain 
Paraspinal at L3 
Paraspinal at L5 
• 
• 
Anterior 
Anterior 
NR 
Te (2017) 11, 11 Patellofemoral pain 
RF 
VL 
VM 
↓ 
↓ 
↓ 
Anterior 
Anterior 
Anterior 
↓ 
↓ 
↓ 
Tsao (2008) 11, 11 Low back pain TrA ↑ 
Posterior and 
lateral 
NA 
Tsao (2011) 9, 11 Low back pain 
Multifidus 
LES 
↓ 
↓ 
• 
Posterior 
↓ 
↓ 
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1.6 Could intracortical inhibition underpin observations of altered corticomotor 
excitability and M1 reorganisation in muscle pain? 
The anatomical arrangement and functional properties of inhibitory interneurons 
place them in a prime position to influence, if not drive, the corticomotor response 
to pain. Indeed, it is estimated that pyramidal neurons receive inputs from 
approximately 70 inhibitory interneurons, each of which may form as many as 30 
synaptic connections. As these synapses are usually distributed across multiple sites, 
inhibitory cells can modulate crucial neural functions such as the generation, timing, 
propagation and discharge of action potentials, as well as functions related to 
synaptic plasticity such as dendritic processing and the integration of other synaptic 
inputs (see Markram et al. 2004 for review). Thus, it is somewhat surprising that few 
studies have examined the effect of muscle pain on cortical inhibition specifically. 
Indeed, despite the availability of several validated methods for assessing 
intracortical activity, there have been less than a dozen investigations of cortical 
inhibition in chronic pain and only a single study in acute pain (Salerno et al. 2000, 
Mhalla et al. 2010, Schwenkreis et al. 2010, Schwenkreis et al. 2011, Masse-Alarie et 
al. 2012, Schabrun et al. 2012, Kittelson et al. 2014, Marker et al. 2014, Bradnam et 
al. 2016, Caumo et al. 2016, Masse-Alarie et al. 2016, Parker et al. 2017).  Fortunately, 
each of these studies examined intracortical activity via TMS, thus permitting direct 
comparisons between studies and conditions.   
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1.6.1 Short interval intracortical inhibition  
The majority of investigations of intracortical activity in musculoskeletal pain report 
an index of GABAergic inhibition known as short interval intracortical inhibition (SICI). 
This form of inhibition is evoked following the delivery of two TMS pulses through the 
same stimulating coil, 1-5ms apart (Kujirai et al. 1993). If the conditioning (first) pulse 
is of subthreshold intensity, inhibition of the MEP generated by the test (second) 
pulse is observed (Figure 1.5). This inhibition (SICI) is expressed as a percentage, 
calculated by dividing the MEP amplitude of the conditioned-test pulse by the MEP 
amplitude of the test pulse alone. 
 
 
Figure 1.5 Short interval intracortical inhibition recorded from the resting extensor 
carpi radials brevis muscle of a healthy individual. SICI is calculated by comparing the 
MEP amplitude following single pulse TMS (A) with the MEP amplitude following 
paired pulse TMS (B). This example is the outcome of 12 trials recorded in random 
order at an inter-stimulus interval of 2ms (B) and for the test stimulus alone (A; rate 
of 1 every 6s, total of 24 trials). Test intensity (black arrows) was set to produce a 
0.5mV MEP and conditioning intensity was set at 90% active motor threshold (AMT; 
grey arrow). Under these conditions, this individual demonstrated 51% SICI (≥100% 
represents no inhibition). 
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Direct cervical epidural recordings of descending corticospinal activity confirm the 
cortical origin of SICI by demonstrating that the conditioned-test pulse evokes 
efferent volleys of a latency consistent with indirect (interneuronal) activation of M1 
neurons (Di Lazzaro et al. 1998c). Pharmacological evidence indicates this measure 
reflects GABAergic activity mediated by type A receptors (α2 and α3 subtypes), as 
SICI is increased by drug formulations which enhance GABA neurotransmission 
through these channels (Ziemann et al. 1996a, Di Lazzaro et al. 2000a, Ilic et al. 2002, 
Di Lazzaro et al. 2005c, Di Lazzaro et al. 2006a, Di Lazzaro et al. 2007a, Florian et al. 
2008, Teo et al. 2009). Based on this receptor profile, it likely that SICI reflects post-
synaptic activity of inhibitory interneurons at the somatic and/or dendritic 
membrane of pyramidal cells  (Markram et al. 2004).  
1.6.1.2 Short interval intracortical inhibition and musculoskeletal pain 
The results of a recent systematic review and meta-analysis suggest that cortical 
inhibition is unaffected by musculoskeletal pain as pooled analyses failed to identify 
a statistically significant effect size for SICI measures in several chronic pain 
conditions (Parker et al. 2016). This result is most likely an accurate representation 
of these data, as only one of the five studies reviewed reported significant differences 
between patients and controls (Mhalla et al. 2010). However, it could be argued that 
the conclusion from the systematic review does not truly reflect the state of cortical 
inhibition in chronic pain as an additional five studies, either not identified, excluded 
or published since Parker et al. (2016), demonstrate significant differences between 
patients and controls (Table 1.4). These studies provide consistent evidence of 
reduced SICI (cortical disinhibition) in fibromyalgia (Schwenkreis et al. 2011, Caumo 
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et al. 2016), chronic LBP (Masse-Alarie et al. 2012, Masse-Alarie et al. 2016) and 
arthritis (Caumo et al. 2016, Parker et al. 2017), as well as preliminary evidence of 
reduced SICI in myofascial pain syndrome (Caumo et al. 2016). These observations 
suggest that cortical inhibition is reduced (disinhibition) in chronic pain, and that this 
effect is the same regardless of the body region or tissue affected.  In contrast, 
evidence suggests cortical inhibition is increased by acute pain. In a study by Schabrun 
et al. (2012), an increase in SICI was observed immediately following the resolution 
of pain due to intramuscular infusion of hypertonic saline. However, as this effect was 
only present post intervention, a linear relationship between SICI and pain severity in 
this study appears unlikely. A significant correlation between SICI and pain severity 
has also yet to be identified in studies of chronic pain, thus it is possible that this non-
linearity exists regardless of the direction of change in SICI or duration of symptoms 
(acute vs. chronic).  Furthermore, since the change in SICI does not follow the 
temporal profile of MEP depression in acute pain (Schabrun et al. 2012), and 
reductions in SICI are rarely accompanied by increased corticomotor excitability in 
chronic pain (Caumo et al. 2016), the relationship between SICI and corticomotor 
adaptations to muscle pain may also be non-linear in nature.
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Table 1.4 Description of studies examining SICI in chronic musculoskeletal pain 
STUDY  
(year) 
N 
(patient, control) 
CONDITION TARGET MUSCLE CS INTENSITY TS INTENSITY ISI (ms) SICI 
(patient vs. control) 
Caumo (2016) 
19, 14 
27, 14 
54, 14 
Fibromyalgia 
Osteoarthritis 
Myofascial pain 
FDI 80% RMT 130% RMT 2 
↓ 
↓ 
↓ 
Kittelson (2014) 17, 20 Osteoarthritis VL 80% RMT 120% RMT 3 • 
Marker (2014) 9, 8 Neck pain Trapezius 70% AMT 120% AMT 2.5 • 
Masse-Alarie (2012) 10, 9 Low back pain TrA/IO 70% AMT 120% AMT 2 ↓ 
Masse-Alarie (2016) 8, 8 Low back pain Multifidus 70% AMT 0.1mV MEP 2 ↓ 
Mhalla (2010) 46, 21 Fibromyalgia FDI 80% RMT 120% RMT 2, 4 ↓ 
Parker (2017) 23, 20 Arthritis FDI 70%, 80%* AMT 1mV MEP 2   ↓* 
Salerno (2000) 13, 13 Fibromyalgia FDI, TA 80% RMT 150% RMT 4 • 
Schwenkreis (2010) 20, 14 Osteoarthritis FDI 80% RMT 1mV MEP 2, 4 • 
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Schwenkreis (2011) 16, 23 Fibromyalgia 
Superficial flexor of 
forearm 
80% RMT 0.5mV MEP 2, 4 ↓ 
CS, conditioning stimulus; TS, test stimulus; ISI, inter stimulus interval; FDI, first dorsal interosseous; TA, tibialis anterior; RMT, resting motor threshold; AMT, active motor 
threshold, MEP, motor evoked potential; TrA/IO, transverse abdominus/internal obliques; VL, vastus lateralis; ↓ decrease SICI; • no difference SICI
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Different SICI responses in the acute and chronic stages of pain may reflect 
fundamental differences in motor strategy at these times (Schabrun et al. 2016). In 
the acute phase, increased cortical inhibition may reduce excitatory drive to muscles 
and restrict movement, while chronic disinhibition may support cortical 
reorganisation and the development of (mal)adaptive motor strategies that facilitate 
movement (Hodges et al. 2011, Schabrun et al. 2012). Although the precise 
relationship between the corticomotor and SICI response to pain has yet to be 
determined, it has been hypothesised that altered SICI may contribute to 
neuroplastic change in chronic pain (Schabrun et al. 2015b). For example, since a key 
function of cortical inhibition is the maintenance of cortical representations (Liepert 
et al. 1998a), reduced SICI in paraspinal and abdominal muscles in LBP (Masse-Alarie 
et al. 2012, Masse-Alarie et al. 2016) could plausibly underpin observations of 
posterior-lateral or anterior shifts in the motor maps of these muscles (Tsao et al. 
2008, Tsao et al. 2011b, Schabrun et al. 2015a). Differential effects for SICI also 
indicate an important role for intracortical inhibition in the transition from acute to 
chronic pain. Indeed, although SICI is increased immediately following an episode of 
acute pain (Schabrun et al. 2012), a shift towards cortical disinhibition (reduced SICI) 
has been demonstrated to occur as early as four days into a study of progressively 
developing muscle pain (Schabrun et al. 2016). While the authors of that study 
speculate that this may reflect the transition from a restrictive to adaptive motor 
strategy (Schabrun et al. 2016), the trigger for this change and the cause of its 
persistence in chronic conditions remains unclear. 
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1.6.2 Other forms of cortical inhibition in musculoskeletal pain 
Two other forms of TMS-evoked cortical inhibition have been investigated in 
musculoskeletal pain. Although these measures are thought to represent distinct and 
competitive inhibitory circuits to those mediating SICI, early data suggests that these 
inhibitions are similarly affected by chronic pain.  
1.6.2.1 Long interval intracortical inhibition 
Long interval intracortical inhibition (LICI) is an alternate measure of GABAergic 
inhibition evoked by paired pulse TMS.  In contrast to SICI, which reflects short-lasting 
inhibition evoked by subthreshold conditioning stimulation, LICI reflects the 
induction of slow inhibitory postsynaptic potentials by identical suprathreshold 
stimuli delivered 50-250ms apart (Claus et al. 1992, Valls-Sole et al. 1992). Similar to 
SICI, LICI is expressed as a percentage, calculated by dividing the MEP amplitude of 
the conditioned-test pulse by the MEP amplitude of the test pulse alone (Figure 1.6).  
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The range of intervals over which LICI can be evoked suggests that this measure may 
reflect long lasting GABAB mediated cortical inhibition (Werhahn et al. 1999, Sanger 
et al. 2001). This origin is supported by neuropharmacological evidence of enhanced 
LICI in the presence of the GABAB receptor agonist drug baclofen (McDonnell et al. 
2006) and direct cervical epidural recordings of descending corticospinal activity 
(Nakamura et al. 1997, Di Lazzaro et al. 2002a). However, since both LICI and 
cervicomedullary evoked potential amplitude are decreased during volitional 
contraction (McNeil et al. 2009, 2011), a potential spinal contribution cannot be ruled 
out. As these interactions have thus far only been documented at LICI(100ms), and two 
distinct phases of inhibition have been demonstrated at 100ms and 150ms (Chu et 
Figure 1.6 Long interval intracortical inhibition recorded from the resting extensor 
carpi radials brevis muscle of a healthy individual. LICI is calculated by comparing the 
MEP amplitude following single pulse TMS (A) with the MEP amplitude following 
paired pulse TMS (B, * denotes the conditioned MEP). This example is the outcome of 
12 trials recorded in random order at an inter-stimulus interval of 160ms (B) and for 
the test stimulus alone (A; rate of 1 every 6s, total of 24 trials). Test intensity (black 
arrows) and conditioning intensity (grey arrow) were both set to produce a 0.5mV 
MEP. Under these conditions, this individual demonstrated 59% LICI (≥100% 
represents no inhibition). 
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al. 2008, Vallence et al. 2012, Vallence et al. 2014), this contribution, particularly at 
later inter-stimulus intervals, requires further investigation. 
Current knowledge of the effect of musculoskeletal pain on LICI is derived from two 
studies performed in clinical pain populations. The first, provides evidence of reduced 
LICI in persons with fibromyalgia (Salerno et al. 2000), while the second reports no 
difference between arthritic individuals and pain-free controls (Parker et al. 2017). 
Aside from obvious differences in pain populations, these discrepancies may be 
explained by differences in methodology since LICI in the first instance was 
investigated at 155/200ms and the second, 99ms. Thus, as discussed above, it is 
possible that these studies examined distinct GABAergic processes. As it is 
hypothesised that LICI(100ms) reflects presynaptic GABAB mediated inhibition, while 
LICI(150ms) reflects post synaptic GABAB mediated inhibition (Chu et al. 2008), these 
preliminary findings suggest that chronic musculoskeletal pain may specifically affect 
GABAB mediated inhibition occurring at the post-synaptic terminal. 
1.6.2.2 Short latency afferent inhibition 
The final form of cortical inhibition investigated in chronic musculoskeletal pain thus 
far is short latency afferent inhibition (SAI). In contrast to other forms of TMS evoked 
inhibition, evocation of afferent inhibition requires a multimodal condition-test 
technique. Although the test stimulus for afferent inhibition is identical to that 
evoking SICI/LICI (suprathreshold TMS pulse at M1), the conditioning stimulus 
typically involves transcutaneous electrical stimulation of a peripheral nerve at the 
wrist (median or ulnar) (Tokimura et al. 2000). Two time dependent phases of 
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inhibition have been described using this method, the first 20ms (SAI), and the second 
200ms (long latency afferent inhibition, LAI), post conditioning stimulus. Although the 
exact pathways travelled by the afferent volley prior to reaching M1 are still being 
elucidated, there is good evidence to suggest that MEP suppression resulting from 
this protocol is of cortical origin as direct epidural recordings demonstrate a 
reduction in the magnitude and number of descending corticospinal volleys to TMS 
following peripheral nerve conditioning stimulation (Tokimura et al. 2000). As is the 
case for other TMS evoked inhibitions, it is standard practice to describe SAI as a 
percentage, calculated by dividing the MEP amplitude of the conditioned-test pulse 
by the MEP amplitude of the test pulse alone (Figure 1.7).  
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Short latency afferent inhibition is thought to be mediated by acetylcholine (ACh) as 
it is reduced in patients with degeneration of the central cholinergic system (Di 
Lazzaro et al. 2002c, Di Lazzaro et al. 2005a). Pharmaco-TMS studies support this 
hypothesis as SAI is reduced by ACh antagonists (Di Lazzaro et al. 2000b), but 
increased by neuroactive drugs that enhance cholinergic neurotransmission (Di 
Lazzaro et al. 2005a). However, there is also pharmacological evidence to indicate 
that this measure is sensitive to GABAAergic neurotransmission (Di Lazzaro et al. 
2005c). This observation is corroborated by findings of triple pulse TMS studies which 
Figure 1.7 Afferent inhibition recorded from the resting first dorsal interosseous 
muscle of a healthy individual. Afferent inhibition is calculated by comparing the MEP 
amplitude following single pulse TMS (A) with the MEP amplitude following peripheral 
nerve stimulation (B, C; * denotes the conditioned MEP). This example is the outcome 
of 12 trials recorded in random order at an inter-stimulus interval of 20ms (SAI; B), 
200ms (LAI; C) and for the test stimulus alone (A; rate of 1 every 6s, total of 36 trials). 
Test intensity (black arrows) was set to produce a 1mV MEP. Conditioning stimulation 
consisted of an electrical pulse (ES, grey arrow) delivered to the ulnar nerve at an 
intensity sufficient to elicit a visible muscle contraction. Under these conditions, this 
individual demonstrated 44% SAI and 33% LAI (≥100% represents no inhibition). 
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demonstrate mutual inhibition between SAI and SICI (GABAA mediated) when one 
mechanism is activated in the presence of the other (Alle et al. 2009). 
Thus far, SAI has only been examined in a small number of individuals with chronic 
shoulder pain (n = 8), where it was reported to be reduced in the infraspinatus 
muscle, compared to pain free controls (Bradnam et al. 2016). Not only is this the 
first example of altered SAI in chronic pain, but it is also one of the first descriptions 
of SAI in a proximal upper limb muscle. However, as these data are derived from a 
small sample of convenience, the reliability and generalisability of these observations 
is unclear. A degree of uncertainty also surrounds these findings since the 
methodology and manifestation of SAI in the upper limb differs to that described for 
the hand (Hendy et al. 2014). For example, since all previous investigations of SAI 
have focused on the effect of somatosensory input on the hand motor cortex, it is 
unclear whether the afferent volley from suprascapular nerve stimulation 
(conditioning stimulus for infraspinatus) traverses the same pathways and engages 
the same neural processes (Tokimura et al. 2000, Tsang et al. 2014). Even if 
confirmed, it remains possible that these findings could be partially spinally 
mediated, since data were recorded from preactivated infraspinatus and muscle 
contraction attenuates hand SAI via both cortical and spinal mechanisms (Asmussen 
et al. 2014). Furthermore, in addition to observing SAI at 20ms inter-stimulus 
intervals, Bradnam et al. (2016) also reported evidence of MEP inhibition at 30 and 
40ms in all participants. This is in direct contrast to what is known to occur in the 
hand, as SAI is typically absent or replaced with MEP facilitation at these intervals 
(Tokimura et al. 2000, Fischer et al. 2011).  
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Reduced SAI in painful infraspinatus may be interpreted several ways. For example, 
as SAI is linked to cholinergic neurotransmission (Di Lazzaro et al. 2000b), it is possible 
that this change reflects impaired cholinergic modulation in this condition.  
Alternatively, as this measure is thought to reflect the effect of sensory input on the 
excitability of M1, reduced SAI may signal a deficiency in processes related to 
sensorimotor integration. Possible contributors to this deficiency include reduced 
activity of interneurons providing direct connections between S1 and M1, and/or 
increased activity of GABAergic interneurons (as SAI is sensitive to GABA) (Udupa et 
al. 2009, Tsang et al. 2014, Udupa et al. 2014).  However, as both M1 and S1 
excitability is reduced by musculoskeletal pain (Schabrun et al. 2013), the exact 
source of this deficit remains unclear.  
1.7 Study rationale 
The studies presented in this introduction, provide initial evidence of altered cortical 
inhibition in acute and chronic musculoskeletal pain.  While pain duration appears to 
be a key determinant of the intracortical response to pain (inhibition is increased in 
acute pain, but decreased in chronic pain), our understanding of these changes is 
restricted to the conditions and mechanisms investigated in these studies. Thus, the 
overarching aim of this thesis was to develop our understanding of the intracortical 
response to musculoskeletal pain by expanding on the conditions and/or mechanisms 
already described in the literature. This aim was achieved by four studies that each 
addressed a key knowledge gap outlined in the introduction. 
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1.7.1 Study 1 
The aim of study 1 (Chapter 2) was to investigate the variable nature of the 
corticomotor response to acute musculoskeletal pain (section 1.5.2). This was 
achieved via a systematic review and meta-analysis of TMS studies examining the 
effect of experimental-induced acute muscle pain on the excitability of the primary 
motor cortex (M1). Somatosensory afference (e.g. nociceptive input) is likely to 
influence M1 via the primary somatosensory cortex (S1), thus, the excitability of this 
brain region was also included. As the hemodynamic and metabolic properties of 
M1/S1 during acute muscle pain are also discussed in this review, this chapter 
provides the first comprehensive summary of the M1/S1 response to acute muscle 
pain.  
1.7.2 Study 2 
As outlined in section 1.6, research regarding the effect of acute muscle pain on 
intracortical mechanisms is lacking. Subsequently, it remains unclear which 
mechanisms, if any, underpin the corticomotor response to acute pain. Thus, the aim 
of study 2 (Chapter 3) was to expand on this research by investigating three measures 
of cortical inhibition previously unexamined in acute musculoskeletal pain; LICI, SAI 
and LAI. The hypertonic saline model of acute pain was selected for this study in order 
to control the location, intensity and duration of pain throughout the experimental 
procedure. As the painful effects of saline are immediate, but quickly resolving, this 
selection enabled the timely completion of data collection, thus limiting the potential 
influence of patient fatigue/attention on neurophysiological outcomes. Additional 
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recommendations outlined by the TMS methodological checklist were also observed 
in order to easily facilitate comparison of these findings in future studies. 
1.7.3 Study 3 
Although altered cortical inhibition is a likely candidate underpinning M1 
reorganisation and motor dysfunction in chronic musculoskeletal pain, our 
understanding of cortical inhibition in conditions displaying these traits is derived 
entirely from studies conducted in LBP. Thus, the aim of study 3 (Chapter 4) was to 
provide further evidence for this hypothesis by examining intracortical mechanisms 
in lateral epicondylalgia (LE). This condition was selected for study as, similar to LBP, 
persons with LE demonstrate significant reorganisation of the motor representation 
of painful muscles, compared to pain-free controls (Table 1.3). In this study, paired-
pulse TMS was used to investigate SICI and LICI in persons with and without LE. An 
additional measure known as intracortical facilitation (ICF) was also included for 
investigation as preliminary data suggest that the activity of glutamatergic 
(excitatory) interneurons may also be affected by musculoskeletal pain (Schabrun et 
al. 2012). In order to minimize the impact of external and internal confounders on 
these findings and to account for the lack of baseline data from patients, each LE 
participant was subject to strict inclusion/exclusion criteria and was age and sex 
matched to a pain-free control participant. 
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1.7.4 Study 4 
With evidence pointing towards reduced intracortical inhibition in chronic pain 
(section 1.6), it is surprising that there has yet to be a discrete investigation of cortical 
disinhibition in chronic musculoskeletal pain. Thus, the objective of study 4 (Chapter 
5) was to examine a single pulse TMS measure known as post-silent period 
electromyographic bursting (EMG bursting) in persons with and without chronic LBP. 
The latency and duration of EMG bursting in the hand, as well as its affiliation with 
LICI and the cortical silent period (both GABAB mediated), suggests that this 
phenomena may be a measure of the depth and magnitude of disinhibition in M1 
due to the action of pre-synaptic GABAB receptors (Chin et al. 2012). As EMG bursting 
is a relatively new measure of cortical inhibition, the first aim of this study was to 
confirm the presence of this phenomena in the low back muscles of pain free 
individuals. The temporal and spatial characteristics of EMG bursting throughout the 
motor representation of the paraspinal muscles of these individuals were then 
compared with those of individuals with LBP (aim 2). 
 
In the following chapters (Chapter 2 to 5) each study is discussed in detail. Following 
this, the findings from the four studies are synthesized to provide an overarching 
theory on the role of cortical inhibition in musculoskeletal pain (Chapter 6).  
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Chapter 2: 
Primary sensory and motor cortex function in 
response to acute muscle pain: a systematic 
review and meta-analysis 
 
As discussed in detail in Chapter 1, there is increasing evidence to suggest that acute 
muscle pain affects the excitability and output of M1. The aim of this chapter is to 
systematically review and meta-analyse these data to determine the direction, 
strength and temporal profile of the cortical response to experimental pain.  The 
content of this chapter has been published in Burns E, Chipchase LS, Schabrun SM 
(2016). Primary sensory and motor cortex function in response to acute muscle pain: 
A systematic review and meta-analysis. European Journal of Pain. 20(8): 1203-13. A 
copy of this publication is provided in Appendix A.
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2.1 Abstract  
Acute muscle pain has both motor and sensory consequences, yet the effect of 
muscle pain on the primary sensory (S1) and motor cortices (M1) has yet to be 
systematically evaluated. Here we aimed to determine the strength of the evidence 
for (1) altered activation of S1/M1 during and after pain, (2) the temporal profile of 
any change in activation and (3) the relationship between S1/M1 activity and the 
symptoms of pain. In September 2015, five electronic databases were systematically 
searched for neuroimaging and electrophysiological studies investigating the effect 
of acute experimental muscle pain on S1/M1 in healthy volunteers. Demographic 
data, methodological characteristics and primary outcomes for each study were 
extracted for critical appraisal. Meta-analyses were performed where appropriate. 
Twenty-five studies satisfied the inclusion criteria. There was consistent evidence 
from fMRI for increased S1 activation in the contralateral hemisphere during pain, 
but insufficient evidence to determine the effect at M1. Meta-analyses of TMS and 
EEG data revealed moderate to strong evidence of reduced S1 and corticomotor 
excitability during and following the resolution of muscle pain. A comprehensive 
understanding of the temporal profile of altered activity in S1/M1, and the 
relationship to symptoms of pain, is hampered by differences in methodological 
design, pain modality and pain severity between studies. Overall, the findings of this 
review indicate reduced S1 and corticomotor activity during and after resolution of 
acute muscle pain, mechanisms that could plausibly underpin altered sensorimotor 
function in pain. 
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2.2 Introduction 
It is well accepted that acute muscle pain alters sensory and motor function. Yet, the 
mechanisms that underpin these changes are poorly understood. Current theories on 
sensorimotor adaptation in pain hypothesize that the primary sensory (S1) and motor 
(M1) cortex contribute to altered sensorimotor function. For instance, reduced S1 
activity is hypothesized to underpin reduced kinaesthesia and position sense (Rossi 
et al. 2003), whereas reduced M1 activity is hypothesised to underpin restriction of 
motor output and afford protection from further pain and injury (Hodges et al. 2011). 
Numerous studies using a range of methodological tools, including positron emission 
tomography (PET), functional magnetic resonance imaging (fMRI), transcranial 
magnetic stimulation (TMS) and electroencephalography (EEG), have investigated 
how and when S1 and M1 activity are altered in response to acute muscle pain 
(Svensson et al. 1997c, Niddam et al. 2002, Schabrun et al. 2013). These studies use 
similar in vivo experimental pain models to induce short-lasting muscle pain that is of 
a clinical quality (deep, constant, dull or a sharp ache) which allow collection of pre-
pain baseline data that cannot be obtained in clinical pain populations (Graven-
Nielsen et al. 1997c). However, despite similarities in pain models and brain regions 
under investigation, there has been no systemic evaluation of S1 or M1 data in acute 
muscle pain. Integration of data obtained from studies using different methodologies 
is essential to drive a comprehensive understanding of the nature and time-course of 
altered S1 and M1 activity in response to acute muscle pain and to elucidate the 
relationship between S1/M1 and the symptoms of pain. 
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Here, we synthesised and critically evaluated data corresponding to activity in S1 and 
M1 cortical regions in order to: (1) examine S1/M1 activation in response to acute 
muscle pain, (2) quantify the direction and temporal profile of change and (3) 
determine the evidence for a relationship between altered S1/ M1 activity and 
symptoms of pain. 
2.3 Literature Search Methods 
2.3.1 Search strategy  
In line with the methodology outlined by the Cochrane Handbook for Systematic 
Reviews of Interventions, the initial search strategy involved examination of major 
biomedical science databases EMBASE and MEDLINE (Higgins et al. 2011). Pubmed, 
Scopus and Web of Science were also examined to ensure comprehensive coverage 
of the literature and minimize selection bias (5 electronic databases in total). 
Together, these databases are a valuable source of both publisher controlled- and 
grey literature (such as conference proceedings). Relevant studies were identified 
using MeSH terms and free text terms including motor cortex, somatosensory cortex, 
muscle pain, acute pain, and experimental pain. The most recent search was 
performed in September 2015. Studies were first screened for relevance by title and 
abstract before analysis of full text. Inclusion was dependent upon the following 
criteria: (1) English language, (2) original, primary research, (3) healthy adult human 
subjects, (4) acute experimental pain was induced in a muscle, (5) acute muscle pain 
was induced in the absence of another stimulation or intervention, and (6) outcome 
measures included full brain image analysis of regional cerebral blood flow (rCBF; 
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measured using PET or fMRI) or blood-oxygen-level dependent contrast imaging 
(BOLD; measured using fMRI), corticomotor excitability (motor evoked potentials; 
measured using TMS) and/or sensory cortex excitability (somatosensory evoked 
potentials; measured using EEG). To ensure the reliability of the process for 
inclusion/exclusion of studies, 10 abstracts were selected at random and 
independently reviewed by three assessors.  
2.3.2 Data extraction and assessment of methodological quality 
A standard form was used to extract subject demographics, methodological 
parameters (techniques, outcome measures) and pain characteristics (modality, 
location, intensity) for each study. Additional technical information specific to EEG 
(electrode orientation, conditioning location and intensity) and TMS (target muscle, 
muscles state, TMS intensity, coil type and position) methodologies was also 
recorded. Primary outcome measures included MEP amplitude/area to single and/or 
paired-pulse TMS, the amplitude/area of SEP components/complexes corresponding 
to S1 activation/processing and the direction of change (increase or decrease) in rCBF 
or BOLD-contrast.  
Methodological quality was appraised using a modified version of the Downs and 
Black’s checklist (Downs et al. 1998) (Appendix A.1). A maximum score of 17 points 
were awarded based on reporting within the text and external and internal validity. 
Studies involving TMS were further appraised using the TMS methodological checklist 
(Chipchase et al. 2012). The maximum score for reported and controlled items was 
26 or 30 points, depending on methodology (single or paired-pulse TMS). The 
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summed score for reported items (r) as a percentage of the maximum score [r/(26 or 
30) x 100] to provide an indication of adherence to the checklist. The summed score 
for controlled items (c) was expressed as a percentage of reported items [(c/r) x 100] 
to determine the extent to which reported items were controlled. 
2.3.4 Meta-analyses 
Meta-analyses were performed on MEP and SEP data but not for rCBF or BOLD-
contrast due to the heterogeneity of the analysis approaches used between studies 
and inconsistent reporting of non-significant findings. Mean ± standard deviation for 
MEP and SEP amplitude/area were extracted at time points ‘baseline’, ‘during pain’ 
and ‘post pain’, where available. When data was not reported within the text, an 
email was sent to the corresponding author to request missing values. If authors were 
no longer contactable, did not respond, or declined requests for data, means ± 
standard deviation/standard error were estimated by handfrom illustrations or 
calculated from available t values, p values or F statistics. Standardized mean 
differences (SMD) and 95% confidence intervals were calculated using a random-
effects model in RevMan 5.2 (Copenhagen: The Nordic Cochrane Centre, The 
Cochrane Collaboration, 2012) and heterogeneity determined using calculations of 
I2.  Effect estimates ≤ 0.2 were considered small, 0.5 moderate and ≥ 0.8 large. 
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2.4. Results 
2.4.1 Search results 
The search strategy retrieved 257 studies, minus duplicates (Figure 2.1). Screening of 
title and abstract and evaluation of full text identified 20 suitable studies. 
Examination of reference lists revealed an additional five studies, thus, a total of 25 
studies were included in the systematic review. 
  
 Figure 2.1 Search strategy flow diagram. 
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2.4.2. Study characteristics 
Of the 25 included studies, four examined rCBF with PET (participants, n = 56), two 
examined rCBF with fMRI (n = 32), eight examined BOLD responses with fMRI (n = 
147), eight examined corticomotor excitability (MEPs) with TMS (n = 80) and three 
examined sensory cortex excitability (SEPs) with EEG (n = 25). One study reported on 
both corticomotor and sensory cortex excitability (Schabrun et al. 2013). Hypertonic 
saline was the most common method of inducing experimental muscle pain (n = 17) 
and most studies (n = 13) induced pain into muscles of the upper extremity (hand, 
forearm or arm). Other sites included muscles of the leg (studies, n = 7), jaw (n = 4), 
neck (n = 1) and low back (n = 1). Demographic information and pain characteristics 
of included studies are presented in Table 2.1.
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Table 2.1 Characteristics of included studies (n = 25). Pain is described as mild, moderate, severe based on reported pain score (mild: < 3.0, 
moderate: 3.0 - 5.4, severe: > 5.4). 
 DEMOGRAPHICS 
                          
METHODOLOGY PAIN CHARACTERISTICS METHODOLOGICAL QUALITY 
STUDY 
(year) 
N 
male, 
female 
Age (years, 
mean ± SD) 
Technique 
Outcome 
measures 
Model Location Intensity 
Downs 
and 
Black 
Checklist 
/17 
TMS 
Checklist 
Reported 
% 
TMS 
Checklist 
Controlled 
% 
Kupers 
(2004) 
10 6,4 21-25 
(range) 
PET rCBF, 
15O 
labelled water 
hypertonic 
saline 
masseter severe p 14 - - 
Svensson 
(1997) 
11 11, 0 30.4 ± 3.5 PET rCBF, 
15O 
labelled water 
electrical 
stimulation 
brachioradialis mild p 14 - - 
Thunberg 
(2005) 
19 19, 0 26.7 ± 7.6 PET rCBF, 
15O 
labelled water 
hypertonic 
saline 
erector spinae at L3 moderate p 14 - - 
Korotkov 
(2002) 
16 16, 0 24.3 ± 7.7 PET rCBF, 
15O 
labelled water 
hypertonic 
saline 
triceps brachii moderate a 13 - - 
Owen 
(2010) 
13 13, 0 29.5 ± 5 fMRI CBF via ASL at 
3T 
hypertonic 
saline 
brachioradialis severe a 14 - - 
Owen 
(2012) 
19 19, 0 26 ± 5 fMRI CBF via ASL at 
3T 
hypertonic 
saline 
brachioradialis moderate a 13 - - 
Nash 
(2010a) 
25 NR NR fMRI BOLD at 3T hypertonic 
saline 
masseter moderate p 12 - - 
Uematsu 
(2011) 
17 10, 7 23-33 
(range) 
fMRI BOLD at 1.5T 
pressure (skin 
anaesthetised), 
10mm probe 
gastrocnemius moderate a 12 - - 
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Henderson 
(2006) 
15 NR NR fMRI BOLD at 3T 
hypertonic 
saline 
tibialis anterior moderate p 11 - - 
Loggia 
(2012) 
16 11, 5 28.8 ± 9.7 fMRI BOLD at 3T 
pressure, 
13.5cm cuff 
gastrocnemius 
7 increments:    
mild p - severe 
p 
14 - - 
Macefield 
(2007) 
22 11, 11 22-49 
(range) 
fMRI BOLD at 3T hypertonic 
saline 
tibialis anterior, 
flexor carpi radialis 
severe p 13 - - 
Nash 
(2010b) 
17 NR NR fMRI BOLD at 3T hypertonic 
saline 
masseter moderate p 13 - - 
Maeda 
(2011) 
12 7, 5 24-56 
(range) 
fMRI BOLD at 1.5T pressure, 10mm 
probe 
gastrocnemius moderate 
a, 
severe a 
14 - - 
Niddam 
(2002) 
10 10, 0 26.8 ± NR 
Event-
related 
fMRI 
BOLD at 3T electrical 
stimulation 
abductor pollicis 
brevis 
NR 13 - - 
Takahashi 
(2011) 
13 13, 0 20-36 
(range) 
Event-
related 
fMRI 
BOLD at 3T electrical 
stimulation 
tibialis anterior 
mild p, 
moderate p, 
severe p 
13 - - 
Schabrun 
(2012) 
11 7, 4 23.3 ± 6.5 TMS MEP amp, 
SICI, ICF. 
hypertonic 
saline 
first dorsal 
interosseous 
severe a 13 87 91 
Svensson 
(2003) 
10 8, 2 34.3 ± 4.0 TMS MEP amp hypertonic 
saline 
first dorsal 
interosseous 
moderate p 13 81 81 
Del Santo 
(2007) 
8 5, 3 33.9 ± 11.5 TMS MEP area ascorbic acid 
abductor digiti 
minimi, biceps 
brachii 
severe p 13 66 95 
Martin 
(2008) 
6 NR NR TMS MEP amp hypertonic 
saline 
biceps brachii moderate p 11 66 83 
Rittig-
Rasmussen 
(2014) 
12 NR 23 ± 2 TMS MEP amp hypertonic 
saline 
neck muscular tissue 
2cm lateral to C3 
moderate a 13 74 90 
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Romaniello 
(2000) 
10 NR NR TMS MEP amp hypertonic 
saline 
masseter moderate a 9 81 96 
Le Pera 
(2001) 
10 
11 
7, 3 
 8, 3 
23.5 ± 2.7 
26.1 ± 4.8 
TMS MEP amp hypertonic 
saline 
abductor digiti 
minimi, first dorsal 
interosseous; flexor 
carpi radialis 
severe p & 
moderate p; 
moderate p 
12 85 91 
Schabrun 
(2013) 
12 5, 7 28 ± 9 TMS, EEG 
MEP amp, SEP 
area 
hypertonic 
saline 
first dorsal 
interosseous 
moderate a 13 81 77 
Rossi 
(2003) 
6 NR NR EEG SEP area 
levo-ascorbic 
acid 
first dorsal 
interosseous 
severe p 12 - - 
Rossi 
(1998) 
7 5, 2 22-40 
(range) 
EEG SEP area levo-ascorbic 
acid 
extensor digitor 
brevis 
severe p 9 - - 
TMS, transcranial magnetic stimulation; EEG, electroencephalography; PET, positron emission tomography; fMRI, functional magnetic resonance imaging; rCBF, regional 
cerebral blood flow; ASL, arterial spin labelling; BOLD, blood-oxygen-dependent level contrast imaging; MEP, motor evoked potential; SEP, somatosensory evoked potential; 
a, average pain score; p , peak pain score; NR, not reported.
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2.4.3 Methodological quality 
Average scores for methodological quality were 12.1 ± 1.5 (out of 17) for MEP studies, 
11.3 ± 2.1 for SEP studies, 13.8 ± 0.5 for rCBF studies and 12.9 ± 0.9 for BOLD studies.  
Items consistently unmet by reviewed studies related to internal and external 
validity. For example, male and female participants were unequally represented in 
the majority of study samples (Macefield et al. 2007) and sample size calculations 
were rarely performed a priori (Rittig-Rasmussen et al. 2014). No study blinded the 
investigator during data analysis and all recruited a sample of convenience. 
The mean score for reported items of the TMS checklist was 78 ± 8%. Compliance was 
high for methodological items, however, items relating to participant characteristics, 
were less well reported. This may be because authors may not have considered it 
necessary to collect or report detailed data on health characteristics for participants 
considered ‘healthy’.  All studies reported on subject age and gender, position and 
contact of EMG electrodes, amount of relaxation/contraction of muscles, prior motor 
activity of the tested muscle, coil location and stability, type of stimulator, stimulation 
intensity, subject attention, number of MEP recordings and the method for 
determining MEP size in analysis. The mean score for controlled items was 88 ± 7%.  
Items reported but poorly controlled included subject gender (bias towards male 
participants), prior activity of the muscle being tested, level of relaxation of muscles 
not being directly tested, and coil stability. Individual study scores are presented in 
Table 2.1. 
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2.4.4 The effect of experimental muscle pain at the primary sensory cortex (S1). 
2.4.4.1 Regional cerebral blood flow (rCBF) 
Four studies investigated rCBF using PET and two studies investigated rCBF using fMRI 
and arterial spin labelling (ASL) (Table S1; Appendix A.2). Full brain image analysis 
using PET (studies, n = 4) revealed no effect of muscle pain on rCBF at S1. There was 
also no effect on ASL-derived rCBF (n = 2) when pain was of moderate intensity (Owen 
et al. 2012), however a bilateral reduction at S1 was observed in response to severe 
pain (Owen et al. 2010). These conflicting findings may be explained by pain severity 
as reduced rCBF at S1 was found to negatively correlate with subjective pain ratings 
for the pain (hypertonic saline) and control groups (isotonic saline) in the latter study 
(contralateral S1: R2 = 0.75, p = 0.000; ipsilateral S1: R2 = 0.69, p = 0.000) (Owen et 
al. 2010). 
2.4.4.2 Blood-oxygen-level dependent (BOLD)-contrast imaging  
Seven of the nine studies that investigated BOLD responses using fMRI reported 
increased S1 activation in response to muscle pain (Table S1; Appendix A.2). Three 
studies reported increased BOLD-contrast bilaterally at S1 (Niddam et al. 2002, Nash 
et al. 2010a, b), while three studies reported increases exclusive to the hemisphere 
contralateral to the side of hypertonic saline- or electrically induced muscle pain 
(Henderson et al. 2006, Macefield et al. 2007, Takahashi et al. 2011). In contrast, 
results for mechanically induced pain were conflicting. For example, Loggia et al 
(Loggia et al. 2012) reported an increased BOLD response at S1 in the contralateral 
hemisphere and a decreased response in the ipsilateral hemisphere following painful 
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pressure stimulation, whereas Uematsu et al and Maeda et al (Maeda et al. 2011, 
Uematsu et al. 2011) reported no change for either hemisphere. These discrepancies 
could be explained by differences in the spatial resolution of the pressure stimulation 
between these studies (pressure cuff vs. pressure probe). 
2.4.4.3 Somatosensory evoked potentials (SEPs) 
Three studies used EEG to investigate the effect of acute muscle pain on S1 
excitability following electrical stimulation of the ulnar (Rossi et al. 2003, Schabrun et 
al. 2013) or peroneal nerve (Rossi et al. 1998) (Table S2; Appendix A.3). Ulnar SEPs 
were recorded using surface electrodes placed on the scalp 2cm posterior to C3 using 
the 10-20 International EEG system, while peroneal SEPs were recorded 
subcutaneously at a location 2cm posterior to Cz on the midline. All studies reported 
on components thought to reflect S1 activation (P14-N20, P40-N50) and processing (N20-
P25-N33, P60-N75). As pooled analyses revealed that the area of components 
corresponding to S1 activation was unchanged both during (Figure S1; Appendix A.5) 
and following (Figure S2; Appendix A.6) the resolution of muscle pain [-0.36 (-0.86, 
0.14), -0.23 (-0.72, 0.26)], this suggests that input to S1 remains stable over time. In 
contrast, pooled effect estimates during pain show a strong reduction in the area of 
components corresponding to S1 processing [1.99 (0.64, 3.34)]. A moderate 
reduction [0.65 (0.15, 1.16)] is also present post pain. Such findings suggest that acute 
muscle pain may exert a lasting inhibitory effect on S1 excitability. 
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2.4.5 The effect of experimental muscle pain on the primary motor cortex (M1) and 
corticomotor pathway. 
2.4.5.1 Regional cerebral blood flow (rCBF) 
Full brain image analysis (PET n = 4, fMRI n = 2) revealed no change in rCBF at M1 in 
any study (Table S1; Appendix A.2). 
2.4.5.2 Blood-oxygen-level dependent (BOLD)-contrast imaging  
At the location of M1, findings for BOLD contrast were mixed (Table S1; Appendix 
A.2). For example, four studies reported increased BOLD responses in the hemisphere 
contralateral to the side of pain (Henderson et al. 2006, Nash et al. 2010b, Takahashi 
et al. 2011, Loggia et al. 2012), while five studies observed no change (Niddam et al. 
2002, Macefield et al. 2007, Nash et al. 2010a, Maeda et al. 2011, Uematsu et al. 
2011). These discrepancies do not appear to be related to the use of different pain 
models between studies but may be related to pain severity since a positive 
relationship between increased BOLD and pain was observed in one study (Loggia et 
al. 2012). However, as the results from two additional studies indicate that increased 
BOLD outlasts peak pain and persists during waning pain (Henderson et al. 2006, 
Takahashi et al. 2011), the nature of this relationship remains uncertain. 
Interpretation of these findings is further complicated by observations from Nash et 
al, who reported that initial increases in BOLD-contrast were followed by lasting 
decreases in signal intensity (Nash et al. 2010b). With the exception of one study 
(Henderson et al. 2006), there is no evidence of an effect of muscle pain on ipsilateral 
BOLD responses.  
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2.4.5.3 Transcranial magnetic stimulation: assessment of corticomotor excitability 
Eight studies investigated corticomotor excitability using TMS (Table S3; Appendix 
A.4). Separate meta-analyses were performed for data collected with the muscle at 
rest and during active contraction and sub group analysis was performed for ‘target’ 
or ‘non-target’ muscles. ‘Target’ refers to the muscle where experimental pain was 
induced, and was reported in all eight studies. The term ‘non-target’ refers to muscles 
remote, synergistic or antagonistic to the ‘target muscle’ and was reported in three 
studies (Le Pera et al. 2001, Svensson et al. 2003c, Martin et al. 2008).  
The size of the MEP to single-pulse TMS was reported by five studies ‘during pain’ 
(Figure S3; Appendix A.7). Pooled effect estimates revealed a moderate reduction in 
corticomotor excitability (MEP amplitude/area) from ‘baseline’ for target and non-
target muscles at rest [0.52 (-0.01, 1.06), 0.72 (0.01, 1.42)], but not for target muscles 
during active contraction [-0.13 (-0.61, 0.35)]. ‘Post pain’ data collected either 0 
(immediately post), 20 or 30 minutes following the cessation of pain or painful 
stimulation was available from all eight studies (Figure S4; Appendix A.8). Compared 
to ‘baseline’ there was a strong reduction in MEP amplitude/area for target muscles 
at rest [0.97 (0.59, 1.35)] and a similar trend for non-target muscles at rest [0.37 (-
0.02, 0.76)}. A moderate reduction in MEP amplitude/area was also detected for 
actively contracting target muscles [0.44 (0.05, 0.83)]. 
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2.4.5.4 Transcranial magnetic stimulation: intracortical inhibitory and facilitatory 
networks 
The MEP response to paired-pulse TMS was examined by one study (Schabrun et al. 
2012). Short-interval intracortical inhibition (at 2 and 3ms inter-stimulus intervals) 
was increased immediately following (2ms: p = 0.012, 3ms: p = 0.007), but not during 
muscle pain (2ms: p = 0.24; 3ms: p = 0.61). In contrast, intracortical facilitation (13ms 
inter-stimulus interval) was reduced compared to baseline both during (p = 0.009) 
and immediately post (p = 0.001) muscle pain. 
2.5 Discussion 
The aim of this review was to synthesize and critically evaluate evidence for altered 
S1 and M1 activity in response to acute muscle pain. The findings provide evidence 
of reduced excitability in the contralateral S1 both during and following pain and 
moderate-strong evidence of reduced corticomotor output to the painful muscle. 
Currently, there is insufficient evidence to draw conclusions regarding effects at 
ipsilateral S1/M1.  
2.5.1 The effect of acute muscle pain on S1 
Eight of nine studies using fMRI provide evidence of altered activation (increased 
BOLD-contrast) at S1 in the hemisphere contralateral to the side of induced pain, 
during pain. As BOLD-contrast is a measure of cerebral metabolism based on the level 
deoxyhaemoglobin content, and oxygen demands are assumed to be higher at areas 
of increased cortical function (Howseman et al. 1999), such observations imply 
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increased synaptic activation. However, as fMRI detects hemodynamic and not 
electrophysiological changes, it is unclear whether increased synaptic activation 
reflects increased or decreased S1 excitability. The inclusion of studies that record 
SEPs in response to pain provides insight into the direction of the effects observed 
with fMRI. The area of the N20-P25-N33 and P60-N75 potential is thought to reflect early 
cortical processing of low-threshold somatosensory afferent information related to 
kinaesthesia and position sense (Rossi et al. 1998, Rossi et al. 2003) and is commonly 
used to infer changes in S1 excitability. Pooled-analysis of the three EEG studies 
provides strong evidence that acute muscle pain activates synaptic processes that 
reduce S1 excitability. Thus, taken together, data from fMRI and SEP studies suggest 
that S1 is altered during acute muscle pain and that this change is in the direction of 
reduced S1 excitability. However, as the relationship between SEP amplitude and 
BOLD contrast has not been characterized at stimulation intensities at or above pain 
threshold, evidence to support a correlation between these methodologies under 
pain conditions is limited. 
Although the functional relevance of altered S1 activity during pain was not directly 
investigated in this review, previous studies have suggested that reduced S1 
excitability may reflect a defensive adaptation designed to orient cortical attention 
towards stimuli that threaten the body’s integrity (Legrain et al. 2011). Such a 
mechanism may reduce processing of non-painful afferent information and thus 
contribute to reduced sensorimotor performance when pain is present (Rossi et al. 
1998, Rossi et al. 2003). However, further work is needed to determine the 
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relationship between reduced S1 excitability during pain and altered sensorimotor 
function. 
The present review provides moderate evidence of reduced S1 excitability following 
the resolution of pain. However, this evidence is drawn exclusively from SEP data 
collected immediately post pain (Rossi et al. 2003, Schabrun et al. 2013) and further 
research is required to determine the duration and reliability of these findings. The 
effect of pain on the ipsilateral S1 also remains unclear as synthesis of fMRI data was 
largely inconclusive and SEPs were not investigated in this hemisphere. The results of 
all five PET studies show no S1 activation during pain. Since previous studies have 
shown that fMRI and PET activations typically correlate under identical stimulus 
conditions (Dettmers et al. 1996, Sadato et al. 1998), these findings were unexpected. 
One explanation may be that the lower temporal resolution of PET precluded the 
identification of rapid and/or transient pain-related neural activity. fMRI images are 
typically sampled between 0.3 and 3s, whereas PET image acquisition is performed 
over a longer time period (50 - 120s). If pain related changes in S1 occurred prior to 
50s they may not have been detected using PET methodologies. Alternatively, as 
analyses are typically performed on data averaged over the entire scanning period, it 
is possible that changes were not detected due to a dynamic, fluctuating pattern of 
cortical activation during acute muscle pain. 
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2.5.2 The effect of acute muscle pain on M1 
The effect of acute muscle pain on BOLD-contrast at M1 in the hemisphere 
contralateral to the side of induced pain varied between studies with some reporting 
increased activation (n = 4), some decreased activation (n = 1) and some no change 
(n = 5) during pain. With the exception of one study (Henderson et al. 2006), there 
was no evidence for an effect of acute muscle pain on BOLD-contrast in the ipsilateral 
M1. In contrast, meta-analyses of MEP data show moderate evidence of reduced 
corticomotor output to painful muscles when pain is present. Inconsistent findings 
between fMRI and TMS could be explained by differences in temporal resolution 
between methodologies or alternatively, by changes occurring at spinal and/or 
peripheral, rather than cortical, level. As the MEP is a summative measure of cortico-
cortical, cortico-motoneuronal and spinal motoneuron synaptic excitability, changes 
occurring at cortical, spinal and/or peripheral level may have contributed to the 
reduction in corticomotor output observed during pain. Few TMS studies controlled 
for changes in peripheral (n = 3) or spinal excitability (n = 3) and only one study 
examined mechanisms thought to directly reflect activity in M1. That study reported 
enhanced activity of M1 intra-cortical circuits mediated by the inhibitory 
neurotransmitter GABA, and decreased activity of facilitatory circuits acting through 
NMDA receptors on glutamatergic interneurons (Schabrun et al. 2012). Therefore, 
further research is required to determine whether reduced corticomotor output 
during pain reflects reduced activity in M1. 
A novel finding during pain was the non-specificity of the corticomotor response. 
Pooled analyses of data from two TMS studies show that muscles in the same body 
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segment, but not directly subjected to pain, exhibit reduced corticomotor output (Le 
Pera et al. 2001, Martin et al. 2008). Although there is currently insufficient data to 
determine whether this effect is limited to muscles at rest, it is possible that a similar 
response may occur in active muscles but remains undetected due to the facilitatory 
influence of volitional contraction on measures of MEPs (Di Lazzaro et al. 1998b). This 
non-specificity suggests that an indiscriminate motor strategy is employed during 
pain. Although the functional significance remains unclear, it is possible that this 
adaptation serves to decrease muscle coordination and splint the affected body part 
(Schabrun et al. 2015b). Such en masse movement strategies would likely prevent 
symptom aggravation and afford protection to an injured limb (Hodges et al. 2011). 
A strong reduction in corticomotor output was also found for painful muscles in the 
post pain period at rest. The relative strength of this response may explain why a low-
moderate reduction in corticomotor output to actively contracting muscles was also 
detected at this time point. A strong trend towards MEP suppression was also 
observed for non-painful muscles at rest. In line with current theories, it is possible 
that these reductions persist in the post-pain period as a defense against the threat 
of further pain and injury (Hodges et al. 2011).  
2.5.3 Relationship between S1 and M1 activity and the symptoms of pain 
There is currently insufficient evidence to determine whether the neurophysiological 
changes described in this review are related to subjective assessments of pain 
severity. Although all fMRI investigations were conducted within the ‘during pain’ 
time period, a relationship to pain severity is impeded by inconsistent findings. For 
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example, one study provided evidence of severity-dependent S1/M1 activations 
during pain (Loggia et al. 2012), whereas several others demonstrate strong cortical 
effects despite waning symptoms (Henderson et al. 2006, Nash et al. 2010b, 
Takahashi et al. 2011). As additional activations/deactivations were also observed in 
the ipsilateral hemisphere by some authors (Niddam et al. 2002, Henderson et al. 
2006, Nash et al. 2010b, a, Owen et al. 2010, Loggia et al. 2012), there is also doubt 
regarding the specificity of this response. Furthermore, although the majority of EEG 
and TMS studies reported findings during pain (Romaniello et al. 2000, Le Pera et al. 
2001, Rossi et al. 2003, Del Santo et al. 2007, Martin et al. 2008, Schabrun et al. 2013), 
few studies explicitly examined S1/M1 excitability in association with pain severity 
(Le Pera et al. 2001, Rossi et al. 2003). However, as meta-analyses of these studies 
show moderate-strong evidence of reduced corticomotor output and S1 excitability 
that persist after pain has resolved, a linear relationship between objective 
neurophysiological measures and subjective pain recordings appears unlikely.  
2.5.4 Limitations and Recommendations 
This review has a number of limitations that require consideration. First, findings 
from multiple methodologies with unique temporal and spatial resolutions were 
included to provide insight regarding the extent, time-course and direction of the 
effect of pain on S1/M1.  However, as the relationship between hemodynamic and 
electrophysiological measures remains uncertain, comparison of findings across 
methodologies is limited. Future protocols that combine PET/fMRI (high spatial 
resolution) with TMS/EEG (high temporal resolution) would clarify the effect of acute 
muscle pain on S1/M1 and the relationship between these measures. 
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The small number of studies identified for each methodology, as well as differences 
in study design, pain modality and severity, also limit discussion. For example, pain 
severity was reported as a value corresponding to either ‘peak’ or ‘average’ and 
ranged in severity from ‘mild’ to ‘severe’. As such, this review was unable to discern 
a clear effect of pain severity and S1/M1 change between or within outcome 
measures. There is also insufficient evidence to ascertain the duration of S1/M1 
change following the resolution of muscle pain due to inconsistent time points in 
TMS/EEG studies and a lack of post-pain data from PET/fMRI. Standardized recording 
intervals, in addition to improved descriptions of whether the interval refers to the 
time elapsed since the cessation of pain or since the cessation of the pain 
intervention (pain remains), would help clarify the duration of these effects. Future 
protocols should also include objective measures of sensory and/or motor function 
in order to elucidate the functional significance of S1/M1 adaptations both during 
and post muscle pain.
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Chapter 3: 
Reduced short- and long-latency afferent 
inhibition following acute muscle pain: a 
potential role in the recovery of motor output 
 
The findings of the Chapter 2 suggest that acute muscle pain exerts a net inhibitory 
effect on the primary motor (M1) and somatosensory cortices (S1). This chapter 
reports on the findings of an experimental study designed to investigate whether 
intracortical inhibitory mechanisms such as long interval intracortical inhibition (LICI) 
and short/long latency afferent inhibition (SAI/LAI) could plausibly contribute to such 
a response.  The content of this chapter has been published in Burns E, Chipchase LS, 
Schabrun SM (2016). Reduced Short- and Long-Latency Afferent Inhibition Following 
Acute Muscle Pain: A Potential Role in the Recovery of Motor Output. Pain Medicine. 
17(7): 1343-52. A copy of this publication is provided in Appendix B. 
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3.1 Abstract  
Corticomotor output is reduced in response to acute muscle pain, yet the 
mechanisms that underpin this effect remain unclear. Here the authors investigate 
the effect of acute muscle pain on short-latency afferent inhibition (SAI), long-latency 
afferent inhibition (LAI) and long-interval intra-cortical inhibition (LICI) to determine 
whether these cortical mechanisms could plausibly contribute to reduced motor 
output in pain. This observational, same subject, pre-post test design study was 
performed in a neuroplasticity research laboratory setting. Twenty-two healthy, 
right-handed human volunteers (nine males; mean age ± standard deviation, 22.6 ± 
7.8 years) participated. Transcranial magnetic stimulation was used to assess 
corticomotor output, SAI, LAI and LICI before, during, immediately after and 15 
minutes after hypertonic saline infusion into right first dorsal interosseous muscle. 
Pain intensity and quality were recorded using an 11-point numerical rating scale and 
the McGill Pain Questionnaire. Compared with baseline, corticomotor output was 
reduced at all time points (p = 0.001). SAI was reduced immediately after (p = 0.039), 
and LAI 15 minutes after (p = 0.035), the resolution of pain. LICI was unchanged at 
any time point (p = 0.36). These findings suggest SAI and LAI, mechanisms thought to 
reflect the integration of sensory information with motor output at the cortex, are 
reduced following acute muscle pain. Although the functional relevance is unclear, 
the authors hypothesize a reduction in these mechanisms may contribute to the 
restoration of normal motor output after an episode of acute muscle pain. 
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3.2 Introduction 
Pain affects sensorimotor function. When pain is present, the capacity of a muscle to 
generate force is diminished (Graven-Nielsen et al. 1997d, Graven-Nielsen et al. 
2002b, Slater et al. 2003), muscle co-ordination is altered (Arendt-Nielsen et al. 1996, 
Henriksen et al. 2009, Henriksen et al. 2011, Jacobs et al. 2011), proprioception is 
distorted (Matre et al. 2002, Rossi et al. 2003, Weerakkody et al. 2008) and the ability 
to integrate sensory information with motor commands (sensorimotor integration) 
is impaired (Malmstrom et al. 2013). A number of authors have shown reduced 
corticomotor output during and after the resolution of muscle pain (Le Pera et al. 
2001, Svensson et al. 2003c, Martin et al. 2008, Schabrun et al. 2012, Schabrun et al. 
2013), and these changes are hypothesized to contribute to altered sensorimotor 
function. However, the mechanisms that underpin reduced corticomotor output in 
pain are unclear. 
Changes occurring across multiple levels of the nervous system (peripheral, spinal, 
cortical) could reasonably contribute to altered motor output in pain. Previous 
studies have excluded changes at the muscle, as the peripheral M-wave (muscle 
compound action potential), contractile properties and conduction velocity of action 
potentials along the muscle fiber membrane are unchanged (Svensson et al. 1998, 
Graven-Nielsen et al. 2002b, Svensson et al. 2003c, Farina et al. 2004). At the level of 
the spinal cord, findings have been contradictory. One study demonstrated 
suppression of motoneurons in the late phase of pain (Le Pera et al. 2001), while 
another demonstrated facilitation (Martin et al. 2008). This discrepancy could be 
explained by the use of different measures (H-reflex vs. cervicomedullary-evoked 
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potentials) to record spinal excitability. Regardless of the direction of spinal effects, 
both studies reported depression of motor cortical excitability, suggesting cortical 
mechanisms may contribute to the reduced motor output observed in pain.  
A recent study has provided the first evidence for altered activity in motor cortical 
inhibitory and facilitatory networks in response to pain (Schabrun et al. 2012). That 
study used transcranial magnetic stimulation (TMS) paired pulse paradigms to show 
a reduction in intracortical facilitatory (glutamate-mediated), and an increase in 
intracortical inhibitory (gamma-aminobutyric acid [GABA]A receptor mediated), 
networks during and immediately after the resolution of pain. The authors 
hypothesized that these changes act to restrict activity of painful muscles and limit 
the range and velocity of movement in pain, protecting the painful part from further 
pain and/or injury (Hodges et al. 2011). However, the impact of acute muscle pain on 
other intracortical networks such as those mediated by GABAB (long-interval 
intracortical inhibition; LICI), or circuits involved in the integration of sensory 
information with motor execution (sensorimotor integration, measured using short- 
[SAI] and long-latency [LAI] afferent inhibition protocols) has not been investigated. 
Thus, here we aimed to examine the effect of acute experimental muscle pain on 
intracortical inhibitory networks, specifically those mediated by GABAB, and networks 
associated with sensorimotor integration. 
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3.3 Methods 
3.3.1 Participants 
Twenty-two healthy, right-handed volunteers participated (mean ± standard 
deviation; nine males, age = 22.6 ± 7.8 years). As afferent inhibition and LICI are yet 
to be investigated in response to acute pain, sample size calculations were based on 
effect sizes from a previous study examining the effect of innocuous afferent input 
(water immersion) on SAI and LAI (Sato et al. 2013). Additional participants were 
recruited to account for the possibility of exclusions, as it has been shown that 
approximately 30% of individuals fail to respond to afferent inhibition protocols at 
baseline under uniform test conditions (Asmussen et al. 2013). Based on these 
assumptions, a sample size of 22 was sufficient to observe a statistically significant 
difference in response to pain (80 % power, alpha 0.05), should one exist. 
Handedness was determined using the Edinburgh Handedness inventory (laterality 
quotient, 88.8 ± 19.6) (Oldfield 1971). All volunteers completed a TMS safety 
screening questionnaire (Keel et al. 2001) and were excluded if they had a recent 
history of arm pain or injury, a personal or family history of epilepsy, major 
neurological, respiratory, orthopaedic or circulatory disorders, were pregnant, had 
metal in their head or jaw or were taking central nervous system acting medication 
(Keel et al. 2001). The study was approved by the institutional human medical 
research ethical committee and performed in accordance with the Declaration of 
Helsinki. All participants provided written, informed consent. All testing took place in 
a University laboratory. 
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3.3.2 Electromyography (EMG) 
Surface EMG was recorded from FDI of the right hand. Dual silver-silver chloride 
disposable electrodes (spacing 2.0 cm; Noraxon Inc, USA) were positioned over the 
muscle in a belly-tendon arrangement and remained in place for the duration for the 
experiment. The ground electrode was positioned over the right olecranon.  EMG 
signals were amplified x1000, band-pass filtered 20-1000 Hz (Neurolog System Pre–
amplifier; Digitimer Ltd, UK), and sampled at 2000 Hz using a Micro3 1401 Data 
Acquisition System and Signal5 software (Cambridge Electronic Design, Cambridge, 
UK).  
3.3.3 Corticomotor output 
Corticomotor output was investigated using single pulse TMS delivered to the 
primary motor cortex (M1) using a Magstim 2002 stimulator (Magstim Co. Ltd., Dyfed, 
UK) connected to a figure–of -eight coil (70mm wing diameter). TMS was performed 
over the left hemisphere (contralateral to the side of pain) for all participants. The 
coil was oriented at a 45-degree angle to induce posterior-anterior current flow and 
positioned over the motor ‘hotspot’ of FDI (Groppa et al. 2012). The motor hotspot 
was determined via systematic application of TMS to the scalp until the site that 
produced the largest motor evoked potential (MEP) was identified. A Brainsight 
neuronavigation system (Rogue Research Inc, Quebec, Canada) was used to target 
this site and ensure accurate coil placement for the duration of the experiment. All 
procedures adhered to the TMS checklist for methodological quality and were 
performed with the muscle at rest (Chipchase et al. 2012). Fifteen MEPs (rate of 1 
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every 6s) were recorded using a constant stimulator intensity sufficient to evoke a 
MEP of approximately 1mV peak-to-peak amplitude in FDI at baseline.  
3.3.4 Long-interval intra-cortical inhibition  
A standard paired-pulse TMS protocol, using a supra-threshold conditioning stimulus 
delivered before a supra-threshold test stimulus (Claus et al. 1992), was used to 
evaluate LICI. Evidence suggests that spinal mechanisms may contribute to the 
inhibitory response when conditioning stimuli precedes the test stimulus by 80-
100ms (McNeil et al. 2009, 2011). Thus, in order to reduce the likelihood of a spinal 
contribution in the present study, LICI was tested using an inter stimulus interval (ISI) 
of 160ms. The intensity for both the conditioning and test stimuli was set to evoke a 
peak-to-peak response of 1mV in FDI.  As the amplitude of the test MEP is known to 
influence the magnitude of the LICI response (McNeil et al. 2011), it is possible that 
pain-induced fluctuations in test MEP amplitude may impact the accuracy of LICI 
estimation in this study. Thus, TMS intensity of the test stimulus was adjusted to 
maintain a consistent 1mV test response throughout the experimental protocol (pre, 
during and post pain). Twelve trials were recorded in random order at ISI 160ms (LICI) 
and for the test stimulus alone (rate of 1 every 6s; total of 24 trials). As test TMS 
intensity was adjusted where necessary, the peak-to-peak amplitude of the test MEP 
alone was not suitable to use as an additional measure of corticomotor output.  
3.3.5 Short- and long-latency afferent inhibition  
SAI and LAI were assessed by pairing a conditioning electrical stimulus with a 
suprathreshold TMS test stimulus at ISIs of 20ms and 200ms respectively (Tokimura 
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et al. 2000).  Electrical stimuli were delivered via a Digitimer Constant Current 
stimulator (DS7A; Digitimer Ltd, UK) connected to surface electrodes placed 2 cm 
proximal to the wrist crease. Single electrical stimuli (100 µs duration, 400V) were 
applied to the ulnar nerve of the right arm at an intensity sufficient to elicit a visible 
muscle contraction (motor threshold) (Fischer et al. 2011). Intensity of the TMS test 
stimulus was adjusted to evoke a peak-to-peak response of 1mV in FDI. Where 
necessary, the amplitude of the test stimulus was adjusted to maintain a consistent 
response at all time points (Bertolasi et al. 1998). Twelve trials were recorded in 
random order for each ISI (20ms, 200ms) and for the test stimulus alone (rate of 1 
every 6s; total of 36 trials). As test TMS intensity was adjusted where necessary, the 
peak-to-peak amplitude of the test MEP alone was not suitable to use as an additional 
measure of corticomotor output. 
3.3.6 Compound muscle action potentials (M-waves) 
To control for changes in excitability occurring at the muscle and neuromuscular 
junction, electrical stimuli (100µs duration, 400V, amplified x100) were applied to the 
right ulnar nerve using the set-up outlined for SAI/LAI above. Five trials were 
recorded at a stimulus intensity 50% above that required to elicit a maximal 
compound muscle action potential (M-wave) in the FDI muscle at rest. 
3.3.7 Hypertonic saline infusion 
Hypertonic saline was infused into right FDI following a standard procedure 
(Schabrun et al. 2012, Schabrun et al. 2013). A 25-gauge disposable cannula (Winged 
Infusion Set, Terumo, Japan) was placed into right FDI with the tip of the cannula at 
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a depth of approximately 0.5cm. A single bolus of 0.2ml of sterile saline (5 % NaCl) 
was infused over 20s using an infusion pump (Harvard Apparatus, SDR Scientific, 
USA), a 10ml plastic syringe (Terumo, Japan) and a low sorbing extension tube (140 
cm length; Braun, Germany). Following the bolus, a steady infusion rate of 6 ml/hour 
was maintained for 10 minutes. Pain intensity and quality were evaluated using an 
11-point numerical rating scale (NRS) anchored with ‘0’ as no pain and ‘10’ as worst 
pain imaginable and the McGill short form pain questionnaire (Melzack 1987). 
3.3.8 Experimental protocol 
As the LICI response has been shown to be influenced by concurrent recording of SAI 
and LAI measures (Sailer et al. 2002, Udupa et al. 2009), data collection was 
performed in two experiments: the effect of acute muscle pain on LICI was examined 
in Experiment 1 and the effect of acute muscle pain on SAI and LAI was assessed in 
Experiment 2. All 22 participants completed both experiments, separated by at least 
36 hours, and experimental order was randomized. The experimental protocol was 
as follows: participants sat upright in a chair with their head and neck supported and 
their arms resting comfortably on a pillow. Data were recorded at four time points: 
(2) baseline, (2) during pain (measurement commenced once pain reached a 
moderate intensity of NRS 5/10), (3) post pain (once pain had returned to 0/10) and 
(4) follow up (15 minutes after pain had returned to 0/10). Measures at each time 
point were performed in the following order: 15 MEPs, either 24 LICI trials 
(Experiment 1) or 36 SAI/LAI trials (Experiment 2) and 5 M-waves. Following the 
completion of baseline assessments, a cannula was inserted into FDI and remained 
in situ for the duration of the ‘during pain’ time period. Immediately after the 
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infusion, the cannula was removed. Participants were asked to verbally rate their pain 
using the NRS after the completion of each measure within the ‘during pain’ time 
period and for every minute after the removal of the cannula, until NRS 0/10 was 
achieved. At the conclusion of each experiment, participants described the location, 
quality and intensity (subjective average) of muscle pain using the McGill short form 
pain questionnaire. The protocol for Experiments 1 and 2 are outlined in Figure 3.1. 
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Figure 3.1 Experimental protocol.  
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3.3.9 Data and statistical analyses 
MEP and Mwave data were measured as peak-to-peak amplitudes (mV) and averaged 
at each time point. To account for any activity-dependent changes in muscle fiber 
action potentials resulting from the induction of pain, statistical analyses for 
corticomotor output were performed with MEP amplitude expressed as a proportion 
of Mwave amplitude (MEP/Mwave amplitude ratio) (Groppa et al. 2012).  To 
determine whether acute muscle pain induced a change in LICI (Experiment 1) or SAI 
and LAI (Experiment 2), peak-to-peak conditioned MEP amplitudes for these data 
were expressed as a percentage of the unconditioned (test) response. It has been 
shown that approximately 30% of individuals fail to respond to afferent inhibition 
protocols at baseline under uniform test conditions (Asmussen et al. 2013), thus, 
consistent with previous work (Asmussen et al. 2013), it was elected to exclude 
participants who did not display inhibition at baseline from further analyses.  
All neurophysiological outcomes (MEP/Mwave amplitude ratio, LICI, SAI and LAI) 
were assessed for normality and compared between time-points (baseline, during 
pain, post pain, follow up) using one-way repeated measures analysis of variance 
(ANOVA) or where data was not normally distributed, a Friedman’s repeated 
measures analysis on ranks. Post hoc analyses were performed using the Student 
Newman Keuls (SNK) test that corrected for multiple comparisons. Significance was 
set at 5%. All data in text is presented as mean ± standard deviation. 
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3.4 Results  
3.4.1 Pain characteristics 
Infusion of hypertonic saline induced an average pain intensity of 5.2 ± 1.7cm for 
Experiment 1 and 5.0 ± 1.7cm for Experiment 2. The most frequent words used to 
describe pain were aching (82%), throbbing (73%), sharp (62%), and cramping (60%). 
The majority of participants reported symptoms localized to the dorsal surface of the 
hand. One participant reported numbness localized to the thumb and an additional 
two participants reported pain that extended beyond the wrist into the proximal 
forearm.  
3.4.2 Corticomotor output is reduced during and after acute muscle pain 
As the effect of acute muscle pain on corticomotor output (MEP/ Mwave amplitude 
ratio) was similar for Experiments 1 and 2 (ANOVA main effect of interaction, F(3,21) = 
0.52, p = 0.67), these data were pooled for analyses. Corticomotor output was 
reduced during pain (ANOVA main effect of time, F(3,21) = 5.77, p = 0.001) relative to 
baseline (SNK p = 0.003) and this reduction persisted immediately (SNK p = 0.003) 
and 15 minutes following the resolution of pain (SNK p = 0.047; Figure 3.2). 
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3.4.3 Long-interval intra-cortical inhibition is unchanged by muscle pain 
Two participants did not display inhibition at baseline (two females, aged 19 years) 
and these individuals were excluded from further analysis of LICI (Asmussen et al. 
2013). Thus, data from 20 participants (nine males, age = 23.0 ± 8.4 years) were 
analyzed.  It was necessary to adjust the intensity of TMS output at each time point 
to maintain test responses of approximately 1 mV peak-to-peak amplitude for all 
participants. The intensity at baseline was 57.3 ± 9.6%, 61.4 ± 9.5% during pain, 64.0 
± 10.2% post pain and 61.8 ± 12.2% at follow up. The induction of acute muscle pain 
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Figure 3.2 Pooled group data from both experiments (n = 22 in each 
experiment) for corticomotor output before, during, immediately 
post, and 15 minutes following the resolution of experimental 
muscle pain. Data are expressed as MEP/Mwave amplitude ratio. 
Corticomotor output is reduced during, immediately post and 15 
minutes following the resolution of muscle pain. *p < 0.05 when 
compared with baseline. 
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did not alter LICI at any time point (ANOVA main effect of time, F(3,19) = 1.09, p = 0.36; 
Figure 3.3A). The amplitude of the test MEP remained stable over time (baseline: 1.10 
± 0.42mV, during: 0.96 ± 0.40mV, post: 1.02 ± 0.37mV, follow up: 0.99 ± 0.37mV; 
ANOVA main effect of time, F(3,19) = 0.73, p = 0.54).  
3.4.4 Short-latency afferent inhibition is reduced immediately after the resolution of                    
acute muscle pain 
Six participants did not display inhibition in response to the SAI protocol at baseline 
(two male, age = 26.0 ± 12.1 years) and were excluded (Asmussen et al. 2013).  Thus, 
data from sixteen participants were included in the analysis (seven male, age = 21.4 
± 4.9 years). It was necessary to adjust the intensity of TMS output at each time point 
to maintain test responses of approximately 1mV peak-to-peak amplitude for all 
participants. The intensity at baseline was 53.2 ± 10.0%, 57.6 ± 12.1% during pain, 
60.9 ± 12.3% post pain and 59.9 ± 12.1% at follow up. Acute muscle pain reduced SAI 
(ANOVA main effect of time, F(3,15) = 3.03, p = 0.039) relative to baseline immediately 
following the resolution of muscle pain (baseline vs. immediate, SNK p = 0.044; Figure 
3.3B).  This effect was not maintained at 15 minutes follow-up (baseline vs. follow-
up, SNK p = 0.16). There was no change in SAI during pain (baseline vs. during, SNK p 
= 0.55). The amplitude of the test MEP remained constant over time (baseline: 1.00 
± 0.13mV, during: 0.93 ± 0.19mV, post: 0.95 ± 0.13mV, follow up: 0.95 ± 0.16mV; 
ANOVA main effect of time, F(3,15) = 1.79, p = 0.16).  
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3.4.5 Long-latency afferent inhibition is reduced 15 minutes after the resolution of 
acute muscle pain  
Six participants did not display inhibition in response to the LAI protocol at baseline 
(two males, age = 20.0 ± 1.7 years) and were excluded. Thus, data from sixteen 
participants were included in the analysis (seven male, age = 24.5 ± 10.4 years). It was 
necessary to adjust the intensity of TMS output at each time point to maintain test 
responses of approximately 1mV peak-to-peak amplitude for all participants. The 
intensity at baseline was 58.8 ± 10.1%, 57.3 ± 12.1% during pain, 60.6 ± 12.6% post 
pain and 59.7 ± 12.8% at follow up. As data was not normally distributed comparisons 
were performed using Friedman’s repeated measures analysis on ranks. Acute 
muscle pain reduced LAI (Friedman: main effect of time, χ2 (3) = 8.63, p = 0.035) 15 
minutes after pain had resolved (follow-up vs. baseline SNK p < 0.05; Figure 3.3C). 
There was no change in LAI during (baseline vs. during, SNK p > 0.05) or immediately 
after the resolution of pain (baseline vs. immediate, SNK p > 0.05). The amplitude of 
the test MEP remained constant over time (baseline: 0.99 ± 0.26mV, during: 0.91 ± 
0.29mV, post: 0.86 ± 0.28mV, follow up: 0.89 ± 0.32mV; ANOVA: main effect of time, 
F(3,15) = 1.40, p = 0.25).  
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Figure 3.3 Group data (mean ± standard 
error) for A) long-interval intracortical 
inhibition (LICI, n = 20), B) short-latency 
afferent inhibition (SAI, n = 16) and C) long-
latency afferent inhibition (LAI, n = 16) at 
baseline, during, immediately post and 15 
minutes following the resolution of 
experimental muscle pain. Individuals who 
did not show inhibition at baseline were 
excluded from analyses. LICI, SAI and LAI 
were determined by expressing the 
conditioned MEP as a percentage of the 
unconditioned test MEP (% of test MEP). 
LICI was not affected by acute muscle pain 
at any time point (A). Compared to 
baseline, SAI was reduced (less inhibition, 
higher proportion of the test MEP) 
immediately post pain (B) and LAI was 
reduced at follow up (C). * p < 0.05.  
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3.5 Discussion 
To our knowledge, this study is the first to examine circuits involved in sensorimotor 
integration (SAI, LAI) and intracortical networks mediated by GABAB (LICI) in response 
to acute muscle pain. The novel finding is that experimental muscle pain reduces SAI 
and LAI (indicative of less inhibition) but only once pain has resolved, whereas intra-
cortical networks mediated by GABAB appear unaffected by acute muscle pain. Our 
data also confirm previous reports of reduced corticomotor output during and 
following the resolution of pain. Taken together, our findings provide new insights 
into mechanisms that may contribute to recovery of motor output following acute 
muscle pain.  
Short- and long-latency afferent inhibition are investigated by coupling peripheral 
nerve stimulation at the wrist with TMS at M1 (Tokimura et al. 2000). When paired 
at short (~20ms) and long (~200ms) inter-stimulus intervals, inhibition of the MEP is 
observed, an effect thought to reflect the interaction between sensory input and 
motor output at the level of the cortex (sensorimotor integration) (Chen et al. 1999, 
Tokimura et al. 2000). The latencies at which inhibition is induced suggest that SAI 
and LAI reflect the activation of distinct sensorimotor pathways and thus are likely to 
represent separate indices of sensorimotor integration. For instance, SAI is 
postulated to involve direct S1-M1 pathways (Tokimura et al. 2000, Sailer et al. 2002, 
Sailer et al. 2003), whereas LAI is thought to involve indirect basoganglia-
thalamocortical pathways (Chen et al. 1999, Abbruzzese et al. 2001, Sailer et al. 2002, 
Sailer et al. 2003). This interpretation is further supported by evidence that SAI and 
LAI display unique interactions with other intracortical circuitry (Sailer et al. 2002, 
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Alle et al. 2009, Udupa et al. 2009), and are differentially affected by pathology 
(Abbruzzese et al. 2001, Sailer et al. 2003, Kessler et al. 2005) and drug formulations 
(Di Lazzaro et al. 2005b, Di Lazzaro et al. 2005c, Di Lazzaro et al. 2007a). In the present 
study, we show reduced SAI immediately following, and reduced LAI 15 minutes 
following, an episode of acute muscle pain. Hence, the different cortical pathways 
that underpin these mechanisms are likely to explain these differential time effects. 
Although it is beyond the scope of the present study to infer causation, it is possible 
is that the timing of these effects may relate to the relative temporal sensitivity of 
the cortical generators of SAI and LAI to salient cues (i.e. the cessation of nociceptive 
input) (Legrain et al. 2011).  
Although the functional significance of reduced SAI and LAI in response to acute 
muscle pain is unclear, evidence suggests that appropriate sensorimotor integration 
constitutes an essential component of fluid, coordinated motor control (Riemann et 
al. 2002). Work performed in non-pain conditions indicate that SAI and LAI support 
the operation of ‘surround inhibition’, a mechanism that facilitates fine motor control 
via regulation of the inhibitory drive to specific muscles (Hallett 2003). Indeed, it has 
been shown during selective movement of the index finger that SAI/LAI to muscles 
necessary for movement is decreased, whilst inhibition to redundant muscles is 
increased (Voller et al. 2005, Voller et al. 2006). One explanation for our data is that 
reduced afferent inhibition (SAI and LAI) following resolution of muscle pain acts to 
facilitate motor recovery, promoting a return to normal motor output of the painful 
part as the threat of pain and injury subsides. Indeed, although motor output remains 
suppressed compared with baseline in the post pain time period, our data 
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demonstrate that motor output has undergone recovery of approximately 50% 15 
minutes after pain has resolved (Figure 3.2). Further work is necessary to determine 
the time course of recovery of motor output and the relationship between motor 
output and afferent inhibition to confirm this hypothesis. 
We contend that motor output in the post-pain period may reflect a balance between 
the need for recovery of motor output and protection from the threat of further pain 
and injury. This is supported by evidence of altered activity in the cortical circuits 
thought to support each of these functions. For instance, although SAI and LAI are 
reduced (less inhibition) in the post-pain period, possibly to facilitate motor recovery, 
other inhibitory mechanisms are increased. Short-interval intracortical inhibition 
(SICI), an index of M1 intracortical activity mediated via GABAA receptors on 
inhibitory interneurons (Ziemann et al. 1996b, Di Lazzaro et al. 2000a), is increased 
immediately following the resolution of muscle pain and this is thought to maintain 
a protective motor strategy in the post-pain period by continuing to limit motor 
output (Schabrun et al. 2012). As SICI is known to inhibit the expression of SAI (Stefan 
et al. 2002, Alle et al. 2009), and interacts in an additive manner with LAI when 
activated concurrently (Sailer et al. 2002), it is possible that SICI is the dominant 
mechanism during this early post-pain time-period, ensuring a protective strategy 
persists until the threat of pain is completely removed. Once all threat has dissipated, 
SICI may reduce, and mechanisms such as SAI and LAI may become dominant, 
facilitating recovery of motor output. However, SICI as only been investigated in the 
period immediately following the resolution of acute pain (Schabrun et al. 2012), and 
it is unknown how the temporal profile of this mechanism is altered in relation to SAI, 
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LAI and motor output over an extend time-frame. Future work should seek to 
examine the interaction of these mechanisms over a prolonged time-period once 
pain has resolved. 
Our observation that LICI remains unchanged in response to pain is further evidence 
that the response to pain varies across different inhibitory networks. Unlike SICI, the 
effects of LICI are mediated via GABAB receptors located on M1 interneurons 
(Werhahn et al. 1999, McDonnell et al. 2006), therefore the results of the present 
study suggest that the effect of pain differs amongst GABA receptor subtypes. 
Although it is unclear why GABAA, but not GABAB mediated inhibition is affected by 
pain, one possible explanation may be that LICI is more robust than SICI and less 
sensitive to transient changes in afferent input. Indeed, since reductions in LICI have 
been observed in chronic pain conditions such as fibromyalgia and rheumatoid 
arthritis (Salerno et al. 2000), it is likely that the effect of pain on LICI may depend 
upon symptom duration. Alternatively, as LAI has been demonstrated to interact with 
LICI in an intensity dependent manner (Sailer et al. 2002), it is possible that LICI 
remained unaffected during or immediately post pain due to the stability of LAI at 
these time points. However, since LAI was reduced 15 minutes post pain but LICI was 
unchanged, further work is needed to determine whether LICI/LAI interactions are 
relevant during and/or following a painful episode. 
A vehicle control was not included in the current study for several reasons. First, use 
of such a control is common in both animal and human studies of experimental pain 
and rarely, if ever, shows an effect (Adachi et al. 2008, Nash et al. 2010b). Indeed, 
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previous studies of similar methodology have demonstrated no effect of 
intramuscular isotonic saline solution on the amplitude or latency of MEPs to muscles 
of the upper limb (Le Pera et al. 2001, Martin et al. 2008). Second, numerous studies 
demonstrate that measures of M1 organisation and function are stable and reliable 
over time (Uy et al. 2002, Malcolm et al. 2006, Ngomo et al. 2012). For example, 
corticomotor output has been shown to be stable during 30 minutes of controlled, 
quiet sitting (Svensson et al. 2003c) and is reliable over short (0-4 days) and long (0-
14 days, 0-1 months) intersession intervals (Malcolm et al. 2006, Ngomo et al. 2012). 
Similarly, LICI and SAI have been shown to be stable over testing intervals of one and 
seven days, respectively (Farzan et al. 2010, Fischer et al. 2011). Taken together, 
these observations indicate that the measures used in this study are not sensitive to 
time effects and our findings are unlikely to be replicated in a no pain control 
condition. 
This study has several limitations that should be acknowledged. First, we did not 
collect data from muscles other than FDI and thus, this study is not able to determine 
whether reductions in SAI and LAI are muscle specific. However, results from previous 
studies suggest a non-specific, but localised, effect of hand pain on corticomotor 
output. For example, muscle pain induced in FDI has been shown to reduce 
corticomotor output of distant hand muscles (abductor digiti minimi) (Le Pera et al. 
2001, Schabrun et al. 2012), but not of proximal forearm muscles (flexor carpi ulnaris) 
(Svensson et al. 2003c). Further research is required to determine whether 
reductions in SAI and LAI are confined to the muscle in pain, or extend to other local 
hand and forearm muscles.  
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The ISIs selected for the assessment of SAI, LAI and LICI also require discussion. In 
early studies of SAI, the ISIs tested were based on calculations of the specific latency 
of the N20 component of the somatosensory evoked potential observed following 
median nerve stimulation for each participant (Tokimura et al. 2000). Following ulnar 
nerve stimulation, the latency of this component is known to occur within the range 
of 19.93 ± 1.1ms (Fischer et al. 2011) to 20.7 ± 0.7ms (Alle et al. 2009). As inter-
individual variability for SAI has been shown to be high within the optimal test range 
(Wassermann 2002, Fischer et al. 2011) and SAI is decreased or absent if afferent 
stimulation fails to correspond with the latency of N20, it is possible that that the 
stimulus parameters used in this present study may have been suboptimal for some 
participants. As this limitation necessitated the exclusion of six participants from SAI 
and LAI analysis, future research should seek to use stimulus parameters specific to 
induce inhibition in each individual participant. Two participants who responded with 
MEP facilitation to the LICI protocol were also excluded as there is evidence that such 
facilitation is due to the interference of intracortical facilitatory mechanisms (Ni et al. 
2007). Future work concerning LICI should seek to investigate the effect of pain at 
intervals < 160ms as recent evidence suggests that LICI evoked using early (~100ms) 
and late (~150ms) test intervals (Vallence et al. 2012, Vallence et al. 2014) may 
differentially reflect pre- and postsynaptic inhibitory processes (Chu et al. 2008).  
Finally, the reliability of these findings may be improved by increasing the number of 
pulses used for cortical assessments. In the present study, 15 MEPs were recorded to 
provide an estimate of corticomotor output, and 12 MEPs for measures of 
afferent/intracortical inhibition.  Although trials of 12-15 MEPs are common among 
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TMS studies of acute muscle pain (Schabrun et al. 2012, Schabrun et al. 2013, 
Schabrun et al. 2016), recent literature indicates that higher numbers of MEPs may 
be required for reliable assessment (Chang et al. 2016, Goldsworthy et al. 2016). 
While increasing the number of TMS pulses may improve accuracy, it is also time 
consuming. As time is a precious commodity in acute pain studies, extending the 
number of MEPs within each testing block should be done with caution.  For example, 
it is likely that increasing the number of trials in the present study from 12/15 to the 
recommended 30 MEPs (Goldsworthy et al. 2016) would have affected the timing 
between measures and thus negatively impacted the integrity of each experiment. In 
the future, studies with similar experimental designs should use the least number of 
trials necessary to achieve reliable outcomes. The minimum number of pulses 
required for the reliable assessment of corticomotor output and intracortical 
inhibition are currently estimated to be 21 and 20, respectively (Chang et al. 2016).  
3.6 Conclusions 
This study is the first to provide evidence of reduced SAI and LAI following acute 
muscle pain. We hypothesize that these responses may reflect the early activation of 
mechanisms that restore normal motor function after the resolution of pain. It is 
possible that a protective motor strategy (reduced corticomotor output) prevails 
early after the resolution of pain, despite reductions in SAI and LAI, due to the 
existence of competitive interactions between SAI/LAI and other inhibitory networks. 
Further studies are required to confirm this hypothesis. If confirmed, these data may 
have relevance for the design of clinical interventions that aim to restore motor 
output in musculoskeletal pain conditions.
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Chapter 4: 
Altered function of intracortical networks in 
chronic lateral epicondylalgia 
 
There is consistent evidence of reduced, or indeed absent, intracortical inhibition in 
chronic musculoskeletal pain. These findings are hypothesized to underpin altered 
M1 function, M1 reorganisation and contribute to pain maintenance in some 
conditions. This chapter reports on the findings of an observational study designed 
to investigate whether intracortical networks associated with long interval 
intracortical inhibition (LICI), short interval intracortical inhibition (SICI) and 
intracortical facilitation (ICF) function differently in persons with chronic elbow pain 
(lateral epicondylalgia) compared to pain-free individuals. The content of this chapter 
has been published in Burns E, Chipchase LS, Schabrun SM (2016). Altered function of 
intracortical networks in chronic lateral epicondylalgia. European Journal of Pain. 
20(7): 1166-75.  A copy of this publication is provided in Appendix C. 
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4.1 Abstract 
Lateral epicondylalgia (LE) is a musculotendinous condition characterized by 
persistent pain, sensorimotor dysfunction and motor cortex reorganisation. Although 
there is evidence linking cortical reorganisation with clinical symptoms in LE, the 
mechanisms underpinning these changes are unknown. Here we investigated activity 
in motor cortical (M1) intracortical inhibitory and facilitatory networks in individuals 
with chronic LE and healthy controls. Surface electromyography was recorded 
bilaterally from the extensor carpi radialis brevis (ECRB) muscle of 14 LE (four males, 
41.5 ± 9.9 years) and 14 control participants (four males, 42.1 ± 11.1 years). 
Transcranial magnetic stimulation of M1 was used to evaluate resting and active 
motor threshold, corticomotor output, short- (SICI) and long-latency intracortical 
inhibition (LICI) and intracortical facilitation (ICF) of both hemispheres. In individuals 
with LE, SICI (p = 0.005), ICF (p = 0.026) and LICI (p = 0.046) were less in the M1 
contralateral to the affected ECRB muscle compared with healthy controls. Motor 
cortical threshold (rest: p = 0.57, active: p = 0.97) and corticomotor output (p = 0.15) 
were similar between groups. No differences were observed between individuals 
with LE and healthy controls for the M1 contralateral to the unaffected ECRB muscle. 
These data provide evidence of less intracortical inhibition mediated by both GABAA 
and GABAB receptors, and less intracortical facilitation in the M1 contralateral to the 
affected ECRB in individuals with LE compared with healthy controls. Similar changes 
were not present in the M1 contralateral to the unaffected ECRB. These changes may 
provide the substrate for M1 reorganisation in chronic LE and could provide a target 
for future therapy. 
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4.2 Introduction 
Lateral epicondylalgia (LE), commonly termed ‘tennis elbow’, is a disabling condition 
affecting the musculotendinous structures at the lateral epicondyle, characterized by 
symptoms of persistent pain and sensorimotor dysfunction (Bisset et al. 2006, 
Skinner et al. 2007, Juul-Kristensen et al. 2008, Coombes et al. 2012). Thought to be 
triggered by repetitive, forceful use of the forearm extensor muscles (Fan et al. 2009), 
LE affects 1-3 per cent of the general population and 15% of workers, with high rates 
of symptom persistence and recurrence (Shiri et al. 2006). Recent evidence suggests 
that altered primary motor cortex (M1) organisation could contribute to symptoms 
of pain and motor dysfunction in this condition. For instance, increased excitability, 
greater overlap and a reduced number of discrete cortical peaks have been 
demonstrated in the representations of the elbow extensor muscles in chronic LE, 
and these changes are associated with pain severity (Schabrun et al. 2015b). As M1 
representations are known to be maintained and adjusted by intracortical inhibitory 
(ICI) and facilitatory (ICF) networks (Liepert et al. 1998a), altered activity in these 
networks could underpin altered M1 organisation in LE. 
Intracortical networks can be probed in the human M1 using paired pulse transcranial 
magnetic stimulation protocols. Intracortical inhibition (ICI) measured at short (SICI)- 
and long (LICI)- latencies is thought to reflect activity in GABAA and GABAB receptor 
systems respectively, while intracortical facilitation (ICF) is thought to reflect activity 
in the glutamatergic (NMDA receptor) system, with a relative spinal contribution 
(Ziemann et al. 1998, Werhahn et al. 1999, McDonnell et al. 2006). Studies have 
shown increased ICI, and reduced ICF, in response to acute muscle pain, and these 
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findings are hypothesized to underpin reduced M1 excitability and restriction of 
motor output observed in acute pain (Hodges et al. 2011, Schabrun et al. 2012). 
Conversely, in persistent neuropathic pain, complex regional pain syndrome and low 
back pain, ICI is reduced, a finding that may underpin increased excitability and 
altered organisation of M1 in these conditions (Schwenkreis et al. 2003, Eisenberg et 
al. 2005, Schwenkreis et al. 2010, Masse-Alarie et al. 2012). Similar alterations in 
intracortical networks could be present in LE, yet no study has investigated these 
mechanisms in this condition.  
Understanding the mechanisms that contribute to chronic LE has the potential to 
provide new targets for therapy. Indeed, use of repetitive transcranial magnetic 
stimulation to restore ICI in chronic neuropathic pain is associated with a reduction 
in pain severity, suggesting that therapies designed to target intracortical networks 
may be effective in ameliorating persistent pain (Lefaucheur et al. 2006). Here we 
aimed to investigate the function of M1 intracortical networks mediated by GABAA 
(short-interval intracortical inhibition, SICI), GABAB (long-interval intracortical 
inhibition; LICI) and NMDA receptors (intracortical facilitation, ICF) in individuals with 
persistent LE and healthy controls. Consistent with findings in other persistent pain 
conditions, we hypothesized a reduction in intracortical inhibition in individuals with 
LE. 
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4.3 Method 
4.3.1 Participants 
Fourteen individuals with LE (mean ± standard deviation; four males, aged 41.5 ± 9.9 
years) and 14 age and gender matched healthy controls (four males, aged matched ± 
5 years: 42.1 ± 11.1) participated. As M1 intracortical mechanism are yet to be 
investigated in LE, sample size calculations were based on effect sizes from a previous 
study examining cortical excitability (motor evoked potential amplitude) in LE 
(Schabrun et al. 2015b). Based on these data (difference of means between patients 
and controls: 83%, standard deviation: 0.625mV), it was calculated that a minimum 
sample size of nine participants in each group were needed to observe a statistically 
significant difference (80% power, alpha 0.05) should one exist (Kadam et al. 2010). 
Individuals with LE were included if they had experienced elbow pain over the lateral 
epicondyle for greater than 6 weeks that was provoked by palpation, gripping, 
resisted wrist and/or middle finger extension (Linaker et al. 1999). Exclusion criteria 
included: (1) use of oral or topical pain-relief medication in the preceding 48 hours 
(2) concomitant neck or arm pain that prevented participation in usual work or 
recreational activities (3) corticosteroid injections in the last 6 months and (5) 
evidence of sensory disturbances, history of fractures, elbow surgery, arthritic or 
inflammatory disorders or pain localized to the radiohumeral joint (Coombes et al. 
2009, Coombes et al. 2013). In addition, participants completed a TMS safety 
screening questionnaire and were excluded from enrolment if they had a personal or 
family history of epilepsy, major neurological, respiratory, orthopaedic or circulatory 
disorders, if they were pregnant, had metal in their head or jaw or were taking central 
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nervous system acting medications (Keel et al. 2001).  The study was approved by the 
institutional human medical research ethical committee and performed in 
accordance with the Declaration of Helsinki. All participants provided written, 
informed consent. 
4.3.2 Clinical measures of LE 
4.3.2.1 Pain and disability 
The Patient Rated Tennis Elbow Evaluation (PRTEE) was used to assess pain and 
disability for the week preceding the experiment (Macdermid 2005). Scores for pain 
(sum of five items out of 50) and function (sum of ten items, divided by 2, out of 50) 
were combined to give a total score ranging from 0 (no pain and no functional 
impairment) to 100 (worst pain imaginable with significant functional impairment). 
Current pain intensity was recorded using an 11-point numerical rating scale (NRS) 
anchored with ‘0’ as no pain and ‘10’ as worst pain imaginable.  
4.3.2.2 Pressure pain thresholds (PPT) 
A handheld pressure algometer (Commander probe size 1cm2, JTECH Medical) was 
applied perpendicular to the extensor carpi radialis brevis (ECRB) muscle at a steadily 
increasing rate of pressure. ECRB was located via palpation during resisted middle 
finger and wrist extension. The location of the muscle belly was marked on the skin 
with an oily-tipped pen to ensure accurate probe placement between trials. 
Participants were instructed to vocalize at the exact moment they perceived the 
sensation of pressure first turn to pain. Pressure pain threshold (N) was assessed for 
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each arm and defined as the average of five consecutive trials (rate of 1 trial every 
10s). 
4.3.2.3 Pain-free grip strength and maximum grip strength 
Pain-free and maximum grip strength were assessed using a hand-held dynamometer 
(Baseline Digital Hand dynamometer, Chattanooga Group, UK). Participants assumed 
a seated position and were assisted in placing their arm in 90° shoulder flexion, full 
elbow extension and neutral forearm pronation (De Smet et al. 1998). For pain-free 
grip strength, participants were instructed to squeeze the dynamometer, but to 
cease immediately at the onset of pain. To assess maximal grip strength, participants 
were instructed to squeeze the dynamometer as hard as possible, regardless of pain. 
Grip strength (kg) of each arm was determined based on the average of three 
consecutive trials (rate 1 trial every 30s).  
4.3.3 Neurophysiological measures 
4.3.3.1 Electromyographic recordings 
Surface electromyography (EMG) was recorded from ECRB using dual silver-silver 
chloride disposable electrodes (spacing 2.0cm). Electrode position was determined 
following palpation of ECRB during resisted wrist and middle finger extension. The 
ground electrode was positioned over the olecranon. EMG signals were amplified 
x1000 (NL844, Digitimer Ltd, Welwyn Garden City, UK), band-pass filtered: 20-1000 
Hz and sampled at 2000 Hz using a Micro3 1401 Data Acquisition System and Signal5 
software (Cambridge Electronic Design, Cambridge, UK).  
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4.3.3.2 Motor threshold and corticomotor output 
Transcranial magnetic stimulation (TMS) was delivered to the primary motor cortex 
using a Magstim 200 stimulator (Magstim Co. Ltd., Dyfed, UK) connected to a circular 
coil (90mm diameter) and all procedures adhered to the TMS checklist for 
methodological quality (Chipchase et al. 2012). Early pilot trials showed that MEPs 
were more reliably elicited from ECRB when TMS was performed using a circular coil.  
Circular coils provide a strong, deep and broad induced electric current and are 
formally recommended for diagnostic TMS (Groppa et al. 2012). The coil was oriented 
to induce posterior-anterior current flow (left hemisphere: anticlockwise current 
direction; right hemisphere: clockwise current direction), and positioned over the 
optimal scalp position for ECRB (Groppa et al. 2012). This position was determined 
by systematic application of TMS to the scalp until the site that produced the largest 
motor evoked potential (MEP) was identified. A Brainsight neuronavigation system 
(Rogue Research Inc, Quebec, Canada) ensured accurate coil placement throughout 
each experiment. Resting and active motor threshold were determined at the optimal 
position via the maximum-likelihood protocol (Motor threshold Assessment Tool, 
version 2.0: http://www.clinicalresearcher.org/software.htm) (Awiszus 2003). 
Resting motor threshold (RMT) was defined as the minimum stimulus intensity that 
evoked a MEP greater than 50µV in the target muscle at rest (Rossini et al. 1994). 
Active motor threshold (AMT) was defined as the minimum stimulus intensity that 
evoked a MEP greater than 200µV during isometric contraction of ECRB (10% 
maximum voluntary contraction [MVC]) (Rossini et al. 1994). Thirty MEPs were 
recorded from resting ECRB at 120% RMT to assess corticomotor output (rate of 1 
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pulse every 6s). Trials containing muscle activity within 50ms preceding the TMS 
pulse were discarded (Groppa et al. 2012). 
4.3.3.3 Short-interval intra-cortical inhibition (SICI) and intra-cortical facilitation (ICF) 
A standard paired-pulse TMS protocol that consisted of a sub-threshold conditioning 
stimulus delivered 2 or 10ms before a supra-threshold test stimulus, was used to 
evaluate short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF), 
respectively (Kujirai et al. 1993). Magnetic stimulation was delivered at the optimal 
scalp site to evoke a response in ECRB with the muscle at rest. Conditioning intensity 
was based on a percentage of AMT to decrease the likelihood of SICI and ICF 
measurements being influenced by other intracortical mechanisms, such as short-
interval intracortical facilitation (sICF) (Ortu et al. 2008, Peurala et al. 2008). However, 
as individual variability for SICI thresholds is known to be high (Orth et al. 2003), 
testing SICI at a single ‘optimal’ conditioning intensity is unlikely to reflect the true 
maximum inhibition for all individuals. Thus, to account for between-subject 
variability to paired-pulse TMS (Boroojerdi et al. 2000, Maeda et al. 2002, 
Wassermann 2002) and to investigate the stimulus-response profile of SICI and ICF, 
three conditioning intensities were used in this experiment. The intensities 70, 80, 
90% of AMT were selected as these are known to elicit reliable SICI and ICF in healthy 
individuals (Ortu et al. 2008, Peurala et al. 2008). As MEPs from proximal upper limb 
muscles are typically smaller and less defined than those evoked from distal muscles 
(Chen et al. 1998, Groppa et al. 2012), test stimulus intensity was set to evoke a test 
MEP with a peak-to-peak amplitude of approximately 0.3 - 0.5mV in all subjects  
(Perez et al. 2008, Schwenkreis et al. 2011). SICI/ICF at 70%, 80% and 90% AMT 
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conditioning intensity were tested in separate blocks. Within each block, twelve trials 
were recorded in pseudorandom order at each inter-stimulus interval (ISI; 2ms, 
10ms) and for the test stimulus alone (rate of 1 every 6s; total of 36 trials).  
4.3.3.4 Long-interval intra-cortical inhibition (LICI) 
Long-interval intracortical inhibition (LICI) was evaluated using a supra-threshold 
conditioning stimulus delivered before a supra-threshold test stimulus (Claus et al. 
1992). Evidence suggests that spinal mechanisms may contribute to the inhibitory 
response when conditioning stimuli precedes the test stimulus by 80-100ms (McNeil 
et al. 2009, 2011). Thus, in order to reduce the likelihood of a spinal contribution in 
the present study, LICI was tested using an inter stimulus interval (ISI) of 160ms. 
Stimulations were performed at the optimal scalp site to evoke a response in ECRB at 
rest. The test and conditioning intensities were equal and set to evoke a peak-to-peak 
response of approximately 0.3 - 0.5mV in ECRB. Twelve trials were recorded in 
pseudorandom order at ISI 160ms and for the test stimulus alone (rate of 1 every 6s; 
total of 24 trials).  
4.3.4 Experimental protocol 
All experimental procedures were conducted in a single test session. Data collection 
was performed in the following order: (1) clinical outcome measures (LE participants 
only), (2) resting and active motor threshold, (3) corticomotor output (MEPs), (4) SICI 
and ICF (three conditioning intensities: 70, 80, 90% of AMT) and (5) LICI. TMS 
measures were repeated over both hemispheres for consenting participants. Rest 
intervals of at least 2 minutes were provided between each measure.  
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4.3.5 Data and statistical analysis 
4.3.5.1 Clinical measures of LE 
Measures of PPT, maximum grip strength and pain-free grip strength were compared 
between sides (affected vs. unaffected arm) for individuals with LE. Pearson 
correlation coefficients were used to evaluate relationships between (1) pain (NRS) 
and disability (PRTEE), sensorimotor function (PPT, max grip strength, pain-free grip 
strength) and (2) SICI, ICF and LICI of the corresponding hemisphere. 
4.3.5.2 Neurophysiological measures 
MEP data were measured as peak-to-peak amplitudes and averaged for each trial. 
Intracortical inhibition (SICI, LICI) and facilitation (ICF) were calculated by expressing 
the mean peak-to-peak conditioned MEP amplitudes as a percentage of the 
unconditioned (test) response. 
All neurophysiological outcomes (RMT, AMT, MEP, SICI, ICF and LICI) were assessed 
for normality via the Shapiro-Wilk test, transformed if necessary, and compared 
between groups (LE vs. control) for each hemisphere using separate one-way 
ANOVAs. To account for any potential influence of handedness, data corresponding 
to the affected/non-affected limb of LE participants was appropriately matched to 
the dominant/non-dominant limb of their specific age and gender matched control. 
As the amplitude of the unconditioned (test) MEP can affect the magnitude of SICI, 
ICF and LICI (Chen et al. 1998, Udupa et al. 2010), test MEP amplitude was also 
compared between groups with one-way ANOVAs. One-way repeated measures 
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ANOVA were used to compare data contralateral and ipsilateral to the affected limb 
within the LE group. Post hoc analyses were corrected for multiple comparisons using 
the Holm-Sidak method. Statistical significance was set at P < 0.05. Data in text are 
expressed as mean ± standard deviation unless stated otherwise. 
4.4 Results  
4.4.1 Clinical measures of LE 
Patient characteristics are summarized in Table 4.1. Average current pain intensity 
was 3.5 ± 2.8 on the NRS and the average combined score for the pain and function 
subscale of the PRTEE was 38.4 ± 19.0. Individuals with LE demonstrated reduced 
strength for the affected arm compared to the unaffected arm in the pain-free 
(affected: 18.6 ± 18.2kg; unaffected:  32.1 ± 12.8kg; main effect, F(1,13) = 12.09, p = 
0.004) and maximal grip strength tasks, however results for the latter failed to reach 
statistical significance (affected: 30.3 ± 15.0 kg; unaffected:  34.7 ± 11.2kg; main 
effect, F(1,13) = 3.75, p = 0.075). Pressure pain thresholds were less for ECRB of the 
affected arm compared to the unaffected arm (affected: 17.8 ± 8.7kg; unaffected:  
21.4 ± 7.4kg; main effect, F(1,13) = 7.42, p = 0.017), suggesting increased sensitivity to 
mechanical stimuli in the affected limb. 
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Table 4.1 Demographic and clinical characteristics for individuals with lateral  
epicondylalgia (n = 14). 
PRTEE, patient rated tennis elbow evaluation (pain and disability); NRS, numerical rating scale. 
  
SUBJECT GENDER 
AGE 
(years) 
DURATION 
(months) 
DOMINANT 
ARM 
AFFECTED 
ARM 
PRTEE 
(/100) 
NRS 
(/10) 
1 F 52 288 R R 35 2 
2 F 38 3 R R 79 7 
3 M 44 12 R R 14 0.5 
4 F 45 7 R R 45 6 
5 F 48 7 R R 31.5 2 
6 F 43 3 R R 17 0 
7 F 50 24 L R 24 0.5 
8 M 46 60 R R 22 2 
9 F 45 3 R R 67 7.5 
10 M 20 3 R R 32.5 1 
11 M 37 4 R R 34.5 6 
12 F 21 24 R L 56 7 
13 F 50 60 R L 30 3 
14 F 42 24 R R 50.5 5 
Chapter 4 
108 
 
4.4.2 Neurophysiological measures 
4.4.2.1 TMS of the hemisphere contralateral to the ‘affected’ arm in LE and the 
matched hemisphere in healthy controls 
There was no difference in resting motor threshold (LE: 48.6 ± 8.5; Control: 50.7 ± 
10.4; main effect, F(1,26) = 0.33, p = 0.57), active motor threshold (LE: 45.6 ± 9.3; 
Control: 45.4 ± 8.9; main effect, F(1,26) = 0.002, p = 0.97) or corticomotor output (LE 
MEP amplitude: 0.30 ± 0.14mV; Control: 0.53 ± 0.46mV; main effect, F(1,26) = 2.19,  p 
= 0.15) between individuals with LE and healthy controls.  
The magnitude of SICI and ICF observed for ECRB of healthy controls was consistent 
with previous investigations of similar methodology (circular coil, 2ms, 10ms ISI) 
(Shimizu et al. 1999). Short-interval intracortical inhibition (SICI) was less in 
individuals with LE compared to healthy controls at a conditioning intensity of 90% 
AMT (main effect, F(1,26) = 9.58, p = 0.005), but was similar between groups at 
conditioning intensities of 70% and 80% AMT (70%: main effect, F(1,26) = 1.46,  p = 
0.24; 80%: main effect, F(1,26) = 0.47, p = 0.50; Figure 4.1A). Similarly, long-interval 
intracortical inhibition (LICI) was less in individuals with LE when compared with 
controls (main effect, F(1,26) = 4.40,  p = 0.046; Figure 4.2A).  Intracortical facilitation 
was less in LE participants compared with healthy controls at a conditioning intensity 
of 80% AMT (main effect, F(1,26) = 5.58,  p = 0.026; Figure 4.1C), but not at 70% (main 
effect, F(1,26) = 0.004, p = 0.95) or 90% AMT (main effect, F(1,26) = 0.64,  p = 0.43). Test 
MEP amplitudes were comparable between groups for LICI (main effect, F(1,26) = 1.10, 
p = 0.30) and for each SICI and ICF conditioning intensity (70% AMT: main effect, F(1,26) 
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= 1.10,  p = 0.30; 80% AMT: main effect, F(1,26) = 0.003,  p = 0.96; 90% AMT: main 
effect, F(1,26) = 0.31, p = 0.58). Taken together, these findings suggest that inhibition 
and facilitation are reduced under certain test conditions, in individuals with LE. The 
magnitude of SICI 90% AMT, ICF80% AMT and LICI did not correlate with pain (SICI: r 
= 0.035, p = 0.91; ICF: r = -0.13, p = 0.65; LICI: r = 0.013, p = 0.97), PRTEE disability 
(SICI: r = -0.11, p = 0.71; ICF: r = -0.20, p = 0.50; LICI: r = -0.01, p = 0.97), PPT (SICI: r = 
-0.35, p = 0.22; ICF: r = -0.40, p = 0.16; LICI: r = -0.34, p = 0.23), max grip strength (SICI: 
r = -0.39, p = 0.17; ICF: r = -0.31, p = 0.29; LICI: r = -0.37, p = 0.19) or pain-free grip 
strength (SICI: r = -0.34, p = 0.23; ICF: r = -0.22, p = 0.46; LICI: r = -0.27, p = 0.35)in the 
affected arm . 
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Figure 4.1 Group data (mean ± standard error) for short-interval intracortical 
inhibition (SICI) and intracortical facilitation (ICF) over the hemisphere contralateral 
(LE, n = 14; control, n = 14) and ipsilateral (LE, n = 10; control, n = 10) to the affected 
arm of LE participants (black bars) and the matched arm of healthy controls (grey 
bars). Trials were performed using conditioning stimulus (CS) intensities 70%, 80% and 
90% of active motor threshold (AMT). SICI and ICF were determined by expressing the 
conditioned MEP as a percentage of the unconditioned test MEP (percentage of test 
MEP). A) LE participants displayed less SICI (less inhibition, higher percentage of the 
test MEP) for the contralateral hemisphere compared to healthy controls at CS 90% 
AMT. B) There was no difference in SICI between groups for the ipsilateral hemisphere. 
C) LE participants displayed less ICF (less facilitation, lower percentage of the test 
MEP) for the contralateral hemisphere compared to healthy controls at CS 80% AMT. 
D) There was no difference in ICF between groups for the ipsilateral hemisphere. * p 
< 0.05. 
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Figure 4.2 Group data (mean ± standard error) for long-interval intracortical 
inhibition (LICI) over the hemisphere contralateral (LE, n = 14; control, n = 14) and 
ipsilateral (LE, n = 10; control, n = 10) to the affected arm of LE participants (black 
bars) and the matched arm of healthy controls (grey bars). LICI was determined by 
expressing the conditioned MEP as a percentage of the unconditioned test MEP 
(percentage of test MEP). LE participants displayed less LICI (less inhibition, higher 
percentage of the test MEP) for the contralateral hemisphere compared to healthy 
controls (A), however no difference was detected between groups for the ipsilateral 
hemisphere (B). * p < 0.05. 
 
 
4.4.2.2 TMS of the hemisphere ipsilateral to the ‘affected’ arm in LE and the matched 
hemisphere in the healthy controls 
Ten LE (three males, aged 40.2 ± 11.8 years) and 10 control participants (three males, 
aged 42.0 ± 12.3 years) consented to TMS of the ipsilateral hemisphere. Of the 
participants who chose to withdraw from this part of the study, all cited poor 
tolerability to TMS as the reason for their decision. Similar to data obtained from the 
contralateral hemisphere, there was no difference in resting motor threshold (LE: 
47.8 ± 10.7; Control: 49.5 ± 13.7; main effect, F(1,18) = 0.10,  p = 0.76), active motor 
threshold (LE: 45.6 ± 10.0; Control: 46.0 ± 9.9; main effect, F(1,18) = 0.008,  p = 0.93) or 
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corticomotor output (LE: 0.28 ± 0.14mV; Control: 0.33 ± 0.22mV; main effect, F(1,18) = 
0.39,  p = 0.54) between groups.  
The magnitude of SICI was similar between those with and without LE under all test 
conditions (70%: main effect, F(1,18) = 0.01,  p = 0.91; 80%: main effect, F(1,18) = 0.004,   
p = 0.95; 90%: main effect, F(1,18) = 0.02,  p = 0.89; Figure 4.1B), and this was the same 
for measures of LICI (main effect, F(1,18) = 2.36, p = 0.14; Figure 4.2B) and ICF (70% 
AMT: main effect, F(1,18) = 0.0003,  p = 0.99; 80%: main effect, F(1,18) = 0.14,  p = 0.71; 
90%: main effect, F(1,18) = 0.65,  p = 0.43; Figure 4.1D). The amplitude of the test MEP 
was comparable between groups for LICI (main effect, F(1,18) = 2.64, p = 0.15) and for 
each SICI and ICF conditioning intensity (70% AMT: main effect, F(1,18) = 0.84,  p = 0.37; 
80% AMT: main effect, F(1,18) = 3.61,  p = 0.07; 90% AMT: main effect, F(1,18) = 1.84,  p 
= 0.19).  
4.4.2.3 Comparison of TMS of the hemisphere contralateral and ipsilateral to the 
‘affected’ arm in LE  
There was no difference in resting motor threshold (F(1,9) = 0.08, p = 0.78), active 
motor threshold (F(1,9) = 0.57, p = 0.47) or corticomotor output (F(1,9) = 0.48, p = 0.50) 
between the motor representations of ECRB of the affected or unaffected arm for 
individuals with LE consenting to TMS of both hemispheres (n = 10). Similarly, there 
was no difference in SICI (70%: F(1,9) = 1.87, p = 0.21, 80%: F(1,9) = 0.00003, p = 0.99, 
90%: F(1,9) = 0.07, p = 0.80) or ICF (70%: F(1,9) = 0.78, p = 0.40, 80%: F(1,9) = 2.55, p = 
0.15, 90%: F(1,9) = 2.34, p = 0.16) at any conditioning intensity. LICI was also 
comparable between hemispheres (F(1,9) = 0.04, p = 0.86) as were test MEP 
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amplitudes for the paired-pulse protocols (SICI/ICF 70%: F(1,9) = 0.009, p = 0.93, 80%: 
F(1,9) = 3.24,  p = 0.11, 90%: F(1,9) = 0.19,  p = 0.68; LICI: F(1,9) = 0.06,  p = 0.81). 
4.5 Discussion 
This study is the first to investigate M1 intracortical networks in individuals with 
chronic LE. We demonstrate less intracortical inhibition mediated by both GABAA and 
GABAB receptors, and less intracortical facilitation, in the M1 contralateral to the 
affected ECRB in individuals with LE compared with healthy controls. Similar changes 
were not present in the M1 contralateral to the unaffected ECRB. These changes may 
provide the substrate for altered M1 organisation in chronic LE and could provide a 
target for future therapy.  
Individuals with LE displayed on average, 27% less inhibition in networks mediated 
by GABAA (SICI) and 50 % less inhibition in networks mediated by GABAB (LICI) for the 
motor representation of the affected ECRB muscle compared with healthy controls. 
These data are suggestive of cortical disinhibition (shift towards greater excitability) 
in LE. However, individuals with LE also displayed 26% less intracortical facilitation 
(ICF) than healthy controls, suggesting that ICI and ICF are differentially affected by 
the presence of chronic elbow pain. This finding is not surprising given that ICI and 
ICF are mediated by different receptor systems and are thought to act independently 
(Ziemann et al. 1996a, Ziemann et al. 1998, Werhahn et al. 1999, Ilic et al. 2002, 
McDonnell et al. 2006, Di Lazzaro et al. 2007a). Indeed, despite similar conditioning 
requirements, ICI and ICF are differentially affected by current direction and intensity 
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(Ziemann et al. 1996c), and evoke different patterns of cerebral blood flow (Strafella 
et al. 2001). 
Previous studies investigating intracortical networks typically report no difference or, 
like the present findings, reduced inhibition/facilitation in persons with chronic 
musculoskeletal pain. For example, some studies report less SICI in fibromyalgia 
(Mhalla et al. 2010, Schwenkreis et al. 2011), low back pain (Masse-Alarie et al. 2012) 
and complex regional pain syndrome (Schwenkreis et al. 2003, Eisenberg et al. 2005) 
compared with healthy controls, others report normal levels of inhibition (Salerno et 
al. 2000). Similarly, less ICF has been demonstrated in fibromyalgia (Salerno et al. 
2000, Mhalla et al. 2010) compared with controls, whereas studies of people with 
osteoarthritis and complex regional pain syndrome report no difference 
(Schwenkreis et al. 2003, Eisenberg et al. 2005, Schwenkreis et al. 2010). Only one 
study has examined the effect of musculoskeletal pain on LICI. That study reported 
less inhibition in individuals with fibromyalgia than controls (Salerno et al. 2000). As 
each of these mechanisms are controlled by independent cortical networks (Ziemann 
et al. 1996c), it is plausible for both intracortical inhibition and facilitation to be 
reduced in individuals with LE. However, since the circuits underpinning these 
mechanisms demonstrate complex interactions (Sanger et al. 2001), the relative 
contribution of each mechanism towards corticomotor output in LE remains 
uncertain. 
Since M1 disinhibition has been demonstrated in conditions characterised by pain of 
neuropathic (neuralgia), but not nociceptive (osteoarthritis) origin (Schwenkreis et al. 
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2010), it has been suggested that discrepancies between studies (no change vs. 
decreased inhibition/facilitation) might reflect differences in the pathological process 
of different chronic conditions. Alternatively, it is possible that symptom duration is 
a significant determinant of the direction and extent of M1 cortical change.  Indeed, 
although there is currently little data detailing the progression of cortical change 
during the transition from the acute to the chronic pain state, there is evidence to 
suggest that the direction of these effects differ for acute experimental pain (e.g. SICI 
increased), compared to clinical chronic pain (e.g. SICI decreased or unchanged) 
(Schabrun et al. 2012). In addition to differences in patient characteristics, 
discrepancies between studies in identical pain conditions may also relate to 
methodological factors. For example, in fibromyalgia, ICI is reduced when TMS pulses 
are separated by 2ms (Mhalla et al. 2010, Schwenkreis et al. 2011), but not at 
intervals of 4ms (Salerno et al. 2000) and in the present study, between-group 
differences were only detected using a conditioning intensity of 90% active motor 
threshold for SICI and 80% active motor threshold for ICF. These data indicate that 
studies investigating M1 intracortical networks should use a range of conditioning 
stimulus intensities and inter-stimulus intervals. 
The conditioning stimulus intensity required to observe differences between people 
with LE and healthy controls provides further information on the integrity of 
intracortical networks in this condition. Data from healthy individuals indicate that 
SICI is strongest at a conditioning intensity of 90% active motor threshold and ICF is 
strongest at a conditioning intensity of 80% active motor threshold (Ortu et al. 2008). 
However, individuals with LE displayed the strongest SICI and ICF at 80% and 90% 
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active motor threshold respectively. As the threshold for evoking ICI/ICF is 
hypothesized to reflect the threshold for stimulating axons belonging to GABAergic 
and glutamatergic interneurons respectively (Ziemann et al. 1998, Ilic et al. 2002, 
Orth et al. 2003), these findings suggest that the electrophysiological properties of 
circuits involving these populations may be altered in LE (Di Lazzaro et al. 1998c, 
Hanajima et al. 1998, Di Lazzaro et al. 2006b). Changes to the structure of these 
circuits, such as the proximity of each population to the stimulating coil and the 
orientation of their axons with respect to the induced current, may also contribute 
to altered ICI/ICF thresholds in this condition (Orth et al. 2003). 
The results of the present study provide insight into mechanisms that may contribute 
to the development of altered M1 organisation and motor dysfunction in LE. Rapid 
reorganisation of M1 is thought to depend on changes in synaptic efficacy that rely 
on GABAergic disinhibition and NMDA receptor dependent long-term potentiation-
like mechanisms (Liepert et al. 1998a). Altered function of intracortical networks is 
therefore a plausible mechanism to explain increased map volume, greater MEP 
amplitude and less separation in the cortical representations of the ED and ECRB 
muscles in LE (Schabrun et al. 2015b). In addition, a key function of intracortical 
networks is to facilitate contraction of muscles required for a motor task while 
preventing unwanted movements, muscle overflow and co-contraction of 
surrounding muscles (Liepert et al. 1998b). Motor dysfunction characterized by 
altered muscle synergies between ECRB and other extensor/flexor muscles of the 
wrist (Alizadehkhaiyat et al. 2007), adoption of a flexed wrist posture (Bisset et al. 
2006), diminished ability to generate force (De Smet et al. 1997, Slater et al. 2005) 
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and reduced fine motor performance (Skinner et al. 2007) have been reported in LE. 
Finally, LE is common in people who perform manual tasks with repeated, rapid 
movements of the wrist and forearm (Fan et al. 2009, Descatha et al. 2013) and 
repetitive movement training has been shown to reduce expression of SICI and ICF 
(Nordstrom et al. 2002, Cirillo et al. 2011). One possibility is that repetitive 
movements drive intracortical changes (reduced ICI and reduced ICF as observed in 
the present study) leading to altered M1 organisation, motor dysfunction and pain 
persistence in LE. However, as this study was exploratory in nature and not designed 
to determine causality, further work using longitudinal study designs are needed to 
confirm this hypothesis. Studies investigating larger cohorts of participants and 
studies including individuals in the acute (< 6 weeks) and chronic (> 3 months) stage 
of disease are required to determine the time-course of altered cortical organisation 
and function in LE. 
We did not observe a relationship between ICI/ICF and measures of pain or disability.  
However, previous studies of M1 organisation in LE have shown a relationship 
between the degree of cortical reorganisation (specifically the degree of overlap 
between the representations of ED and ECRB) and pain severity in the last 6 months 
(Schabrun et al. 2015b). It is conceivable that any relationship between ICI/ICF and 
outcomes of pain and disability is non-linear, and depends on the relative 
contribution of changes in ICI and ICF to M1 organisation. This hypothesis would 
explain why features of altered M1 organisation are associated with pain severity in 
LE while intracortical mechanisms are not. Furthermore, although SICI has been 
shown to correlate with pain measures in myofascial pain syndrome (Volz et al. 2013) 
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and complex regional pain syndrome (Schwenkreis et al. 2003), similar findings have 
not been reported for other conditions such as low back pain or fibromyalgia (Mhalla 
et al. 2010, Schwenkreis et al. 2011, Masse-Alarie et al. 2012). Despite these findings, 
it remains possible that therapies that normalise activity in intracortical networks 
could have a role in the treatment of LE and other chronic pain conditions by 
preventing maladaptive reorganisation of M1. Future studies should seek to 
investigate whether therapies capable of targeting intracortical networks, such as 
repetitive TMS, are of benefit in persistent LE and whether normalization of these 
networks is associated with improved M1 organisation.  
Finally, there are several limitations of the present study that should be 
acknowledged. First, it is unclear whether the present findings are typical of the 
general LE population as data were collected from a small sample of convenience. 
Studies involving a larger number of participants are required to confirm our results 
and to further examine potential relationships between neurophysiological 
outcomes and clinical characteristics. Larger trials would also be better able to 
control for confounding variables such as ‘handedness’- a factor not accounted for in 
the in the present study due to the small proportion of LE participants (n = 3) 
experiencing symptoms in the non-dominant arm. Second, since we did not assess 
muscle representations other than ECRB, it is not clear whether the observed changes 
are restricted to the ‘painful’ muscle. Indeed, since the M1 representation of a muscle 
adjacent to ECRB (extensor digitorum) has been found to be similarly altered in LE in 
a previous study (Schabrun et al. 2015b), it may be anticipated that altered inhibitory 
and/or facilitatory network activity may extend to other local muscles. Further 
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research is required to determine whether M1 cortical change is confined to muscles 
located within the immediate vicinity or pain in LE or whether these effects also 
extend to muscles distal and/or proximal to ECRB. Third and final, the reliability of 
these findings may be improved by increasing the number of pulses used for 
intracortical assessments. In the present study, intracortical inhibition/facilitation 
was estimated from the average of twelve pulses at each ISI. As previous 
investigations of these mechanisms in persons with chronic musculoskeletal pain 
have been based on four to ten pulses (Salerno et al. 2000, Mhalla et al. 2010, 
Schwenkreis et al. 2011, Masse-Alarie et al. 2012, Volz et al. 2013, Caumo et al. 2016, 
Masse-Alarie et al. 2016), it was assumed that twelve would be adequate to provide 
a reliable measure of SICI, ICF and LICI in LE. However, more recent evidence suggests 
that a minimum of 20 pulses are required to achieve a reliable estimate of SICI, while 
23 are required for ICF (Chang et al. 2016).  Thus, extending the number of pulses 
used to assess these mechanisms is an important step towards increasing the 
reliability and quality of findings in the future. 
4.6 Conclusion 
This study is the first to provide evidence of reduced intracortical activity mediated 
by GABAA (short-interval intracortical inhibition, SICI), GABAB (long-interval 
intracortical inhibition; LICI) and NMDA (intracortical facilitation, ICF) receptors in 
individuals with chronic LE. We hypothesize that these mechanisms may drive altered 
M1 organisation and aspects of motor dysfunction in this condition. However, 
longitudinal trials on larger subject numbers are required to confirm this relationship. 
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If confirmed, therapies that restore intracortical function may have the potential to 
normalise cortical abnormalities and improve outcomes in LE.
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Chapter 5: 
Temporal and spatial characteristics of post silent 
period electromyographic bursting in low back 
muscles: comparison between persons with and 
without low back pain  
 
The findings of the previous chapter, in conjunction with previous research in this field, 
suggest that cortical disinhibition may be common amongst chronic musculoskeletal 
pain conditions.  This chapter reports on the findings of an observational study designed 
to investigate the temporal and spatial characteristics of a novel, direct measure of 
corticomotor disinhibition (EMG bursting) in persons with chronic low back pain and 
pain-free individuals. The content of this chapter has been published in Burns E, 
Chipchase LS, Schabrun SM (2017). Temporal and spatial characteristics of post silent 
period electromyographic bursting in low back muscles: comparisons between persons 
with and without low back pain. International Journal of Neuroscience. 1-23. A copy of 
this publication is provided in Appendix D. 
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5.1 Abstract 
Recently, a novel measure of cortical disinhibition was identified using transcranial 
magnetic stimulation (TMS). This measure, described as post silent period 
electromyographic (EMG) bursting, may inform on the corticomotor control of 
movement in health and disease, however it has not been investigated for muscles 
outside the hand or in musculoskeletal conditions. Thus, the aim of this study was to 
investigate the temporal and spatial characteristics of ‘EMG bursting’ in individuals with 
and without low back pain (LBP). TMS was used to map the motor cortical representation 
of paraspinal muscles in eleven individuals with LBP and eleven pain-free controls. The 
latency, duration and magnitude of bursting, number of active burst sites, map volume 
and coordinates of the burst ‘hotspot’ were compared between groups.  In pain-free 
controls, the latency, duration and magnitude of bursts were similar to the hand 
however bursts occurred earlier and were of smaller magnitude in LBP. Bursting was 
widespread throughout the cortical representation in both groups, however there was a 
trend towards smaller mean EMG burst and map volume in LBP. Here we confirm the 
presence of EMG bursting in back muscles and provide a description of the spatial profile 
of this mechanism. Our observations in LBP suggest that cortical disinhibition may be 
altered in this condition. 
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5.2 Introduction 
Transcranial magnetic stimulation (TMS) can be used to assess features of the 
corticomotor control of movement in health and disease. In particular, paired pulse 
paradigms have been used to investigate inhibitory activity mediated by gamma-
Aminobutyric acid (GABA) in healthy individuals and in a range of pathological 
conditions. In low back pain (LBP) for example, there is evidence of reduced inhibition in 
networks mediated by GABAA receptors, suggesting changes in these networks might be 
involved in this condition. Recently, a novel single pulse measure of intracortical activity 
has been identified. This response, described as post silent period ‘EMG bursting’, has 
been hypothesized to reflect the activation of GABAB receptors on inhibitory 
interneurons and represent a measure of corticomotor disinhibition (Chin et al. 2012). 
However, despite recurrent observations (Ferbert et al. 1992, Wilson et al. 1995, 
Kimiskidis et al. 2005, King et al. 2006), few studies have specifically examined this 
measure in healthy individuals and there have been no studies in musculoskeletal pain 
conditions. 
EMG burst responses following the cortical silent period have been demonstrated 
following magnetic stimulation of the cortical territory devoted to the hand (Wilson et 
al. 1995, Chin et al. 2012). In a recent investigation, TMS delivered over the motor 
hotspot during volitional contraction consistently evoked transient (~60ms) but distinct 
bursts of muscle activity up to three times the amplitude of background EMG. A 
GABAergic origin for this response was proposed since bursts were largest following 
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longer cortical silent periods (GABAB mediated) and occurred at latencies corresponding 
with a known period of reduced corticomotor inhibition (also GABAB mediated) (Cash et 
al. 2010).  Hence, measurement of EMG bursting may provide further insight into cortical 
processes involving GABA mediated networks in pathological conditions such as LBP. 
However, the temporal characteristics and the cortical distribution of EMG bursts have 
yet to be investigated for muscles outside the hand. It is also unknown whether EMG 
bursting differs between healthy individuals and those with musculoskeletal pathology. 
Thus, the aims of the present study were to: (1) confirm the presence of post silent 
period EMG bursting in low back muscles and (2) examine the spatial and temporal 
profile of EMG bursting using TMS mapping, in persons with and without LBP. We 
hypothesize that examination of burst characteristics in individuals with LBP will reveal 
further evidence of reduced cortical inhibition in this condition. 
5.3 Methods 
5.3.1 Participants 
Eleven right-handed individuals with a history of recurring episodes of non-specific LBP 
(six males, aged 29 ± 7 years) and eleven age and gender matched pain-free controls (six 
males, 27 ± 5 years) participated. Sample size calculations were based on effect sizes 
from a previous study examining GABAergic cortical inhibition in LBP(Masse-Alarie et al. 
2012). Based on these data (difference of means between patients and controls: 56%, 
standard deviation: ± 40.05), it was calculated that a minimum sample size of eight 
participants in each group were needed to observe a statistically significant difference 
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(80% power, alpha 0.05) should one exist (Kadam et al. 2010). Individuals with LBP were 
recruited during an active episode of low back pain (with or without buttock pain). To be 
eligible for inclusion, average pain intensity was required to be greater than 3 on an 11-
point numerical rating scale (NRS) anchored with “no pain” at zero and “worst pain 
imaginable” at 10, and of sufficient intensity to interfere with at least three important 
activities of daily living (assessed via a Patient-Specific Functional Scale) (Stratford et al. 
1995). All participants completed a TMS safety screening questionnaire and were 
excluded from enrolment if they had a personal or family history of epilepsy, major 
neurological, respiratory, orthopaedic or circulatory disorders, if they were pregnant, 
had metal in their head or jaw or were taking central nervous system acting medications 
(Rossi et al. 2011). Additional exclusion criteria for LBP participants included previous 
spinal surgery, the use of analgesic or anti-inflammatory medication in the last month or 
the receipt of treatment from a health professional in the last month. The study was 
approved by the institutional human medical research ethical committee and performed 
in accordance with the Declaration of Helsinki. All participants provided written, 
informed consent. 
5.3.2 Electromyography (EMG) 
Surface electromyography (EMG) was recorded bilaterally from the paraspinal muscles 
3cm lateral to the spinous process of L3 and 1cm lateral to the spinous process of L5 via 
dual silver-silver chloride disposable electrodes (spacing 2.0cm, Noraxon USA Inc, Az, 
USA). These sites record EMG from deep and superficial back muscles including 
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multifidus and erector spinae (Lariviere et al. 2003). Ground electrodes were positioned 
over the anterior superior iliac spine of the same side. EMG signals were amplified x1000 
(NL844, Digitimer Ltd, Welwyn Garden City, UK), band-pass filtered: 20-1000 Hz and 
sampled at 2000 Hz using a Micro1401 data acquisition System and Spike2 software 
(Cambridge Electronic Design, Cambridge, UK).  
5.3.3 Transcranial magnetic stimulation (TMS) 
TMS mapping of the cortical representation of the lumbar paraspinal muscles was 
performed according to procedures outlined previously (O'Connell et al. 2007, Schabrun 
et al. 2014, Schabrun et al. 2015a).  In brief, TMS was delivered to the primary motor 
cortex contralateral to the side of worst pain (or the matched side for pain-free controls) 
using a Magstim 200 stimulator (Magstim Co. Ltd., Dyfed, UK) connected to a figure-of-
eight coil (70 mm wing diameter), oriented with the handle facing posteriorly with 
respect to the midline. The location of the vertex (Cz) was determined using the 10/20 
International EEG Electrode Placement system and registered using a Brainsight 
neuronavigation system (Rogue Research Inc, Quebec, Canada). Starting at the vertex, 
five magnetic stimuli were delivered at 1cm intervals on a 6 x 7cm grid with the aid of 
the neuronavigation instrument.  Stimuli were applied at 100% of stimulator output with 
an inter-stimulus interval of 6 s while participants performed a low-level voluntary 
contraction (20% maximum) of the paraspinal muscles. Target amplitude was 
determined based on the largest root mean square (RMS) EMG achieved during three 3 
second maximal trunk extension efforts performed against manual resistance in sitting 
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(Schabrun et al. 2015a). During testing, participants maintained the appropriate level of 
muscle contraction by sitting forward with the back straight (Tsao et al. 2011a, Schabrun 
et al. 2015a). Visual feedback was provided on a computer monitor to ensure 
symmetrical pre-activation. To ensure that the prolonged sitting and high TMS stimulator 
output required during the mapping procedure did not exacerbate LBP symptoms, pain 
severity was monitored verbally throughout, and evaluated on completion of TMS 
mapping using an 11-point NRS. All procedures adhered to the TMS checklist for 
methodological quality (Chipchase et al. 2012).  
5.3.4 Data analyses  
Analysis of TMS map data was performed using MATLAB 7 (The Mathsworks, USA). EMG 
was full-wave rectified and trials (five) at each scalp site were averaged. Five parameters 
were extracted from these data: (1) MEP amplitude, (2) cortical silent period, (3) 
percentage burst ratio (PBR), (4) burst duration, and (5) burst silent period. To account 
for pre-activation, MEP amplitude (uV) was calculated by subtracting the RMS EMG 
recorded 55 to 5ms prior to stimulation (background EMG) from the RMS EMG between 
MEP onset and offset (Strutton et al. 2005, Tsao et al. 2008, Tsao et al. 2010, Tsao et al. 
2011b). The duration of the cortical silent period (ms) was determined as the time 
between MEP offset and the resumption of EMG equivalent to or greater than that 
present pre-stimulus. If a clear burst in EMG activity was identified following the cortical 
silent period, the RMS of the burst was calculated by manually cursoring burst onset and 
offset. Where a burst was not apparent in a trial, but could be identified in other trials 
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within the set of five, the mean of those bursts were used to calculate RMS EMG for that 
map site (Chin et al. 2012). If no bursts were identified within the set of five trials, RMS 
EMG for that map site was calculated from background EMG 0 - 50ms after the cortical 
silent period. The PBR (%) was calculated by expressing mean burst RMS EMG as a 
percentage of mean background EMG (Chin et al. 2012). The duration of the burst silent 
period (ms) was determined to be the period between burst offset and the resumption 
of RMS EMG equivalent to or greater than that observed pre-stimulus.  To examine the 
spatial profile of EMG bursting in M1, PBR were superimposed over the respective scalp 
sites to generate a ‘PBR map’ for each participant. The number of active burst sites, mean 
PBR of the map (%), PBR map volume and the anterior-posterior and medial-lateral 
location (cm) of the largest MEP (the ‘motor hotspot’) and PBR (‘burst hotspot’) were 
identified for each map. For a map site to be considered ‘active’, at least one trial out of 
five was required to display evidence of EMG bursting. Mean PBR of the map (%) and 
PBR map volume were calculated as the average or sum of PBR recorded at each active 
site, respectively. 
5.3.5 Statistical analyses  
Data for MEP amplitude, cortical silent period, PBR, map volume, burst duration, burst 
silent period were assessed for normality via the Shapiro-Wilk test and compared 
between groups (Control vs. LBP) using separate one-way analyses of variance (ANOVA). 
To ensure that pre-activation during TMS testing did not aggravate pain in the LBP group, 
pain intensity before and after TMS were compared using one-way repeated measures 
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ANOVA. Separate two-way ANOVA were used to compare map hotspots (MEP vs. PBR) 
between groups (Control vs. LBP) in the anterior-posterior and medial-lateral direction. 
Post hoc analyses were corrected for multiple comparisons using the Holm-Sidak 
method. Eta-squared was calculated as a measure of the effect size for each outcome. 
Pearson correlation analyses were performed to examine the relationship between (1) 
cortical silent period duration and PBR in both groups and (2) pain severity and 
neurophysiological outcomes in LBP. Statistical significance was set at P < 0.05. Data in 
text are expressed as mean ± standard deviation unless stated otherwise.  
5.4 Results  
As there was no difference between responses at L3 and L5 within the LBP or pain-free 
groups (p > 0.42), data generated from both recording sites were pooled and compared 
between groups. Normative data and data from individuals with LBP are presented in 
Table 5.1. 
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Table 5.1 Group data (mean ± SD) for controls and individuals with LBP. *p < 0.05. 
 
CONTROL 
(n = 11) 
LBP 
(n = 11) 
Active burst sites (n/42) 38.6 ± 3.5 36.5 ± 7.6 
Map volume (%) 5406 ± 734 4794 ± 1327 
Mean PBR of map (%) 140 ± 13 131 ± 18 
Max PBR of map (%) 229 ± 59 209 ± 77 
MEP at motor hotspot (mV) 0.019 ± 0.013 0.010 ± 0.009* 
Cortical silent period at motor hotspot (ms) 81.4 ± 49.3 53.7 ± 21.3* 
PBR at motor hotspot (%) 150 ± 62 117 ± 46* 
Burst onset at motor hotspot (ms) 123 ± 54 88 ± 23* 
Burst duration at motor hotspot (ms) 57.0 ± 33.6 61.2 ± 25.4 
Burst silent period duration at motor hotspot (ms) 54.3 ± 34.2 54.7 ± 33.1 
PBR, percentage burst ratio; MEP, motor evoked potential. 
 
5.4.1 EMG bursting is present in the low back muscles of pain-free individuals 
5.4.1.1 Burst characteristics of the map in pain-free individuals 
The present data indicate that EMG bursting can be elicited by stimulating multiple scalp 
sites overlying the cortical territory of the low back muscles. Example traces of EMG 
bursting are presented in Figure 5.1 and average PBR maps are presented in Figure 5.2.  
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In pain-free controls, approximately 92% of map sites showed evidence of EMG bursting. 
In this group, the largest burst was more than double the amplitude of background RMS 
EMG (PBR ~229%) and was located 1.3 ± 1.8cm anterior and 1.7 ± 1.7cm lateral to Cz. 
Mean PBR of the map was 140 ± 13% and map volume was 5406 ± 734%.  
 
 
 
Figure 5.1 Representative waveforms demonstrating EMG bursting in the lumbar 
paraspinal muscles of two pain-free subjects (a, b) and one LBP subject (c) during 
sustained 20% MVC. Note that two types of responses were typically observed: a) the 
cortical silent period is terminated by a burst of EMG activity, or b/c) the cortical silent 
period is interrupted by a burst of EMG activity. MEP amplitudes were typically smaller 
and bursts occurred earlier in persons with LBP compared to controls. *Indicates position 
of burst 
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Figure 5.2 Averaged and normalised PBR maps obtained from the lumbar paraspinal 
muscles of a) pain-free individuals and b) individuals with LBP. The horizontal dashed line 
represents the inter-aural line and the vertical dashed line represents the line from the 
nasion to the inion. Cz is located at coordinate 0, 0. Note the difference in magnitude and 
distribution of EMG bursting between groups. 
 
5.4.1.2 Burst characteristics at the motor hotspot in pain-free individuals 
At the motor hotspot, normative data indicated that burst amplitude was approximately 
1.5 times larger than that of background RMS EMG. On average, burst activity 
commenced 123 ± 54ms following magnetic stimulation and lasted 57 ± 33ms. This was 
immediately followed by a period of EMG silence in 10 out of 11 control participants 
(Figure 5.1B). In these participants, the duration of the burst silent period was 54 ± 34ms.  
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A positive correlation between the PBR and the duration of the cortical silent period was 
detected at the motor hotspot (r = 0.54, p = 0.0096). 
5.4.2 Burst characteristics differ for individuals with low back pain compared to pain-free 
controls 
Patient characteristics are summarized in Table 5.2. Average pain intensity on the day of 
testing was 4.0 ± 2.0 on the NRS and the time elapsed since first pain episode was 56 ± 
40 months. The procedure of TMS mapping did not alter pain intensity (F(1,10) = 2.41, p = 
0.15, η2 = 0.028). At the motor hotspot, EMG bursts occurred earlier (F(1,42) = 7.62, p = 
0.009, η2 = 0.15) and were of smaller magnitude in individuals with LBP compared to 
controls (F(1,42) = 4.09, p = 0.050 , η2 = 0.091). There was, however, no detectable 
correlation between pain severity and PBR (r = 0.27, p = 0.22) or pain severity and burst 
onset (r = 0.26, p = 0.24).  Other characteristics including the duration of the burst (F(1,42) 
= 0.23, p = 0.64, η2 = 0.005) and burst silent period did not differ (F(1,30) = 0.001, p = 0.97, 
η2 < 0.001) between groups. The number of active burst sites were also similar for 
individuals with and without LBP (F(1,42) = 1.43, p = 0.24, η2 = 0.033; Figure 5.2A,B), as was 
the maximum PBR of the map (F(1,42) = 1.03, P = 0.32, η2 = 0.024). A trend towards smaller 
mean PBR and map volume was detected for LBP but failed to reach statistical 
significance (mean: F(1,42) = 3.48, p = 0.069, η2 = 0.076; volume: F(1,42) = 3.58, p = 0.065, η2 
= 0.079). The PBR hotspot was located 1.2 ± 1.7cm anterior and 1.8 ± 1.7cm lateral to Cz. 
Two-way ANOVA revealed that the burst hotspot was located significantly closer to the 
midline compared to the MEP hotspot in both groups (Figure 5.3; post hoc: p =0.007) 
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however did not identify an interaction between groups (Medial-Lateral: F(1,84) = 0.38, p 
= 0.54, η2 = 0.004). 
 
Table 5.2 Demographic and clinical characteristics for individuals with LBP (n = 11).  
SUBJECT 
 
GENDER 
 
AGE 
(years) 
SIDE OF PAIN 
 
CURRENT PAIN 
(NRS/10) 
PAIN DURATION 
(months) 
1 F 27 L 1 84 
2 M 36 R 7.5 60 
3 M 39 R 4 100 
4 F 19 R 2 60 
5 M 27 R 6 18 
6 M 41 L 3 60 
7 F 31 R 5 6 
8 M 31 R 6 108 
9 M 24 L 5 6 
10 F 27 L 2 100 
11 F 19 R 3 17 
NRS, numerical rating scale. 
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Figure 5.3 Topographical location (mean ± standard error) of MEP 
hotspot (open markers) and PBR hotspot (filled markers) for LBP 
(squares) and pain-free controls (circles). The horizontal dashed 
line represents the inter-aural line and the vertical dashed line 
represents the line from the nasion to the inion. Cz is located at 
coordinate 0, 0. Each grid square represents 1 x 1cm. Note that the 
PBR hotspot is positioned medially to the MEP hotspot in both 
groups. 
 
 
5.4.3 MEP amplitude and the duration of the cortical silent period are less in LBP 
compared to pain-free controls 
At the motor hotspot, MEP amplitudes were smaller (F(1,42) = 5.90, p = 0.019, η2 = 0.12) 
and the cortical silent period was shorter (F(1,42) = 5.87, p = 0.02, η2 = 0.12) for individuals 
with LBP compared to controls. In contrast to pain-free controls, there was no correlation 
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between PBR and cortical silent period duration at this site for individuals with LBP (r = 
0.21, p = 0.34).  There was also no significant correlation between pain severity and MEP 
amplitude (r = -0.20, p = 0.37) or pain severity and cortical silent period duration (r = 
0.074, p = 0.75) in this group.  
5.5 Discussion 
The results of the present study confirm the presence of post silent period EMG bursting 
in muscles of the low back. We also provide a description of the spatial distribution of 
bursting in the primary motor cortex (M1), and the first account of differences between 
healthy individuals and those with musculoskeletal pain.  
5.5.1 Spatial and temporal characteristics of EMG bursting in the back 
This study utilised TMS mapping techniques to examine the spatial profile of post silent 
period EMG bursting in M1. Our findings show that, like MEPs, EMG bursts may be 
elicited from a number of scalp sites overlying the cortical representation of the lumbar 
paraspinal muscles in individuals with and without LBP. While the magnitude of bursting 
varied across sites, we found the largest responses to be distributed within the posterior 
half of the map. Here, we observed a clear peak in PBR approximately 2cm medial to the 
location of the motor hotspot (Figure 5. 3). In pain-free individuals, PBR at the burst 
hotspot was 53% greater than that recorded at the motor hotspot. Interestingly, this 
difference was more pronounced in LBP (~77%). Differences in PBR at the burst and 
motor hotspots could be evidence that burst and MEP responses are generated by 
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independent cortical networks and may explain previous accounts of bursting in the 
absence of an evoked potential (Ferbert et al. 1992, Wilson et al. 1995). These findings 
also suggest that the motor hotspot may not be the optimal location to assess EMG 
bursting, particularly in patient populations.  
In pain-free individuals, EMG bursts at the motor hotspot demonstrated a similar 
latency, duration and magnitude to those reported in the hand under similar test 
conditions (Chin et al. 2012). Similarly, a positive correlation between the cortical silent 
period and PBR was detected in the present study. Taken together, these findings 
suggest that burst characteristics may be similar across distal and axial muscles. If 
confirmed, responses recorded from the hand could be used to provide a global estimate 
of EMG bursting in M1. This method would be particularly advantageous in patient 
studies where the cortical representation of the affected muscle is positioned deep in 
the cortex and is difficult to target with TMS (e.g. low back or leg muscles) or where 
volitional contraction aggravates pain. However, as we only investigated EMG bursting 
at the site of pain in LBP, further work is needed to determine whether burst 
characteristics are identical for painful and pain-free muscles in this and other 
musculoskeletal pain conditions. 
By confirming the latency and duration of the burst and its affiliation with the cortical 
silent period, our data further supports the hypothesis that post silent period EMG 
bursting represents a measure of the depth and magnitude of disinhibition in M1 (Chin 
et al. 2012). As was the case in the hand, the latency (~120ms) and duration (~50ms) of 
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bursting in the back muscles is consistent with that of a recently described period of late 
cortical disinhibition (Cash et al. 2010). In that study, a period of raised corticomotor 
excitability was noted following the evocation of a form of GABAB-mediated inhibition 
known as long-interval intracortical inhibition (LICI). This effect was attributed to the 
action of pre-synaptic GABAB receptors which function to negatively regulate GABA 
release and facilitate excitatory post-synaptic potentials (Mott et al. 1991, Otis et al. 
1993). This, taken together with evidence linking EMG bursts with the cortical silent 
period (also GABAB-mediated), suggests that this mechanism may reflect the depth and 
magnitude of disinhibition in M1. However, as LICI and late cortical disinhibition have yet 
to be investigated in muscles of the trunk, further work is necessary to determine 
whether these mechanisms are present in the low back and whether this hypothesis also 
holds for our results. 
A novel outcome of the present study was identification of the ‘burst silent period’. While 
previous studies show evidence of EMG bursts terminating the cortical silent period or 
trains of bursts interspersed with low-level EMG in a proportion of test subjects, EMG 
bursts in the present study were followed by a clear period of EMG silence in 20 of 22 
participants (Ferbert et al. 1992, Chin et al. 2012). In pain-free individuals, this episode 
appeared 200ms post stimulus and persisted for ~50ms. Since cortical silent periods 
longer than 85ms have yet to be demonstrated in muscles of the low back (Ferbert et al. 
1992, Strutton et al. 2005), we suggest that this response represents a separate entity, 
rather than a continuation of the cortical silent period. It is possible that this ‘burst silent 
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period’ may signify a return of post-synaptic GABAergic activity following the conclusion 
of the EMG burst, however further work is necessary to establish causation and identify 
the mechanisms involved.  
5.5.2 EMG bursting in Low Back Pain  
At the location of the motor hotspot, bursts occurred earlier and were smaller in 
magnitude in individuals with LBP compared to pain-free controls.  In keeping with 
current hypotheses, we interpret smaller bursts in LBP as evidence of reduced cortical 
disinhibition in this condition. Previous estimates of disinhibition in LBP have been based 
on chance observations in paired pulse studies investigating inhibitory networks in M1. 
In contrast to the present study, those studies cite lower levels of short interval 
intracortical inhibition (SICI) in abdominal and paravertebral muscles in LBP as evidence 
of increased disinhibition in this condition (Masse-Alarie et al. 2012, Masse-Alarie et al. 
2016). Although it is common to interpret a reduction in SICI as a form of disinhibition, 
pharmacological evidence indicates that this mechanism reflects inhibitory processes 
mediated by post-synaptic GABAA receptors (Ziemann et al. 1996a, Di Lazzaro et al. 
2000a), which, unlike the pre-synaptic GABAB receptors proposed to underlie EMG 
bursting (Chin et al. 2012), do not have the innate capacity to negatively regulate 
GABAergic transmission. Furthermore, a number of competitive interactions have been 
documented between SICI and other inhibitory and excitatory mechanisms in M1 
(Sanger et al. 2001, Stefan et al. 2002, Ortu et al. 2008, Alle et al. 2009). Therefore, we 
suggest that the present findings may provide a more accurate account of the depth and 
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duration of M1 disinhibition in LBP.  However, as we found no evidence of a relationship 
between burst characteristics and pain, the clinical significance of these findings remains 
unclear.  
Despite no statistical difference between the location of hotspots between groups, there 
was a trend towards smaller mean PBR and smaller map volume in individuals with LBP. 
These findings are further evidence that the topography and mean excitability of the 
motor representation of low back muscles is altered compared to controls (Tsao et al. 
2011b, Schabrun et al. 2014, Schabrun et al. 2015a). As these changes are hypothesized 
to underpin altered trunk muscle coordination and postural control in LBP, it is possible 
that an abnormal burst mechanism may similarly contribute to motor dysfunction in this 
condition (Tsao et al. 2011b). 
In addition to altered burst characteristics, we also report reduced MEP amplitudes and 
shorter cortical silent periods at the motor hotspot in LBP. While these findings 
complement previous observations of decreased corticomotor excitability (Strutton et 
al. 2005, Tsao et al. 2011c, Schabrun et al. 2015a) and dysfunctional GABAergic 
disinhibition in LBP (Masse-Alarie et al. 2012, Masse-Alarie et al. 2016), they are not 
entirely compatible with our conclusion of reduced cortical disinhibition. Discrepant 
responses to TMS are not uncommon in observational studies and serve to highlight the 
intricate nature of M1, however, methodological factors also have the potential to affect 
study outcomes. For example, in the present study TMS mapping was performed with 
maximum stimulator output (100% intensity) in all participants. While in line with 
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previous studies using surface EMG over muscles of the low back during volitional 
contraction (Ferbert et al. 1992, O'Connell et al. 2007, Schabrun et al. 2014, Schabrun et 
al. 2015a), this methodology may give rise to erroneous results if differences in 
corticomotor excitability exist between groups. Indeed, since the magnitude of the MEP, 
the cortical silent period and EMG burst are reportedly intensity-dependent (Chin et al. 
2012, Kojima et al. 2013), it is possible that our observation of smaller MEPs, smaller 
bursts, shorter silent periods and earlier burst onset in LBP may be a consequence of 
raised motor threshold. However, as motor threshold was not an outcome of the present 
study and there is a lack of consensus regarding this aspect of cortical excitability for low 
back muscles in LBP (Strutton et al. 2005, Masse-Alarie et al. 2016), the impact of this 
factor on our results remains unclear. To prevent such ambiguity in the future, we 
recommend that future studies requiring maximum stimulator output to generate M1 
maps include a measure of active motor threshold to validate their findings, especially if 
abnormal motor threshold is suspected. 
5.5.3 Conclusion 
This study confirms the presence of post silent period EMG bursting in low back muscles. 
We found that the latency, duration and magnitude of bursting in healthy persons was 
similar to that reported previously in the hand however our novel observation of a ‘burst 
silent period’ suggests that this feature may be specific to the back. TMS mapping 
revealed a graded distribution of EMG bursting throughout M1, culminating in one 
definitive ‘hotspot’. Our observation of spatial and temporal differences between 
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individuals with and without LBP may be evidence of altered cortical disinhibition in this 
condition, however further work is necessary to confirm this hypothesis.
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Chapter 6: General discussion 
 
The primary aim of this thesis was to determine the effect of acute (lasting minutes) and 
chronic (lasting months) muscle pain on intracortical inhibition within the primary motor 
cortex (M1). In this chapter, findings from the four studies will be synthesized and 
discussed ‘in toto’ to provide insight into the role of cortical inhibition in acute and 
chronic musculoskeletal pain. Limitations, clinical implications and future directions for 
research will be discussed.  
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6.1 Contribution of the thesis to the body of evidence 
This thesis provides novel and original data on the role of cortical inhibitory mechanisms 
in acute and chronic musculoskeletal pain.  Although musculoskeletal pain is a common 
health complaint affecting up to 47% of the general population (Cimmino et al. 2011), 
the mechanisms associated with the development, maintenance and resolution of pain 
are poorly understood. Current evidence suggests that the organisation and function of 
the primary motor cortex (M1) is altered when pain is present and these changes 
contribute to symptoms of pain and movement dysfunction. Altered cortical inhibition is 
one mechanism that could underpin changes in M1 organisation and function in the 
acute and persistent stages of pain. However, only a small number of studies have 
investigated cortical inhibitory mechanisms in pain. Understanding these mechanisms is 
essential to improve our understanding of a challenging condition and to reveal new 
targets for future treatment. 
A number of different forms of cortical inhibition exist within M1 that can be quantified 
using specific single pulse, paired pulse and mixed stimulation TMS protocols.  Inhibitory 
activity mediated by post-synaptic GABAA and GABAB receptors located on M1 
interneurons can be examined via delivery of paired pulses at specific short (short 
interval intracortical inhibition; SICI) and long (long interval intracortical inhibition; LICI) 
inter-stimulus intervals, while pre-synaptic GABAB mediated disinhibition can be 
observed in electromyographic recordings following single pulse stimulation (post silent 
period electromyographic bursting) (Claus et al. 1992, Kujirai et al. 1993, Ziemann et al. 
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1998, Werhahn et al. 1999, McDonnell et al. 2006, Chin et al. 2012). The interaction 
between sensory input and motor output at the level of the cortex (sensorimotor 
integration) can also be assessed by pairing peripheral nerve stimulation at the wrist with 
cortical stimuli (Chen et al. 1999, Tokimura et al. 2000). Each of these mechanisms has 
the capacity to influence the overall level of inhibition within M1, however the relative 
contribution of each is dependent on the presiding state of cortical excitability and 
complex interactions between specific neural populations. Indeed, results from triple 
pulse protocols indicate that GABAB, GABAA and cholinergic forms of inhibition (SAI/LAI) 
are activated in a hierarchical manner. For example, SICI is suppressed in the presence 
of LICI, yet dominates SAI and is completely independent of LAI (Sanger et al. 2001, Sailer 
et al. 2002, Alle et al. 2009). Thus, investigation of each form of intracortical inhibition is 
essential to inform our understanding of these mechanisms in pain. This thesis explored 
each of these inhibitory mechanisms in the M1 of people experiencing acute and chronic 
pain. In brief, the findings of each study were: 
Study 1:  Provides the first systematic evaluation of the primary sensory (S1) and 
primary motor (M1) cortex response to acute experimental muscle pain 
in healthy volunteers. Synthesis of data from a range of methodologies 
showed moderate to strong evidence of reduced S1 and M1 excitability 
during, and following the resolution of acute experimental muscle pain. 
Study 2:  Provides the first description of the effect of acute experimental muscle 
pain on SAI, LAI and LICI in healthy volunteers. Results demonstrated a 
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reduction in sensorimotor integration (SAI, LAI), but not GABAB mediated 
inhibition (LICI), following the resolution of acute muscle pain. 
Study 3:  Provides the first evidence of reduced intracortical inhibition mediated via 
GABAA/B receptors (SICI and LICI) and reduced intracortical facilitation 
(ICF) in the M1 contralateral to the affected extensor carpi radialis brevis 
muscle in persons with chronic lateral epicondylalgia (elbow pain) 
compared to healthy volunteers. 
Study 4:  Provides the first description of the temporal and spatial profile of 
electromyographic bursting in low back muscles of persons with chronic 
low back pain. Results suggest that cortical disinhibition (GABAB 
mediated) is reduced in persons with chronic low back pain compared to 
healthy volunteers. 
Although each study provided an original contribution to the body of evidence, findings 
from the four studies can be synthesized and discussed ‘in toto’ to provide greater 
insights into the role of cortical inhibition in acute and chronic musculoskeletal pain 
conditions.  
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6.2 Cortical inhibition in acute musculoskeletal pain 
Acute musculoskeletal pain is experienced by almost everyone at some stage in his or 
her life. The onset of acute musculoskeletal pain is accompanied by disturbances in 
sensory and motor function yet, the mechanisms that underpin these changes are poorly 
understood. The first two studies in this thesis provide a comprehensive understanding 
of cortical inhibition in the presence of acute musculoskeletal pain. The first study, a 
systematic review and meta-analysis, aimed to establish the effect of acute muscle pain 
on the primary motor and somatosensory cortices, whereas the second study, extended 
our understanding of several forms of cortical inhibition (SAI, LAI, LICI) that had not 
previously been examined in acute musculoskeletal pain. 
Study 1 provides the first systematic evidence of reduced corticomotor output both 
during and following the resolution of acute experimental muscle pain in healthy 
volunteers.  This effect was strongest for painful muscles tested at rest in the period 
following the resolution of pain, however a moderate reduction in corticomotor output 
was also detected during pain. Due to the small number of studies and differences in 
study design, the duration of corticomotor depression following the resolution of pain 
remains unclear, however data from individual studies suggests that this effect may 
persist for up to 20 minutes following pain (Le Pera et al. 2001). Study 2 confirmed this 
profile of corticomotor depression for the period up to and including 15 minutes post 
pain (Figure 6.1). As a similar effect and time course were also detected for S1 (S1 
excitability was strongly reduced during pain and moderately reduced post pain), it may 
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be concluded that acute muscle pain affects S1 excitability and corticomotor output 
similarly. 
 
The results of the first two studies demonstrate that reductions in corticomotor output 
are accompanied by altered intracortical inhibition. As inhibitory mechanisms play an 
important role in controlling the direction and magnitude of plastic change of excitatory 
corticospinal projections (Murakami et al. 2012), it is possible that altered intracortical 
inhibition may underpin the corticomotor response to pain. For example, increased 
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Figure 6.1 Temporal profile of the corticomotor response to acute 
muscle pain. Data points correspond to before (Baseline), during, 
immediately post (Post), and 15 minutes following (Follow up) the 
resolution of pain. Corticomotor output is expressed as 
MEP/Mwave amplitude ratio. *p < 0.05. Figure appropriated from 
(Burns et al. 2016c). 
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activity in inhibitory networks (and/or decreased activity in excitatory networks) could 
produce a reduction in M1 excitability that in turn, would manifest as a reduction in 
corticomotor output when tested using TMS. Since the systematic review identified 
evidence of increased SICI (enhanced inhibition) in the immediate post pain period and 
reduced ICF (reduced excitation) during and post pain, it is possible that these 
mechanisms underpin reductions in corticomotor output at these time points. However, 
study 2 provided evidence of the opposite effect (less intracortical inhibition) in the post 
pain period when measures of afferent inhibition were made (decreased SAI, LAI). Taken 
together, these data suggest that reductions in corticomotor output could be exclusively 
due to reduced ICF during pain (since SICI, SAI, LAI, LICI are unchanged), but due to a 
combination of reduced ICF and increased inhibition (due to the relative dominance of 
SICI over SAI) in the immediate post pain period. Following this, the corticomotor 
response, although still depressed, begins to recover, perhaps due to the rising influence 
of LAI (decreased inhibition) and potential normalisation of SICI/ICF. The temporal profile 
of these mechanisms in relation to pain and corticomotor output are provided in Figure 
6.2. Together, these data provide novel insight into the temporal profile of intracortical 
inhibitory and facilitatory mechanisms in acute muscle pain. 
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While study 1 and 2 provide detail on the temporal characteristics of intracortical change 
during acute pain, causation remains uncertain. The systematic review found insufficient 
evidence to determine whether reductions in S1 and M1 activity are directly related to 
acute pain, while study 2 demonstrated intracortical change only after the resolution of 
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Figure 6.2 Intracortical activity before, during, immediately post (0 
min), and 15 minutes following the resolution of acute experimental 
muscle pain. Dominant mechanisms at each time point are marked 
by dashed circles. a (Schabrun et al. 2012); b (Burns et al. 2016b); ICF, 
intracortical facilitation; SICI, short interval intracortical inhibition; 
SAI, short latency afferent inhibition; LAI, long latency afferent 
inhibition; LICI, long interval intracortical inhibition; ?, unknown; •, no 
change. 
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pain. Thus, a linear relationship between intracortical measures and pain appears 
unlikely. While further work is needed to identify the internal and/or external factors 
triggering the SICI and ICF response to pain, the findings of study 1 provide insight into 
the origins of reduced SAI/LAI. For example, since the afferent volley that conditions SAI 
and LAI traverses a number of sensory areas before facilitating the inhibitory response 
at M1 (Chen et al. 1999, Abbruzzese et al. 2001, Sailer et al. 2002, Sailer et al. 2003), it is 
possible that reduced SAI/LAI may be a direct consequence of reduced S1 excitability 
during and post pain. Indeed, changes in sensory processing would likely affect 
propagation of the afferent signal along sensorimotor pathways underpinning SAI and 
LAI and culminate in reduced expression of these forms of inhibition at M1. The alternate 
timing of reductions (SAI: immediately post, LAI: 15 minutes post) may reflect the 
differential effect of acute muscle pain on sensorimotor integration involving direct (S1-
M1: SAI) and indirect (basoganglia-thalamocortical: LAI) pathways. 
The M1 response to pain likely reflects a balance between the timely recovery of motor 
output and protection from the threat of further pain and injury. This hypothesis is 
supported by current theory which suggests decreased output to muscles at the site of 
pain may be an adaptation that serves to decrease muscle coordination, prevent 
symptom aggravation and protect an injured limb (Hodges et al. 2011).  The present 
results suggest that this protective strategy may be sustained in the early post pain 
period by an increase in SICI.  Although the temporal profile of SICI after this time is 
unknown, it is possible that SICI may normalise as the threat of pain and injury subsides, 
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allowing mechanisms such as SAI and LAI to become dominant, facilitating a return to 
normal corticomotor output to the painful body part.  
6.3 Cortical inhibition in chronic musculoskeletal pain 
In contrast to observations in acute pain, the effect of chronic musculoskeletal pain on 
M1 excitability and corticomotor output is unclear. For example, motor threshold (a 
measure of the resting membrane potential of corticospinal neurons and a key 
determinant of corticomotor output) is increased for painful muscles in low back pain 
(Strutton et al. 2005), fibromyalgia (Salerno et al. 2000, Mhalla et al. 2010) and the 
shoulder (Bradnam et al. 2016), but unchanged in osteoarthritis and lateral 
epicondylalgia (Schwenkreis et al. 2010, Schabrun et al. 2015b).  Map volume (a measure 
of the aggregate excitability of cells projecting to a given muscle) is reduced for painful 
muscles in low back pain and patellofemoral pain (Tsao et al. 2011b, Te et al. 2017), but 
increased for painful forearm muscles in lateral epicondylalgia (Schabrun et al. 2015b). 
While these findings are generally suggestive of reduced M1 excitability in chronic pain 
(increased motor threshold and decreased map volume), reports of unchanged or 
increased excitability imply that these effects may be disease-specific. 
Contrary to observations of cortical inhibitory pathways in acute musculoskeletal pain, 
there is evidence of less intracortical inhibition in chronic musculoskeletal pain 
conditions when compared with pain free individuals. For example, SICI is reduced in low 
back pain (Masse-Alarie et al. 2012, Masse-Alarie et al. 2016), SICI and LICI are reduced 
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in persons with diffuse pain due to fibromyalgia (Salerno et al. 2000, Mhalla et al. 2010, 
Schwenkreis et al. 2011, Caumo et al. 2016) and SAI is reduced in chronic shoulder pain 
(Bradnam et al. 2016). This thesis expands on these findings by examining inhibitory 
mechanisms previously unexplored in lateral epicondylalgia (SICI, LICI) and chronic low 
back pain (post silent period electromyographic bursting). 
The results of study 3 and 4 demonstrate a reduction in GABAergic inhibition in persons 
with low back pain (LBP) and lateral epicondylalgia (LE). This effect was present for forms 
of inhibition mediated by both GABAA (SICI) and GABAB receptor subtypes (LICI, EMG 
bursting). Reductions in SICI and LICI in LE suggest a shift towards cortical disinhibition 
(greater excitability) whereas the reduced magnitude of EMG bursting in LBP is indicative 
of less cortical disinhibition. Taken together, these findings appear contradictory, 
however since SICI and LICI (at ~150ms latency) are hypothesized to reflect activity 
primarily at the postsynaptic terminal of M1 interneurons (Chu et al. 2008) and EMG 
bursting is thought to reflect the action of presynaptic GABAB receptors (Chin et al. 2012), 
it is physiologically possible that these observations coexist. Indeed, although there has 
yet to be an investigation of EMG bursting in LE or any other musculoskeletal condition, 
previous studies indicate that SICI is also reduced in LBP and fibromyalgia (Mhalla et al. 
2010, Schwenkreis et al. 2011, Masse-Alarie et al. 2012, Caumo et al. 2016, Masse-Alarie 
et al. 2016). Thus, it is possible that simultaneous reductions in these forms of cortical 
inhibition may be present across a range of musculoskeletal conditions, regardless of the 
anatomical site of pain.  
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An additional finding of study 3 was the complete absence of inhibition in some 
individuals with chronic musculoskeletal pain. Although not explicitly stated within the 
manuscript text (due to publishing restrictions), a significant number of individuals with 
LE (7/14) were found to display MEPs greater than 100% of baseline amplitude at one or 
more inhibitory inter stimulus interval (i.e. a facilitatory response). These findings are 
consistent with those of a recent investigation in which SICI was found to be absent in 
six of eight participants with chronic LBP (Masse-Alarie et al. 2016). Like many biological 
characteristics, responses to paired pulse TMS conform to a normal distribution 
(Wassermann 2002) and demonstrate high interindividual variation (Boroojerdi et al. 
2000). Thus, it is possible that responses falling outside of the expected range of values 
merely sit on the tail of this distribution. Indeed, normative values for SICI in the first 
dorsal interosseous muscle have been shown to range from 0% (total inhibition of the 
test MEP) to 330% (test MEPs 3.3 times larger than baseline) for individuals aged 50 years 
or younger (median SICI ~ 20%) (Cueva et al. 2016). Interindividual variability is also 
common for other forms of inhibition, as demonstrated by the small number of subjects 
that did not display SAI, LAI or LICI at baseline in study 2 (Burns et al. 2016c). While 
correlational studies cite physiological differences between individuals such as skull 
thickness or intrinsic neuronal properties as the main source of variation within the 
normal population (Wassermann 2002), it is unclear why such a significant proportion of 
individuals with chronic musculoskeletal pain fail to respond to paired pulse inhibitory 
protocols. Although a pathological origin is possible, current literature has yet to identify 
evidence of a relationship between measures of cortical inhibition and pain severity, 
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level of disability or duration of musculoskeletal pain (Schwenkreis et al. 2011, Kittelson 
et al. 2014, Burns et al. 2016a, Masse-Alarie et al. 2016). A relationship has, however, 
been found between less inhibition and increased levels of catastrophizing and 
depression in persons with fibromyalgia and myofascial pain syndrome (Mhalla et al. 
2010, Volz et al. 2013). As individuals with chronic pain often present with comorbid 
mood/anxiety disorders (Askari et al. 2017), it is possible that behavioural and 
psychological traits could also underpin the tendency towards absent inhibition in LE and 
LBP.  
Taken together, the results of study 3 and 4 provide insight into mechanisms that may 
contribute to the development and maintenance of chronic musculoskeletal pain. 
Inhibitory mechanisms play an important role in the maintenance and adjustment of M1 
motor representations (Liepert et al. 1998a). Thus, although neither study provided 
direct evidence linking neurophysiological outcomes with pain, disability or 
sensorimotor impairments in LE or LBP, it is plausible that these mechanisms underpin 
previous observations of altered map volume, M1 reorganisation and associated motor 
dysfunction in these conditions (Tsao et al. 2008, Tsao et al. 2011b, Schabrun et al. 2014, 
Schabrun et al. 2015a, Schabrun et al. 2015b). Our observation of reduced GABAB 
mediated inhibition in chronic (Burns et al. 2016a, 2017), but not acute musculoskeletal 
pain (Burns et al. 2016c), also suggests that these forms of inhibition may be involved in 
the transition to chronicity. While it remains unclear why LICI is unaffected by acute pain, 
one explanation could be that changes in this mechanism depend upon symptom 
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duration (Parker et al. 2017). In the event of delayed healing and/or ongoing nociceptive 
input, it is possible that GABAB mediated inhibition reduces, which, due to competitive 
interactions with other inhibitory circuits (LICI inhibits SICI, SICI inhibits SAI), ultimately 
influences a shift towards decreased cortical inhibition. This reversal of inhibitory activity 
in chronic musculoskeletal pain may facilitate M1 remodeling and support motor 
adaptations designed to unload painful joints and muscles, redistribute muscle activity 
and minimize discomfort (Hodges et al. 2011). 
6.4 Clinical Implications 
This thesis provides a comprehensive examination of cortical inhibition in acute and 
chronic musculoskeletal pain that can assist our understanding of this condition and 
inform the development of future treatments. Rehabilitation of movement is a mainstay 
of interventions for musculoskeletal pain but there is considerable debate over the type, 
timing and quantity of movement needed to improve symptoms and effect sizes of most 
movement based treatments are at best, modest (Menke 2014). One explanation for 
these small effects is that current treatments are not optimized to target the 
mechanisms of pain. This thesis provides evidence of increased intracortical inhibition in 
acute pain and decreased intracortical inhibition in chronic pain. While both effects likely 
afford protection to the injured body part (either by limiting or modifying movement), 
this distinction highlights the importance of tailoring treatment to the current stage of 
pain and underlying mechanisms. 
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Over the course of the past decade, there has been a dramatic increase in research 
regarding the use of peripheral and central neuromodulatory interventions as 
standalone and/or adjunct therapies for the management of persistent pain conditions 
(Nitsche et al. 2011, O'Connell et al. 2011).  Interventions such as repetitive transcranial 
magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS) and 
peripheral nerve stimulation (PNS), have the capacity to induce shifts in cortical 
excitability and therefore the potential to benefit persons in both the acute and chronic 
stages of pain. For example, 1mA cathodal-tDCS applied over M1 (presumed to shift 
neuronal membrane potentials towards hyperpolarization and decreased cortical 
excitability) has been demonstrated to increase SICI (Batsikadze et al. 2013) while 
anodal-tDCS (shift towards depolarization, increased cortical excitability) decreases SICI 
(Antal et al. 2010). Thus, it is possible that such interventions could be efficacious in 
restoring defective inhibitory processes in chronic and acute pain, respectively. 
Multimodal interventions may also have a place in future treatment programs since 
preliminary evidence in low back pain indicates that PNS in conjunction with motor 
training restores SICI and reduces pain (Masse-Alarie et al. 2013), while concurrent 
application of PNS and tDCS reduces pain, improves sensorimotor function and 
normalises motor cortical organisation (Schabrun et al. 2014). However, the translation 
of neuromodulatory interventions into clinical practice is currently hampered by the 
tendency to adopt a ‘one-size fits all’ strategy that fails to consider the presiding state of 
cortical excitability and high inter-individual variability. The successful transition of these 
therapies from experimental to clinical use depends on identification of specific cortical 
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mechanisms present in different musculoskeletal pain conditions and an understanding 
of the variability present between individuals. Thus, further research building on the 
work presented in this thesis is essential to drive the development and application of 
efficacious mechanism based therapies in the future. 
6.5 Limitations 
Limitations are acknowledged and discussed within each individual study and thus, the 
limitations presented here are those relevant to the framework of this thesis as a whole.  
One criticism that may be leveled against this thesis is that it is comprised of standalone 
research projects examining different mechanisms, muscle groups and populations. At 
first glance, this composition may appear haphazard, especially compared to theses 
constructed from a series of interdependent experiments. However, each study was 
subject to careful consideration and planning in order to ensure that this work, as whole, 
would provide a broad contribution to our understanding of cortical inhibition in acute 
and chronic musculoskeletal pain. For example, the muscles studied in each project were 
purposely selected based on their proximity to pain rather than anatomical position in 
order to better enable comparisons with previous and future studies. Ordinarily, 
comparisons between TMS studies with different target muscles is difficult due to the 
distal-proximal and upper-lower limb attenuation of MEP amplitudes (Groppa et al. 
2012), however, this is less of an issue for measures of cortical inhibition which are 
expressed as relative (%), rather than absolute (mV) values. Furthermore, the magnitude 
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of SAI, SICI and ICF have all been found to be similar for muscles of the hand and forearm 
(Bikmullina et al. 2009). Thus, it is likely that the findings of study 2 and 3, for example, 
may be confidently compared with previous and future research in the upper limb. 
However, as cortical inhibition was not investigated for muscles other than those 
immediately affected by pain, it is unknown whether the results of the present studies 
are muscle specific. Future work is needed to clarify the extent of these observations and 
to determine whether, as suggested by the systematic review,  a non-specific, but 
localised effect also occurs for non-painful muscles within the immediate vicinity of pain 
(Burns et al. 2016b).   
It is also unclear whether the findings presented in this thesis are typical of the 
populations investigated (pain-free, LE, LBP) as data were collected from relatively small 
samples of convenience. Although small sample sizes are not uncommon in this field 
(Burns et al. 2016b) or for the neurosciences in general (Button et al. 2013), this is a 
noteworthy limitation as studies with small sample sizes often demonstrate low 
statistical power. Median statistical power in the neurosciences is estimated to sit 
around 21% (Button et al. 2013). This means that for every 100 genuine significant 
observations, these studies would, at best, be capable of identifying 21 significant 
findings (Sterne et al. 2001). Thus, it is possible that the small sample sizes in this thesis 
precluded the detection of significant findings between time points (study 2) and 
patient/control groups (study 3 and 4). However, since sample size calculations were 
performed prior to conducting each research project, the likelihood of these studies 
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being underpowered is low. Yet the possibility remains, since the studies used as 
reference for these statistics also involved small samples and, thus, were themselves 
potentially underpowered (Masse-Alarie et al. 2012, Sato et al. 2013, Schabrun et al. 
2015b).  This is important to note as it is also possible for low powered studies to produce 
inflated estimates of effects as the relative impact of sampling variation and random 
error is much greater in studies with small samples (Ioannidis 2008). Therefore, it is 
imperative that the findings described in Chapters 3 to 5, as well as those included in the 
systematic review (Chapter 2), are examined in replication studies with larger sample 
sizes and adequate statistical power (i.e. ≥ 80%) (Cohen 1992). 
Larger sample sizes would also improve the rigor of the main experimental studies by 
allowing for increased control of extraneous variables. For example, participant age and 
sex were accounted for in the experimental design of studies 3 and 4, however, due to 
the heterogeneity of clinical presentations and small sample size it was difficult, if not 
impossible, to control for other patient characteristics. In the future, studies should be 
large enough to confidently employ statistical methods of control, such as covariate 
analysis, to determine whether variables such as symptom duration, pain severity or 
level of disability have significant bearing on study outcomes.  
Another limitation of this work and the field in general is the use of experimental pain 
models to study acute pain, rather than clinical populations. There are several 
advantages to this approach, including the ability to carefully regulate the dose, intensity 
and duration of pain as well as the ability to perform standardized assessments. It is also 
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considerably easier to recruit healthy participants for these studies compared to acute 
patient populations, due to the typically short duration of clinical pain. However, the 
appropriateness of extrapolating findings from ‘artificial’ pain studies to clinical 
populations is somewhat questionable since responses to acute experimental pain can 
be variable (Graven-Nielsen et al. 1997b) and often contrary to what is observed in 
clinical conditions (Schabrun et al. 2012). Thus, although experimentally induced pain 
remains well practiced, and is a valuable method for studying the healthy nociceptive 
system, it is important that this methodology continues to be used as a precursor for 
studying clinical pain, rather than a substitute for population based studies. 
There are a few other limitations relevant to the studies conducted within this thesis. For 
example, it is important to recognise that data collected within a single test session 
cannot be used to establish causation in patient studies. Hence, while this thesis 
identifies a number of mechanisms that could plausibly contribute to the transition from 
acute to chronic pain, longitudinal trials are required to confirm these hypotheses. It is 
also difficult to comment on the functional significance of altered intracortical activity in 
musculoskeletal pain states based on this thesis alone since there was no discernable 
relationship between neurophysiological outcomes and sensorimotor function in study 
3 and a relative lack of functional measures in studies 2 and 4. Thus, replication studies 
examining intracortical activity in LE and LBP should consider including additional 
functional measures such as upper limb reaction times/speed of movement tests or 
postural tasks to determine whether intracortical changes could be linked to impaired 
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motor control in these conditions (Bisset et al. 2006, Masse-Alarie et al. 2012). Offline 
analysis of concurrent EMG recordings may also be useful in determining whether 
intracortical mechanisms directly contribute to transient changes in muscle behaviour 
during and following the resolution of acute experimental pain (Del Santo et al. 2007, 
Martin et al. 2008).  
A final limitation to consider is that the investigator was not blinded to the time point of 
testing in study 2 or to the group in study 3 and 4. To improve internal validity and reduce 
the risk of bias, future studies should consider employing blinding practices during data 
analysis. 
6.6 Directions for future research 
As mentioned in the preceding section, longitudinal trials are required to clarify the 
direction and extent of cortical change in acute and chronic musculoskeletal pain 
conditions. Longitudinal studies involving larger cohorts of healthy participants as well 
as individuals in acute (< 6 weeks) and chronic (> 3 months) stages of disease will improve 
our understanding of the intracortical response to musculoskeletal pain, the relationship 
between mechanisms and symptoms, and has the potential to drive the development of 
neuromodulatory therapies in the future. Longer follow up times in experimental studies 
would also improve our understanding of the temporal dispersion of cortical effects in 
the acute phase of pain. For example, the work described in Chapter 3 (study 2) could be 
improved in the future by extending post pain recording intervals by 30 minutes or until 
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baseline cortical function is restored. Future studies would also benefit from addressing 
the limitations and recommendations outlined in the systematic review (Burns et al. 
2016b). For example, implementation of standardized recording intervals and objective 
measures of sensory/motor function would enable comparisons between studies and 
inform the functional significance of findings in the acute and chronic stages of pain. 
Future studies of cortical inhibition should also note the methodology adopted in this 
thesis. A novel finding of study 3 was that significant differences between health and 
disease were only detected under certain test conditions (Burns et al. 2016a). Thus, 
future studies examining forms of inhibition present over a range of latencies and/or 
stimulation intensities (i.e. SICI, LICI, SAI, LAI) should include a variety of test conditions 
to provide a comprehensive and complete description of the effect of pain on these 
mechanisms. Inclusion of a base measure of cortical excitability such as motor threshold 
or MEP amplitude would also be ideal to account for the high interindividual variability 
associated with cortical measures. Optimization of stimulation parameters to each 
individual participant is also likely to be particularly important if neurophysiological 
measures are used to prescribe courses of neuromodulatory treatment in the future.  
6.7 Conclusion 
This thesis provides evidence of altered cortical inhibition in acute and chronic 
musculoskeletal pain. Immediate, transient changes in inhibition in the acute stage of 
pain likely reflect the initiation of a protective motor strategy designed to restrict 
movement, whereas lasting changes in chronic conditions probably support the 
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development and maintenance of motor adaptations that facilitate task performance yet 
minimize pain. Further work is needed to confirm these hypotheses and the effect of 
pain on the intracortical mechanisms investigated in this thesis. Confirmation of these 
findings in larger trials and other musculoskeletal conditions may lead to the 
development of novel mechanism based therapies for those living with musculoskeletal 
pain and, ideally, interventions that prevent the transition from acute to chronic 
musculoskeletal pain states. 
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Abstract
Acute muscle pain has both motor and sensory consequences, yet the
effect of muscle pain on the primary sensory (S1) and motor (M1)
cortices has yet to be systematically evaluated. Here we aimed to
determine the strength of the evidence for (1) altered activation of S1/
M1 during and after pain, (2) the temporal profile of any change in
activation and (3) the relationship between S1/M1 activity and the
symptoms of pain. In September 2015, five electronic databases were
systematically searched for neuroimaging and electrophysiological
studies investigating the effect of acute experimental muscle pain on S1/
M1 in healthy volunteers. Demographic data, methodological
characteristics and primary outcomes for each study were extracted for
critical appraisal. Meta-analyses were performed where appropriate.
Twenty-five studies satisfied the inclusion criteria. There was consistent
evidence from fMRI for increased S1 activation in the contralateral
hemisphere during pain, but insufficient evidence to determine the
effect at M1. Meta-analyses of TMS and EEG data revealed moderate to
strong evidence of reduced S1 and corticomotor excitability during and
following the resolution of muscle pain. A comprehensive understanding
of the temporal profile of altered activity in S1/M1, and the relationship
to symptoms of pain, is hampered by differences in methodological
design, pain modality and pain severity between studies. Overall, the
findings of this review indicate reduced S1 and corticomotor activity
during and after resolution of acute muscle pain, mechanisms that could
plausibly underpin altered sensorimotor function in pain.
What does this review add?: We provide the first systematic
evaluation of the primary sensory (S1) and motor (M1) cortex response
to acute experimental muscle pain in healthy volunteers. We present
evidence from a range of methodologies to provide a comprehensive
understanding of the effect of pain on S1/M1. Through meta-analyses
we evaluate the strength of evidence concerning the direction and
temporal profile of the S1/M1 response to acute muscle pain.
1. Introduction
It is well accepted that acute muscle pain alters sen-
sory and motor function. Yet, the mechanisms that
underpin these changes are poorly understood.
Current theories on sensorimotor adaptation in pain
hypothesize that the primary sensory (S1) and motor
(M1) cortex contribute to altered sensorimotor
function. For instance, reduced S1 activity is
© 2016 European Pain Federation - EFIC Eur J Pain 20 (2016) 1203--1213 1203
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hypothesized to underpin reduced kinaesthesia and
position sense (Rossi et al., 2003), whereas reduced
M1 activity is hypothesized to underpin restriction of
motor output and afford protection from further
pain and injury (Hodges and Tucker, 2011).
Numerous studies using a range of methodological
tools, including positron emission tomography (PET),
functional magnetic resonance imaging (fMRI), tran-
scranial magnetic stimulation (TMS) and electroen-
cephalography (EEG), have investigated how and
when S1 and M1 activity are altered in response to
acute muscle pain (Svensson et al., 1997; Niddam
et al., 2002; Schabrun et al., 2013). These studies
use similar in vivo experimental pain models to
induce short-lasting muscle pain that is of a clinical
quality (deep, constant, dull or a sharp ache) that
allow collection of pre-pain baseline data that cannot
be obtained in clinical pain populations (Graven-
Nielsen et al., 1997). However, despite similarities in
pain models and brain regions under investigation,
there has been no systemic evaluation of S1 or M1
data in acute muscle pain. Integration of data
obtained from studies using different methodologies
is essential to drive a comprehensive understanding
of the nature and time-course of altered S1 and M1
activity in response to acute muscle pain and to elu-
cidate the relationship between S1/M1 and the
symptoms of pain.
Here, we synthesized and critically evaluated
data corresponding to activity in S1 and M1 corti-
cal regions in order to: (1) examine S1/M1 activa-
tion in response to acute muscle pain, (2) quantify
the direction and temporal profile of change and
(3) determine the evidence for a relationship
between altered S1/ M1 activity and symptoms of
pain.
2. Literature search methods
2.1 Search strategy
Relevant studies were identified from five electronic
databases (Scopus, Medline, Embase, Pubmed and
Web of Science) using MeSH terms and free-text
terms including motor cortex, somatosensory cortex, mus-
cle pain, acute pain and experimental pain. The most
recent search was performed in September 2015.
Studies were first screened for relevance by title
and abstract before analysis of full text. Inclusion
was dependent upon the following criteria: (1) Eng-
lish language, (2) original, primary research, (3)
healthy adult human subjects, (4) acute experimen-
tal pain was induced in a muscle, (5) acute muscle
pain was induced in the absence of another stimu-
lation or intervention and (6) outcome measures
included full brain image analysis of regional cere-
bral blood flow (rCBF; measured using PET or
fMRI) or blood-oxygen-level-dependent contrast
imaging (BOLD; measured using fMRI), corticomo-
tor excitability (motor evoked potentials; measured
using TMS) and/or sensory cortex excitability (so-
matosensory evoked potentials; measured using
EEG). To ensure the reliability of the process for
inclusion/exclusion of studies, 10 abstracts were
selected at random and independently reviewed by
three assessors.
2.2 Data extraction and assessment of
methodological quality
A standard form was used to extract subject demo-
graphics, methodological parameters (techniques,
outcome measures) and pain characteristics (modal-
ity, location, intensity) for each study. Additional
technical information specific to EEG (electrode ori-
entation, conditioning location and intensity) and
TMS (target muscle, muscles state, TMS intensity,
coil type and position) methodologies was also
recorded. Primary outcome measures included MEP
amplitude/area to single and/or paired-pulse TMS,
the amplitude/area of SEP components/complexes
corresponding to S1 activation/processing and the
direction of change (increase or decrease) in rCBF or
BOLD contrast.
Methodological quality was appraised using a
modified version of the Downs and Black’s checklist
(Downs and Black, 1998; Supporting Information
Appendix S1). A maximum score of 17 points were
awarded based on reporting within the text and
external and internal validity. Studies involving TMS
were further appraised using the TMS methodologi-
cal checklist (Chipchase et al., 2012). The maximum
score for reported and controlled items was 26 or 30
points, depending on methodology (single or paired-
pulse TMS). The summed score for reported items (r)
as a percentage of the maximum score [r/(26 or
30) 9 100] to provide an indication of adherence to
the checklist. The summed score for controlled items
(c) was expressed as a percentage of reported items
[(c/r) 9 100] to determine the extent to which
reported items were controlled.
2.3 Meta-analyses
Meta-analyses were performed on MEP and SEP data
but not for rCBF or BOLD contrast due to the
heterogeneity of the analysis approaches used
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between studies and inconsistent reporting of non-
significant findings. Mean  standard deviation for
MEP and SEP amplitude/area were extracted at time
points ‘baseline’, ‘during pain’ and ‘post pain’, where
available. When data were not reported within the
text, an email was sent to the corresponding author
to request missing values. If authors were no longer
contactable, did not respond, or declined requests for
data, means  standard deviation/standard error
were estimated from illustrations or calculated from
available t values, p values or F statistics. Standard-
ized mean differences (SMD) and 95% confidence
intervals were calculated using a random-effects
model in RevMan 5.2 (The Nordic Cochrane Centre,
The Cochrane Collaboration, Copenhagen) and
heterogeneity determined using calculations of I2.
Effect estimates ≤0.2 were considered small, 0.5
moderate and ≥0.8 large.
3. Results
3.1 Search results
The search strategy retrieved 257 studies, minus
duplicates (Fig. 1). Screening of title and abstract
and evaluation of full text identified 20 suitable
studies. Examination of reference lists revealed an
additional five studies, thus, a total of 25 studies
were included in the systematic review.
3.2 Study characteristics
Of the 25 included studies, four examined rCBF with
PET (participants, n = 56), two examined rCBF with
fMRI (n = 32), eight examined BOLD responses with
fMRI (n = 147), eight examined corticomotor
excitability (MEPs) with TMS (n = 80) and three
examined sensory cortex excitability (SEPs) with
Figure 1 Search strategy flow diagram.
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EEG (n = 25). One study reported on both cortico-
motor and sensory cortex excitability (Schabrun
et al., 2013). Hypertonic saline was the most com-
mon method of inducing experimental muscle pain
(n = 17) and most studies (n = 13) induced pain into
muscles of the upper extremity (hand, forearm or
arm). Other sites included muscles of the leg (stud-
ies, n = 7), jaw (n = 4), neck (n = 1) and low back
(n = 1). Demographic information and pain charac-
teristics of included studies are presented in Table 1.
3.3 Methodological quality
Average scores for methodological quality were
12.1  1.5 (out of 17) for MEP studies, 11.3  2.1
for SEP studies, 13.8  0.5 for rCBF studies and
12.9  0.9 for BOLD studies. Items consistently
unmet by reviewed studies related to internal and
external validity. For example, male and female par-
ticipants were unequally represented in the majority
of study samples (Macefield et al., 2007) and sample
size calculations were rarely performed a priori (Rit-
tig-Rasmussen et al., 2014). No study blinded the
investigator during data analysis and all recruited a
sample of convenience.
The mean score for reported items of the TMS
checklist was 78  8%. Compliance was high for
methodological items, however, items relating to
participant characteristics, were less well reported.
This may be because authors did not consider it nec-
essary to collect or report detailed data on health
characteristics for participants considered ‘healthy’.
All studies reported on subject age and gender, posi-
tion and contact of EMG electrodes, amount of
relaxation/contraction of muscles, prior motor activ-
ity of the tested muscle, coil location and stability,
type of stimulator, stimulation intensity, subject
attention, number of MEP recordings and the
method for determining MEP size in analysis. The
mean score for controlled items was 88  7%. Items
reported but poorly controlled included subject gen-
der (bias towards male participants), prior activity of
the muscle being tested, level of relaxation of mus-
cles not being directly tested, and coil stability. Indi-
vidual study scores are presented in Table 1.
3.4 The effect of experimental muscle pain at
the primary sensory cortex (S1)
3.4.1 Regional cerebral blood flow (rCBF)
Four studies investigated rCBF using PET and two
studies investigated rCBF using fMRI and arterial
spin labelling (ASL; Supporting Information
Table S1). Full brain image analysis using PET (stud-
ies, n = 4) revealed no effect of muscle pain on rCBF
at S1. There was also no effect on ASL-derived rCBF
(n = 2) when pain was of moderate intensity (Owen
et al., 2012), however a bilateral reduction at S1 was
observed in response to severe pain (Owen et al.,
2010). These conflicting findings may be explained
by pain severity as reduced rCBF at S1 was found to
negatively correlate with subjective pain ratings for
the pain (hypertonic saline) and control groups (iso-
tonic saline) in the latter study (contralateral S1:
R2 = 0.75, p = 0.000; ipsilateral S1: R2 = 0.69,
p = 0.000; Owen et al., 2010).
3.4.2 Blood-oxygen-level-dependent (BOLD)
contrast imaging
Seven of the nine studies that investigated BOLD
responses using fMRI reported increased S1 activa-
tion in response to muscle pain (Supporting Infor-
mation Table S1). Three studies reported increased
BOLD contrast bilaterally at S1 (Niddam et al., 2002;
Nash et al., 2010a,b), while three studies reported
increases exclusive to the hemisphere contralateral
to the side of hypertonic saline- or electrically
induced muscle pain (Henderson et al., 2006; Mace-
field et al., 2007; Takahashi et al., 2011). In contrast,
results for mechanically induced pain were conflict-
ing. For example, Loggia et al. (2012) reported an
increased BOLD response at S1 in the contralateral
hemisphere and a decreased response in the ipsilat-
eral hemisphere following painful pressure stimula-
tion, whereas Uematsu et al. (2011) and Maeda
et al. (2011) reported no change for either hemi-
sphere. These discrepancies could be explained by
differences in the spatial resolution of the pressure
stimulation between these studies (pressure cuff vs.
pressure probe).
3.4.3 Somatosensory evoked potentials (SEPs)
Three studies used EEG to investigate the effect of
acute muscle pain on S1 excitability following electri-
cal stimulation of the ulnar (Rossi et al., 2003; Schab-
run et al., 2013) or peroneal nerve (Rossi et al., 1998;
Supporting Information Table S2). Ulnar SEPs were
recorded using surface electrodes placed on the scalp
2 cm posterior to C3 using the 10–20 International
EEG system, while peroneal SEPs were recorded sub-
cutaneously at a location 2 cm posterior to Cz on the
midline. All studies reported on components thought
to reflect S1 activation (P14–N20, P40–N50) and pro-
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cessing (N20–P25–N33, P60–N75). As pooled analyses
revealed that the area of components corresponding
to S1 activation was unchanged both during (Sup-
porting Information Fig. S1) and following (Support-
ing Information Fig. S2) the resolution of muscle pain
[0.36 (0.86, 0.14), 0.23 (0.72, 0.26)], this
suggests that input to S1 remains stable over time. In
contrast, pooled effect estimates during pain show a
strong reduction in the area of components
corresponding to S1 processing [1.99 (0.64, 3.34)]. A
moderate reduction [0.65 (0.15, 1.16)] is also pre-
sent post pain. Such findings suggest that acute
muscle pain may exert a lasing inhibitory effect on S1
excitability.
3.5 The effect of experimental muscle pain on
the primary motor cortex (M1) and
corticomotor pathway
3.5.1 Regional cerebral blood flow (rCBF)
Full brain image analysis (PET n = 4, fMRI n = 2)
revealed no change in rCBF at M1 in any study
(Supporting Information Table S1).
3.5.2 Blood-oxygen-level-dependent (BOLD)
contrast imaging
At the location of M1, findings for BOLD contrast
were mixed (Supporting Information Table S1). For
example, four studies reported increased BOLD
responses in the hemisphere contralateral to the side
of pain (Henderson et al., 2006; Nash et al., 2010b;
Takahashi et al., 2011; Loggia et al., 2012), while
five studies observed no change (Niddam et al.,
2002; Macefield et al., 2007; Nash et al., 2010a;
Maeda et al., 2011; Uematsu et al., 2011). These dis-
crepancies do not appear to be related to the use of
different pain models between studies but may be
related to pain severity since a positive relationship
between increased BOLD and pain was observed in
one study (Loggia et al., 2012). However, as the
results from two additional studies indicate that
increased BOLD outlasts peak pain and persists dur-
ing waning pain (Henderson et al., 2006; Takahashi
et al., 2011), the nature of this relationship remains
uncertain. Interpretation of these findings is further
complicated by observations from Nash et al.,
(2010b), who reported that initial increases in BOLD
contrast were followed by lasting decreases in signal
intensity. With the exception of one study (Hender-
son et al., 2006), there is no evidence of an effect of
muscle pain on ipsilateral BOLD responses.
3.5.3 Transcranial magnetic stimulation:
assessment of corticomotor excitability
Eight studies investigated corticomotor excitability
using TMS (Supporting Information Table S3). Sepa-
rate meta-analyses were performed for data collected
with the muscle at rest and during active contraction
and sub group analysis was performed for ‘target’ or
‘non-target’ muscles. ‘Target’ refers to the muscle
where experimental pain was induced, and was
reported in all eight studies. The term ‘non-target’
refers to muscles remote, synergistic or antagonistic
to the ‘target muscle’ and was reported in three
studies (Le Pera et al., 2001; Svensson et al., 2003;
Martin et al., 2008).
The size of the MEP to single-pulse TMS was
reported by five studies ‘during pain’ (Supporting
Information Fig. S3). Pooled effect estimates revealed
a moderate reduction in corticomotor excitability
(MEP amplitude/area) from ‘baseline’ for target and
non-target muscles at rest [0.52 (0.01, 1.06), 0.72
(0.01, 1.42)], but not for target muscles during active
contraction [0.13 (0.61, 0.35)]. ‘Post-pain’ data
collected either ‘0’ (immediately post), ‘20’ or ‘30’
minutes following the cessation of pain or painful
stimulation was available from all eight studies (Sup-
porting Information Fig. S4). Compared to ‘baseline’
there was a strong reduction in MEP amplitude/area
for target muscles at rest [0.97 (0.59, 1.35)] and a
similar trend for non-target muscles at rest [0.37
(0.02, 0.76)]. A moderate reduction in MEP ampli-
tude/area was also detected for actively contracting
target muscles [0.44 (0.05, 0.83)].
3.5.4 Transcranial magnetic stimulation: intra-
cortical inhibitory and facilitatory networks
The MEP response to paired-pulse TMS was exam-
ined by one study (Schabrun and Hodges, 2012).
Short-interval intra-cortical inhibition (at 2 and 3 ms
inter-stimulus intervals) was increased immediately
following (2 ms: p = 0.012, 3 ms: p = 0.007), but not
during muscle pain (2 ms: p = 0.24; 3 ms: p = 0.61).
In contrast, intra-cortical facilitation (13 ms inter-sti-
mulus interval) was reduced compared to baseline
both during (p = 0.009) and immediately post
(p = 0.001) muscle pain.
4. Discussion
The aim of this review was to synthesize and criti-
cally evaluate evidence for altered S1 and M1 activ-
ity in response to acute muscle pain. The findings
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provide evidence of reduced activity in the contralat-
eral S1 both during and following pain and moder-
ate-strong evidence of reduced corticomotor output
to the painful muscle. Currently, there is insufficient
evidence to draw conclusions regarding effects at
ipsilateral S1/M1.
4.1 The effect of acute muscle pain on S1
Eight of nine studies using fMRI provide evidence of
altered activation (increased BOLD contrast) at S1 in
the hemisphere contralateral to the side of induced
pain, during pain. As BOLD contrast is a measure of
cerebral metabolism based on the level deoxy-
haemoglobin content, and oxygen demands are
assumed to be higher at areas of increased cortical
function (Howseman and Bowtell, 1999), such obser-
vations imply increased synaptic activation. However,
as fMRI detects hemodynamic and not electrophysio-
logical changes, it is unclear whether increased synap-
tic activation reflects increased or decreased S1
excitability. The inclusion of studies that record SEPs
in response to pain provides insight into the direction
of the effects observed with fMRI. The area of the
N20–P25–N33 and P60–N75 potential is thought to
reflect early cortical processing of low-threshold
somatosensory afferent information related to kinaes-
thesia and position sense (Rossi et al., 1998, 2003)
and is commonly used to infer changes in S1
excitability. Pooled analysis of the three EEG studies
provides strong evidence that acute muscle pain acti-
vates synaptic processes that reduce S1 excitability.
Thus, taken together, data from fMRI and SEP studies
suggest that S1 is altered during acute muscle pain
and that this change is in the direction of reduced S1
excitability. However, as the relationship between
SEP amplitude and BOLD contrast has not been char-
acterized at stimulation intensities at or above pain
threshold, evidence to support a correlation between
these methodologies under pain conditions is limited.
Although the functional relevance of altered S1
activity during pain was not directly investigated in
this review, previous studies have suggested that
reduced S1 excitability may reflect a defensive adap-
tation designed to orient cortical attention towards
stimuli that threaten the body’s integrity (Legrain
et al., 2011). Such a mechanism may reduce pro-
cessing of non-painful afferent information and thus
contribute to reduced sensorimotor performance
when pain is present (Rossi et al., 1998, 2003).
However, further work is needed to determine the
relationship between reduced S1 excitability during
pain and altered sensorimotor function.
The present review provides moderate evidence of
reduced S1 excitability following the resolution of
pain. However, this evidence is drawn exclusively
from SEP data collected immediately post pain (Rossi
et al., 2003; Schabrun et al., 2013) and further
research is required to determine the duration and
reliability of these findings. The effect of pain on the
ipsilateral S1 also remains unclear as synthesis of
fMRI data was largely inconclusive and SEPs were
not investigated in this hemisphere. The results of all
five PET studies show no S1 activation during pain.
Since previous studies have shown that fMRI and
PET activations typically correlate under identical
stimulus conditions (Dettmers et al., 1996; Sadato
et al., 1998), these findings were unexpected. One
explanation may be that the lower temporal resolu-
tion of PET precluded the identification of rapid and/
or transient pain-related neural activity. fMRI images
are typically sampled between 0.3 and 3 s, whereas
PET image acquisition is performed over a longer
time period (50–120 s). If pain-related changes in S1
occurred prior to 50 s they may not have been
detected using PET methodologies. Alternatively, as
analyses are typically performed on data averaged
over the entire scanning period, it is possible that
changes were not detected due to a dynamic, fluctu-
ating pattern of cortical activation during acute
muscle pain.
4.2 The effect of acute muscle pain on M1
The effect of acute muscle pain on BOLD contrast at
M1 in the hemisphere contralateral to the side of
induced pain varied between studies with some
reporting increased activation (n = 4), some
decreased activation (n = 1) and some no change
(n = 5) during pain. With the exception of one study
(Henderson et al., 2006), there was no evidence for
an effect of acute muscle pain on BOLD contrast in
the ipsilateral M1. In contrast, meta-analyses of MEP
data show moderate evidence of reduced corticomo-
tor output to painful muscles when pain is present.
Inconsistent findings between fMRI and TMS could
also be explained by differences in temporal resolu-
tion between methodologies or alternatively, by
changes occurring at spinal and/or peripheral, rather
than cortical, level. As the MEP is a summative mea-
sure of cortico-cortical, cortico-motoneuronal and
spinal motoneuron synaptic excitability, changes
occurring at cortical, spinal and/or peripheral level
may have contributed to the reduction in corticomo-
tor output observed during pain. Few TMS studies
controlled for changes in peripheral (n = 3) or spinal
1210 Eur J Pain 20 (2016) 1203--1213 © 2016 European Pain Federation - EFIC
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excitability (n = 3) and only one study examined
mechanisms thought to directly reflect activity in
M1. That study reported enhanced activity of M1
intra-cortical circuits mediated by the inhibitory neu-
rotransmitter GABA, and decreased activity of facili-
tatory circuits acting through NMDA receptors on
glutamatergic interneurons (Schabrun and Hodges,
2012). Therefore, further research is required to
determine whether reduced corticomotor output
during pain reflects reduced activity in M1.
A novel finding during pain was the non-specifi-
city of the corticomotor response. Pooled analyses of
data from two TMS studies show that muscles in the
same body segment, but not directly subjected to
pain, exhibit reduced corticomotor output (Le Pera
et al., 2001; Martin et al., 2008). Although there is
currently insufficient data to determine whether this
effect is limited to muscles at rest, it is possible that a
similar response may occur in active muscles but
remains undetected due to the facilitatory influence
of volitional contraction on measures of MEPs (Di
Lazzaro et al., 1998). This non-specificity suggests
that an indiscriminate motor strategy is employed
during pain. Although the functional significance
remains unclear, it is possible that this adaptation
serves to decrease muscle coordination and splint the
affected body part (Schabrun et al., 2014). Such en
masse movement strategies would likely prevent
symptom aggravation and afford protection to an
injured limb (Hodges and Tucker, 2011).
A strong reduction in corticomotor output was
also found for painful muscles in the post-pain per-
iod at rest. The relative strength of this response
may explain why a low-moderate reduction in corti-
comotor output to actively contracting muscles was
also detected at this time point. A strong trend
towards MEP suppression was also observed for non-
painful muscles at rest. In line with current theories,
it is possible that these reductions persist in the post-
pain period as a defence against the threat of further
pain and injury (Hodges and Tucker, 2011).
4.3 Relationship between S1 and M1 activity
and the symptoms of pain
There is currently insufficient evidence to determine
whether the neurophysiological changes described in
this review are related to subjective assessments of
pain severity. Although all fMRI investigations were
conducted within the ‘during pain’ time period, a
relationship to pain severity is impeded by inconsis-
tent findings. For example, one study provided evi-
dence of severity-dependent S1/M1 activations
during pain (Loggia et al., 2012), whereas several
others demonstrate strong cortical effects despite
waning symptoms (Henderson et al., 2006; Nash
et al., 2010b; Takahashi et al., 2011). As additional
activations/deactivations were also observed in the
ipsilateral hemisphere by some authors (Niddam
et al., 2002; Henderson et al., 2006; Nash et al.,
2010a,b; Owen et al., 2010; Loggia et al., 2012),
there is also doubt regarding the specificity of this
response. Furthermore, although the majority of
EEG and TMS studies reported findings during pain
(Romaniello et al., 2000; Le Pera et al., 2001; Rossi
et al., 2003; Del Santo et al., 2007; Martin et al.,
2008; Schabrun et al., 2013), few studies explicitly
examined S1/M1 excitability in association with pain
severity (Le Pera et al., 2001; Rossi et al., 2003).
However, as meta-analyses of these studies show
moderate-strong evidence of reduced corticomotor
output and S1 excitability that persist after pain has
resolved, a linear relationship between objective
neurophysiological measures and subjective pain
recordings appears unlikely.
4.4 Limitations and recommendations
This review has a number of limitations that require
consideration. First, findings from multiple method-
ologies with unique temporal and spatial resolutions
were included to provide insight regarding the
extent, time-course and direction of the effect of
pain on S1/M1. However, as the relationship
between hemodynamic and electrophysiological
measures remains uncertain, comparison of findings
across methodologies is limited. Future protocols that
combine PET/fMRI (high spatial resolution) with
TMS/EEG (high temporal resolution) would clarify
the effect of acute muscle pain on S1/M1 and the
relationship between these measures.
The small number of studies identified for each
methodology, as well as differences in study design,
pain modality and severity, also limit discussion. For
example, pain severity was reported as a value corre-
sponding to either ‘peak’ or ‘average’ and ranged in
severity from ‘mild’ to ‘severe’. As such, this review
was unable to discern a clear effect of pain severity
and S1/M1 change between or within outcome mea-
sures. There is also insufficient evidence to ascertain
the duration of S1/M1 change following the resolu-
tion of muscle pain due to inconsistent time points
in TMS/EEG studies and a lack of post-pain data
from PET/fMRI. Standardized recording intervals, in
addition to improved descriptions of whether the
interval refers to the time elapsed since the cessation
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of pain or since the cessation of the pain interven-
tion (pain remains), would help clarify the duration
of these effects. Future protocols should also include
objective measures of sensory and/or motor function
in order to elucidate the functional significance of
S1/M1 adaptations both during and post muscle
pain.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article at the publisher’s web-site:
Figure S1. The effect of acute muscle pain on S1 excitabil-
ity: a forest plot of baseline versus during pain data.
Figure S2. The effect of acute muscle pain on S1 excitabil-
ity: a forest plot of baseline versus post-pain data.
Figure S3. The effect of acute muscle pain on corticomotor
excitability: a forest plot of baseline versus during pain data
for resting and actively contracting muscles.
Figure S4. The effect of acute muscle pain on corticomotor
excitability: a forest plot of baseline versus post-pain data
for resting and actively contracting muscles.
Table S1. Summary of S1/M1 activations (as determined
via rCBF and BOLD contrast), during pain.
Table S2. Summary of study characteristics for studies
investigating somatosensory evoked potentials (SEPs).
Table S3. Summary of study characteristics for studies
investigating corticomotor excitability (motor evoked
potentials: MEPs).
Appendix S1. Modified Downs and Black (1998) checklist
for assessment of methodological quality of observational
trials.
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Modified Downs and Black (1998) checklist for assessment of methodological 
quality of observational trials 
Reporting 
1 
Is the hypothesis/aim/objective of the study 
clearly described? 
6 Does the study provide estimates of the 
random variability in the data for the main 
outcomes?  
In non normally distributed data the inter-
quartile range of results should be reported. 
In normally distributed data the standard 
error, standard deviation or confidence 
intervals should be reported. If the 
distribution of the data is not described, it 
must be assumed that the estimates used 
were appropriate and the question should 
be answered yes. 
yes 1 
no 0 
2 Are the main outcomes to be measured clearly 
described in the Introduction or Methods 
section? 
If the main outcomes are first metioned in the 
Results section, the question should be 
answered no. 
yes 1 
yes 1 no 0 
no 0 
7 Have the characteristics of patients lost to 
follow-up been described? 3 Are the characteristics of the patients included 
in the study clearly described? This should be answered yes where there 
were no losses to follow-up or where losses 
to follow-up were so small that findings 
would be unaffected by their inclusion. 
This should be answered no where a study 
does not report the number of patients lost 
to follow-up. 
In cohort studies and trials, inclusion and/or 
exclusion criteria should be given. In case-
control studies, a case-definition and the 
source for controls should be given. 
yes 1 
no 0 
yes 1 
4 Are the distributions of principal confounders 
in each group of subjects to be compared 
clearly described? 
no 0 
unable to 
determine/ not 
applicable 
0 
A list of principal confounders is provided. 
Possible confounding variables include age, 
gender, duration of pain and severity of pain. 8 Have actual probability values been 
reported ( e.g. 0.035 rather than <0.05) for 
the main outcomes except where the 
probability value is less than 0.001? yes 2 
partially 1 
no 0 yes 1 
no 0 
5 
Are the main findings of the study clearly 
described? 
203
Simple outcome data (including denominators 
and numerators) should be reported for all 
major findings so that the reader can check the 
major analyses and conclusions. (This 
question does not cover statistical tests which 
are considered below). 
yes 1 
no 0 
External validity 
All the following criteria attempt to address the 
representatives of the findings of the study and 
whether they may be generalised to the population 
from which the study subjects were derived. 
yes 1
9 
Were the subjects asked to participate in the 
study representative of the entire population 
from which they were recruited? 
no 0 
unable to 
determine 0 
The study must identify the source population 
for patients were selected. Patients would be 
representative if they comprised the entire 
source population, an unselected sample of 
consecutive patients, or a random sample. 
Random sampling is only feasible where a list 
of all members of the relevant population 
exists. Where a study does not report the 
proportion of the source population from 
which the patients are derived, the question 
should be answered as unable to determine. 
12 If any of the results of the study were based 
on “data dredging”, was this made clear? 
Any analyses that had not been planned at 
the outset of the study should be clearly 
indicated. If no retrospective unplanned 
subgroup analyses were reported, then 
answer yes. 
yes 1 
no 0 
unable to 
determine 0 
yes 1 
13 Were the statistical tests used to assess the 
main outcomes appropriate? 
no 0 
unable to determine 0 
The statistical techniques used must be 
appropriate to the data. For example non-
parametric methods should be used for 
small sample sizes. Where little statistical 
analysis has been undertaken but where 
there is no evidence of bias, the question 
should be answered yes. If the distribution 
of the data (normal or not) is not described 
it must be assumed that the estimates used 
were appropriate and the question should 
be answered yes. 
10 Were those subjects who were prepared to
participate representative of the entire 
population from which they were recruited? 
The proportion of those asked who agreed 
should be stated. Validation that the sample 
was representative would include 
demonstrating that the distribution of the main 
confounding factors was the same in the study 
sample and the source population. 
yes 1 
yes 1 
no 0 
no 0 
unable to 
determine 0 
Appendix A.1
Internal validity - bias 
11 Was an attempt made to blind those 
measuring the main outcomes? 
14 Were the main outcome measures used 
accurate (valid and reliable)? 
For studies where the outcome measures 
are clearly described, the question should 
be answered yes. For studies which refer to 
other work or that demonstrates the 
outcome measures are accurate, the 
question should be answered as yes. 
yes 1 
no 0 
unable to 
determine 0 
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Internal validity - confounding (selection bias) 
15 Was there adequate adjustment for 
confounding in the analyses from which the 
main findings were drawn? 
This question should be answered no for trials 
if: the distribution of known confounders in 
the different treatment groups was not 
described; the distribution of known 
confounders differed between treatment 
groups but was not taken into account in the 
analyses; or the confounding variables were 
not mentioned. For studies where covariate 
analysis  (including confounding) was 
performed or non-significant difference 
between confounding variables was found, the 
question should be answered as yes.   
yes 1 
no 0 
unable to determine 0 
16 Were losses of patients to follow-up taken into 
account? 
If the numbers of patients lost to follow-up are 
not reported, the question should be answered 
as unable to determine. If the proportion lost to 
follow-up was too small to affect the main 
findings, the question should be answered yes. 
yes 1 
no 0 
unable to determine/ 
not applicable 
0 
Appendix A.1
Power 
17 Was sample size calculation done a priori? 
yes 1 
no 0 
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Table S1. Summary of S1/M1 activations (as determined via rCBF and BOLD-contrast), during pain. 
 S1  M1 
 Study (year) Technique Outcome contralateral ipsilateral contralateral ipsilateral 
Kupers (2004) PET rCBF ● ● ● ● 
Svensson (1997) PET rCBF ● ● ● ● 
Thunberg (2005) PET rCBF ● ● ● ● 
Korotkov (2002) PET rCBF ● ● ● ● 
Owen (2010) fMRI CBF (ASL) ↓a ↓a ● ● 
Owen (2012) fMRI CBF (ASL) ● ● ● ● 
Nash (2010a) fMRI BOLD ↑ ↑ ● ● 
Uematsu (2011) fMRI BOLD ● ● ● ● 
Henderson (2006) fMRI BOLD ↑ ● ↑b ↑b 
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Loggia (2012) fMRI BOLD ↑a ↓ ↑a ● 
Macefield (2007) fMRI BOLD ↑ ● ● ● 
Nash (2010b) fMRI BOLD ↑ ↑ ↑ then ↓b ● 
Niddam (2002) fMRI BOLD ↑ ↑ ● ● 
Takahashi (2011) fMRI BOLD ↑ ● ↑a ● 
Maeda (2011) fMRI BOLD ● ● ● ● 
Abbreviations; ↓: decreased, ↑: increased, ●: no change reported, a linear relationship to pain, b effect outlasts peak pain, persist during 
waning pain. Contralateral and ipsilateral refer to the hemisphere in relation to the side of induced muscle pain. 
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Table S2. Summary of study characteristics for studies investigating somatosensory evoked potentials (SEPs). 
Study (year) Pain location 
Electrode 
orientation 
Conditioning 
location 
Conditioning intensity SEP components 
baseline vs. 
during pain 
baseline vs. 
post pain 
Schabrun 
(2013) 
first dorsal interosseous  C3' ulnar nerve 
300% sensory perceptual 
threshold 
P14-N20,  
N20-P25-N33 
yes 
yes 
(0 mins) 
Rossi (2003) first dorsal interosseous C3' ulnar nerve 95% motor threshold 
P14-N20,  
N20-P25-N33 
yes     
(1-3, 3-6, 6-9, 9-
12, 12-15 mins) 
yes 
(0, 20 mins) 
Rossi (1998) extensor digitor brevis Cz' peroneal nerve NR (< motor threshold) 
P40-N50,  
P60-N75 
yes     
(0-5, 5-10, 10-15, 
15-20 minutes) 
yes 
(0, 30 mins) 
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Table S3. Summary of study characteristics for studies investigating corticomotor excitability (motor evoked potentials: MEPs) 
Study (year) Pain location 
Muscle(s) 
targeted with 
TMS 
Muscle State TMS intensity 
Coil 
Type 
Coil 
position 
baseline vs. during 
pain 
baseline vs. post 
pain 
Le Pera (2001) 
abductor digiti 
minimi 
abductor digiti 
minimi 
rest 
RMT+5% 
stimulator output 
figure 8 hotspot 
yes     
(peak pain & post 
peak pain) 
yes (20mins) 
first dorsal 
interosseous 
abductor digiti 
minimi 
flexor carpi 
radialis 
flexor carpi 
radialis 
Schabrun 
(2012) 
first dorsal 
interosseous 
first dorsal 
interosseous & 
abductor digiti 
minimi 
rest 120% RMT figure 8 hotspot no yes (0 mins) 
Schabrun 
(2013) 
first dorsal 
interosseous 
first dorsal 
interosseous 
rest 120% RMT figure 8 hotspot yes yes (0 mins) 
Svensson (2003) 
first dorsal 
interosseous 
first dorsal 
interosseous & 
flexor carpi 
ulnaris 
rest 
95% RMT to150% 
RMT 
figure 8 hotspot no yes (0 mins) 
Del Santo 
(2007) 
abductor digiti 
minimi 
abductor digiti 
minimi 
active (30% MVC) 120% AMT figure 8 hotspot yes yes (0 mins) 
biceps brachii biceps brachii 
Martin (2008) biceps brachii 
biceps brachii & 
triceps brachii 
rest & active (20% 
MVC) 
MEP amp 10-15% 
Mmax 
circular vertex yes yes (0 mins) 
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Rittig-
Rasmussen 
(2014) 
neck tissue 2cm 
lateral to C3 
trapezius & 
abductor pollicis 
brevis 
active (trap only, % 
MVC NR) & rest 
(APB only) 
MEP max amp 
(120-140% RMT 
or AMT) 
figure 8 hotspot no 
yes (30mins, 
1hour) 
Romaniello 
(2000) 
masseter masseter 
active (15%, 30%, 
45% MVC) 
110% RMT circular hotspot yes yes (20 mins) 
Abbreviations, TMS: transcranial magnetic stimulation; RMT: resting motor threshold; AMT: active motor threshold; MVC: 
maximum voluntary contraction; NR: not reported.
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Appendix A.5 
Figure S1. The effect of acute muscle pain on S1 excitability: a forest plot of baseline vs. during pain data. The standardized mean 
difference and confidence interval for the area of SEP components reflective of S1 activation and processing is indicated with a box 
and horizontal line for each study. The pooled effect estimates for each subgroup is denoted by a diamond
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Appendix A.6 
Figure S2. The effect of acute muscle pain on S1 excitability: a forest plot of baseline vs. post pain data. The standardized mean 
difference and confidence interval for the area of SEP components reflective of S1 activation and processing is indicated with a box and 
horizontal line for each study. The pooled effect estimates for each subgroup is denoted by a diamond. 
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Appendix A.7 
Figure S3. The effect of acute muscle pain on corticomotor excitability: a forest plot of baseline vs. during pain data for resting and 
actively contracting muscles. The standardized mean difference and confidence interval for MEP amplitude/area recorded from ‘target’ 
and ‘non-target’ muscles is indicated with a box and horizontal line for each study. The pooled effect estimates for each subgroup is 
denoted by a diamond. 
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Figure S4. The effect of acute muscle pain on corticomotor excitability: a forest plot of baseline vs. post pain data for resting and actively 
contracting muscles. The standardized mean difference and confidence interval for MEP amplitude/area recorded from ‘target’ and ‘non-
target’ muscles is indicated with a box and horizontal line for each study. The pooled effect estimates for each subgroup is denoted by a 
diamond. 
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Abstract
Objective. Corticomotor output is reduced in re-
sponse to acute muscle pain, yet the mechanisms
that underpin this effect remain unclear. Here the au-
thors investigate the effect of acute muscle pain on
short-latency afferent inhibition, long-latency afferent
inhibition, and long-interval intra-cortical inhibition to
determine whether these mechanisms could plausibly
contribute to reduced motor output in pain.
Design. Observational same subject pre-post test
design.
Setting. Neurophysiology research laboratory.
Subjects. Healthy, right-handed human volunteers
(n522, 9 male; mean age 6 standard deviation,
22.66 7.8 years).
Methods. Transcranial magnetic stimulation was
used to assess corticomotor output, short-latency
afferent inhibition, long-latency afferent inhibition,
and long-interval intra-cortical inhibition before,
during, immediately after, and 15minutes after
hypertonic saline infusion into right first dorsal
interosseous muscle. Pain intensity and quality
were recorded using an 11-point numerical rating
scale and the McGill Pain Questionnaire.
Results. Compared with baseline, corticomotor out-
put was reduced at all time points (p5 0.001). Short-
latency afferent inhibition was reduced immediately
after (p50.039), and long-latency afferent inhibition
15minutes after (p5 0.035), the resolution of pain.
Long-interval intra-cortical inhibition was un-
changed at any time point (p5 0.36).
Conclusions. These findings suggest short- and
long-latency afferent inhibition, mechanisms thought
to reflect the integration of sensory information with
motor output at the cortex, are reduced following
acute muscle pain. Although the functional relevance
is unclear, the authors hypothesize a reduction in
these mechanisms may contribute to the restoration
of normal motor output after an episode of acute
muscle pain.
Key Words. Experimental Muscle Pain; Long-Interval
Intracortical Inhibition; Long-Latency Afferent
Inhibition; Sensorimotor Integration; Short-Latency
Afferent Inhibition; Transcranial Magnetic Stimulation
Introduction
Pain affects sensorimotor function. When pain is pre-
sent, the capacity of a muscle to generate force is
VC 2016 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 1343
Pain Medicine 2016; 17: 1343–1352
doi: 10.1093/pm/pnv104
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diminished [1–3], muscle co-ordination is altered [4–7],
proprioception is distorted [8–10], and the ability to inte-
grate sensory information with motor commands (sen-
sorimotor integration) is impaired [11]. A number of
authors have shown reduced corticomotor output dur-
ing and after the resolution of muscle pain [12–16], and
these changes are hypothesized to contribute to altered
sensorimotor function. However, the mechanisms that
underpin reduced corticomotor output in pain are
unclear.
Changes occurring across multiple levels of the nervous
system (peripheral, spinal, cortical) could reasonably
contribute to altered motor output in pain. Previous
studies have excluded changes at the muscle, as the
peripheral M-wave (muscle compound action potential),
contractile properties, and conduction velocity of action
potentials along the muscle fiber membrane are un-
changed [3,16–18]. At the level of the spinal cord, find-
ings have been contradictory. One study demonstrated
suppression of motoneurons in the late phase of pain
[14], while another demonstrated facilitation [15].
This discrepancy could be explained by the use of dif-
ferent measures (H-reflex vs cervicomedullary-evoked
potentials) to record spinal excitability. Regardless of the
direction of spinal effects, both studies reported depres-
sion of motor cortical excitability, suggesting cortical
mechanisms may contribute to the reduced motor out-
put observed in pain.
A recent study has provided the first evidence for
altered activity in motor cortical inhibitory and facilitatory
networks in response to pain [12]. That study used
transcranial magnetic stimulation (TMS) paired pulse
paradigms to show a reduction in intracortical facilitatory
(glutamate-mediated) and an increase in intracortical in-
hibitory (gamma-aminobutyric acid [GABA]A receptor
mediated) networks during and immediately after the
resolution of pain. The authors hypothesized that these
changes act to restrict activity of painful muscles and
limit the range and velocity of movement in pain, pro-
tecting the painful part from further pain and/or injury
[19]. However, the impact of acute muscle pain on other
intracortical networks such as those mediated by
GABAB (long-interval intracortical inhibition;[ LICI]), or cir-
cuits involved in the integration of sensory information
with motor execution (sensorimotor integration, meas-
ured using short- [SAI] and long-latency [LAI] afferent in-
hibition protocols) has not been investigated. Thus, here
we aimed to examine the effect of acute experimental
muscle pain on intracortical inhibitory networks, specific-
ally those mediated by GABAB, and networks associ-
ated with sensorimotor integration.
Methods
Participants
Twenty-two healthy, right-handed volunteers partici-
pated (mean 6 standard deviation; 9 male, age ¼ 22.6
6 7.8 years). Handedness was determined using the
Edinburgh Handedness inventory (laterality quotient,
88.8 6 19.6) [20]. All volunteers completed a TMS
safety screening questionnaire [21] and were excluded if
they had a recent history of arm pain or injury; a per-
sonal or family history of epilepsy; major neurological,
respiratory, orthopaedic, or circulatory disorders; were
pregnant; had metal in their head or jaw; or were taking
central nervous system acting medication [21]. The
study was approved by the institutional human medical
research ethical committee and performed in accord-
ance with the Declaration of Helsinki. All participants
provided written, informed consent. All testing took
place in a University laboratory.
Electromyography (EMG)
Surface EMG was recorded from FDI of the right hand.
Dual silver-silver chloride disposable electrodes (spacing
2.0cm; Noraxon Inc, USA) were positioned over the
muscle in a belly-tendon arrangement and remained in
place for the duration for the experiment. The ground
electrode was positioned over the right olecranon. EMG
signals were amplified x1000, band-pass filtered 20-
1000 Hz (Neurolog System Pre–amplifier; Digitimer Ltd,
UK), and sampled at 2000 Hz using a Micro3 1401 Data
Acquisition System and Signal5 software (Cambridge
Electronic Design, Cambridge, UK).
Corticomotor Output
Corticomotor output was investigated using single pulse
TMS delivered to the primary motor cortex (M1) using a
Magstim 2002 stimulator (Magstim Co. Ltd., Dyfed, UK)
connected to a figure-of -eight coil (70mm wing diam-
eter). TMS was performed over the left hemisphere
(contralateral to the side of pain) for all participants. The
coil was oriented at a 45 degree angle to induce poster-
ior-anterior current flow and positioned over the motor
‘hotspot’ of FDI [22]. The motor hotspot was deter-
mined via systematic application of TMS to the scalp
until the site that produced the largest motor evoked
potential (MEP) was identified. A Brainsight neuronaviga-
tion system (Rogue Research Inc, Quebec, Canada)
was used to target this site and ensure accurate coil
placement for the duration of the experiment. All pro-
cedures adhered to the TMS checklist for methodo-
logical quality and were performed with the muscle at
rest [23]. Fifteen MEPs (rate of 1 every 6 s) were re-
corded using a constant stimulator intensity sufficient to
evoke a MEP of approximately 1mV peak-to-peak amp-
litude in FDI at baseline.
Long-Interval Intra-Cortical Inhibition
A standard paired-pulse TMS protocol, using a supra-
threshold conditioning stimulus delivered 160 ms before
a suprathreshold test stimulus [24], was used to evalu-
ate LICI. The intensity for both stimuli was set to evoke
a peak-to-peak response of 1mV in FDI. As the ampli-
tude of the test MEP is known to influence the LICI re-
sponse [25], TMS intensity was adjusted where
Burns et al.
1344
215
Appendix B
necessary, to maintain a consistent 1mV test response
at all time points. Twelve trials were recorded in random
order at an inter-stimulus interval (ISI) of 160 ms and for
the test stimulus alone (rate of 1 every 6 s; total of 24
trials).
Short- and Long-Latency Afferent Inhibition
SAI and LAI were assessed by pairing a conditioning
electrical stimulus with a suprathreshold TMS test stimu-
lus at ISIs of 20 ms and 200 ms, respectively [26].
Electrical stimuli were delivered via a Digitimer Constant
Current stimulator (DS7A; Digitimer Ltd, UK) connected
to surface electrodes placed 2 cm proximal to the wrist
crease. Single electrical stimuli (100ms duration, 400V)
were applied to the ulnar nerve of the right arm at an in-
tensity sufficient to elicit a visible muscle contraction
(motor threshold) [27]. Intensity of the TMS test stimulus
was adjusted to evoke a peak-to-peak response of
1mV in FDI. Where necessary, the amplitude of the test
stimulus was adjusted to maintain a consistent re-
sponse at all time points [28]. Twelve trials were re-
corded in random order for each ISI (20 ms, 200 ms)
and for the test stimulus alone (rate of 1 every 6 s; total
of 36 trials).
Compound Muscle Action Potentials (M-Waves)
To control for changes in excitability occurring at the
muscle and neuromuscular junction, electrical stimuli
(100ms duration, 400V, amplified x100) were applied to
the right ulnar nerve using the set-up outlined for SAI/
LAI above. Five trials were recorded at a stimulus inten-
sity 50% above that required to elicit a maximal com-
pound muscle action potential (M-wave) in the FDI
muscle at rest.
Hypertonic Saline Infusion
Hypertonic saline was infused into right FDI following a
standard procedure [12,13]. A 25-gauge disposable
cannula (Winged Infusion Set, Terumo, Japan) was
placed into right FDI with the tip of the cannula at a
depth of approximately 0.5 cm. A single bolus of 0.2 ml
of sterile saline (5% NaCl) was infused over 20 seconds
using an infusion pump (Harvard Apparatus, SDR
Scientific, USA), a 10 ml plastic syringe (Terumo, Japan),
and a low sorbing extension tube (140cm length; Braun,
Germany). Following the bolus, a steady infusion rate of
6 ml/hour was maintained for 10 minutes. Pain intensity
and quality were evaluated using an 11-point numerical
rating scale (NRS) anchored with ‘0’ as no pain and
‘10’ as worst pain imaginable and the McGill short form
pain questionnaire [29].
Experimental Protocol
As the LICI response has been shown to be influenced
by concurrent recording of SAI and LAI measures
[30,31], data collection was performed in two experi-
ments: the effect of acute muscle pain on LICI was
examined in Experiment 1 and the effect of acute
muscle pain on SAI and LAI was assessed in
Experiment 2. All 22 participants completed both experi-
ments, separated by at least 36 hours, and experimental
order was randomized. The experimental protocol was
as follows: participants sat upright in a chair with their
head and neck supported and their arms resting com-
fortably on a pillow. Data were recorded at four time
points: i) baseline, ii) during pain (measurement com-
menced once pain reached a moderate intensity of
NRS 5/10), iii) post pain (once pain had returned to 0/
10), and iv) follow up (15 minutes after pain had returned
to 0/10). Measures at each time point were performed
in the following order: 15 MEPs, either 24 LICI trials
(Experiment 1) or 36 SAI/LAI trials (Experiment 2) and 5
M-waves. Following the completion of baseline assess-
ments, a cannula was inserted into FDI and remained in
situ for the duration of the ‘during pain’ time period.
Immediately after the infusion, the cannula was
removed. Participants were asked to verbally rate their
pain using the NRS after the completion of each meas-
ure within the ‘during pain’ time period and for every mi-
nute after the removal of the cannula, until NRS 0/10
was achieved. At the conclusion of each experiment,
participants described the location, quality and intensity
(subjective average) of muscle pain using the McGill
short form pain questionnaire. The protocol for
Experiments 1 and 2 is outlined in Figure 1.
Data and Statistical Analyses
MEP and Mwave data were measured as peak-to-peak
amplitudes (mV) and averaged at each time point. To
account for any activity-dependent changes in muscle
fiber action potentials resulting from the induction of
pain, statistical analyses for corticomotor output were
performed with MEP amplitude expressed as a propor-
tion of Mwave amplitude (MEP/Mwave amplitude ratio)
[22]. To determine whether acute muscle pain induced
a change in LICI (Experiment 1) or SAI and LAI
(Experiment 2), peak-to-peak conditioned MEP ampli-
tudes for these data were expressed as a percentage of
the unconditioned (test) response. It has been shown
that approximately 30% of individuals fail to respond to
afferent inhibition protocols at baseline under uniform
test conditions [32], thus, consistent with previous work
[32], it was elected to exclude participants who did not
display inhibition at baseline from further analyses.
All neurophysiological outcomes (MEP/Mwave amplitude
ratio, LICI, SAI, and LAI) were assessed for normality
and compared between time points (baseline, during
pain, post pain, follow up) using a one-way repeated
measures analysis of variance (ANOVA) or where data
was not normally distributed, a Friedman’s repeated
measures analysis on ranks. Post hoc analyses were
performed using the Student Newman Keuls (SNK) test
that corrected for multiple comparisons. Significance
was set at 5%. All data in text is presented as mean 6
standard deviation.
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Results
Pain Characteristics
Infusion of hypertonic saline induced an average pain
intensity of 5.261.7 cm for Experiment 1 and 5.06
1.7 cm for Experiment 2. The most frequent words used
to describe pain were aching (82%), throbbing (73%),
sharp (62%), and cramping (60%). The majority of par-
ticipants reported symptoms localised to the dorsal sur-
face of the hand. One participant reported numbness
localised to the thumb and an additional two partici-
pants reported pain that extended beyond the wrist into
the proximal forearm.
Corticomotor Output Is Reduced During and After
Acute Muscle Pain
As the effect of acute muscle pain on corticomotor out-
put (MEP/Mwave amplitude ratio) was similar for
Experiments 1 and 2 (ANOVA main effect of interaction,
p¼0.67), these data were pooled for analyses.
Corticomotor output was reduced during pain (ANOVA
main effect of time, p¼ 0.001) relative to baseline (SNK
p¼0.003) and this reduction persisted immediately
(SNK p¼ 0.003) and 15 minutes following the resolution
of pain (SNK p¼0.047; Figure 2).
Long-Interval Intra-Cortical Inhibition Is Unchanged by
Muscle Pain
Two participants did not display inhibition at baseline
(two females, aged 19 years) and these individuals were
excluded from further analysis of LICI [32]. Thus, data
from 20 participants (nine male, age ¼ 23.06 8.4 years)
were analyzed. It was necessary to adjust the intensity
of TMS output at each time point to maintain test re-
sponses of approximately 1mV peak-to-peak amplitude
for all participants. The intensity at baseline was
57.36 9.6%, 61.469.5% during pain, 64.06 10.2%
post pain, and 61.86 12.2% at follow up. The induction
of acute muscle pain did not alter LICI at any time point
(ANOVA main effect of time, p¼ 0.36; Figure 3A). The
amplitude of the test MEP remained stable over time
(baseline: 1.106 0.42 mV, during: 0.966 0.40 mV, post:
1.0260.37 mV, follow up: 0.9960.37 mV; ANOVA
main effect of time, p¼ 0.54).
Short-Latency Afferent Inhibition Is Reduced
Immediately After the Resolution of Acute Muscle Pain
Six participants did not display inhibition in response to
the SAI protocol at baseline (two male, age ¼
26.0612.1 years) and were excluded [32]. Thus, data
Figure 1 Experimental protocol. Measures of corticomotor output (MEP), long-interval intra-cortical inhibition (LICI),
short- and long-latency afferent inhibition (SAI/LAI), and peripheral excitability (Mwave) were made at i) baseline,
ii) during pain (once pain reached 5/10 intensity), iii) immediately post pain (pain 0/10), and iv) 15 minutes following
the resolution of pain (follow up). LICI and SAI/LAI were assessed in separate experiments (EXP 1 and 2) to avoid
inhibitory interactions. Cannulae were inserted after completion of baseline measures and were removed once the
infusion was terminated. During and following infusion of hypertonic saline, pain intensity was monitored using a nu-
merical rating scale (NRS). The McGill short form pain questionnaire (McGill Questions) was completed at the conclu-
sion of EXP 1 and 2.
Figure 2 Pooled group data from both experiments
(n¼ 22 in each experiment) for corticomotor output be-
fore, during, immediately post, and 15 minutes following
the resolution of experimental muscle pain. Data are ex-
pressed as MEP/Mwave amplitude ratio. Corticomotor
output is reduced during, immediately post, and 15 mi-
nutes following the resolution of muscle pain. *p < 0.05.
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from 16 participants were included in the analysis
(seven male, age ¼ 21.46 4.9 years). It was necessary
to adjust the intensity of TMS output at each time point
to maintain test responses of approximately 1mV peak-
to-peak amplitude for all participants. The intensity at
baseline was 53.26 10.0%, 57.6612.1% during pain,
60.9612.3% post pain, and 59.96 12.1% at follow up.
Acute muscle pain reduced SAI (ANOVA main effect of
time, p¼ 0.039) relative to baseline immediately follow-
ing the resolution of muscle pain (baseline vs immediate,
SNK p¼ 0.044; Figure 3B). This effect was not main-
tained at 15 minutes follow-up (baseline vs follow-up,
SNK p¼ 0.16). There was no change in SAI during
pain (baseline vs during, SNK p¼ 0.55). The ampli-
tude of the test MEP remained constant over time
(baseline: 1.0060.13 mV, during: 0.936 0.19 mV, post:
0.9560.13 mV, follow up: 0.9560.16 mV; ANOVA
main effect of time, p¼ 0.16).
Long-Latency Afferent Inhibition Is Reduced
15Minutes After the Resolution of Acute Muscle Pain
Six participants did not display inhibition in response to
the LAI protocol at baseline (two male, age ¼
20.061.7 years) and were excluded. Thus, data from
16 participants were included in the analysis (seven
male, age ¼ 24.56 10.4 years). It was necessary to ad-
just the intensity of TMS output at each time point to
maintain test responses of approximately 1mV peak-to-
peak amplitude for all participants. The intensity at
baseline was 58.86 10.1%, 57.3612.1% during pain,
60.6612.6% post pain, and 59.76 12.8% at follow up.
As data was not normally distributed, comparisons were
performed using Friedman’s repeated measures analysis
on ranks. Acute muscle pain reduced LAI (Friedman:
main effect of time, p¼ 0.035) 15 minutes after pain
had resolved (follow-up vs baseline SNK p< 0.05;
Figure 3C). There was no change in LAI during (baseline
vs during, SNK p>0.05) or immediately after the reso-
lution of pain (baseline vs immediate, SNK p> 0.05).
The amplitude of the test MEP remained constant over
time (baseline: 0.996 0.26 mV, during: 0.9160.29 mV,
Figure 3 Group data (mean 6 standard error) for
(A) long-interval intracortical inhibition (LICI, n¼20),
(B) short-latency afferent inhibition (SAI, n¼16), and
(C) long-latency afferent inhibition (LAI, n¼ 16) at base-
line, during, immediately post, and 15 minutes following
the resolution of experimental muscle pain. Individuals
who did not show inhibition at baseline were excluded
from analyses and are not shown in the Figure. LICI,
SAI, and LAI were determined by expressing the condi-
tioned MEP as a percentage of the unconditioned test
MEP (% of test MEP). LICI was not affected by acute
muscle pain at any time point (A). Compared with base-
line, SAI was reduced (less inhibition, higher proportion
of the test MEP) immediately post pain (B) and LAI was
reduced at follow up (C). *p < 0.05.
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post: 0.866 0.28 mV, follow up: 0.896 0.32 mV;
ANOVA: main effect of time, p¼0.25).
Discussion
To our knowledge, this study is the first to examine cir-
cuits involved in sensorimotor integration (SAI, LAI) and
intracortical networks mediated by GABAB (LICI) in re-
sponse to acute muscle pain. The novel finding is that
experimental muscle pain reduces SAI and LAI (indica-
tive of less inhibition) but only once pain has resolved,
whereas intra-cortical networks mediated by GABAB ap-
pear unaffected by acute muscle pain. Our data also
confirm previous reports of reduced corticomotor output
during and following the resolution of pain. Taken to-
gether, our findings provide new insight into mechan-
isms that may contribute to recovery of motor output
following acute muscle pain.
Short- and long-latency afferent inhibition is investigated
by coupling peripheral nerve stimulation at the wrist with
TMS at M1 [26]. When paired at short (20ms) and
long (200ms) inter-stimulus intervals, inhibition of the
MEP is observed, an effect thought to reflect the inter-
action between sensory input and motor output at the
level of the cortex (sensorimotor integration) [26,33]. The
latencies at which inhibition is induced suggest that SAI
and LAI reflect the activation of distinct sensorimotor
pathways and thus are likely to represent separate indi-
ces of sensorimotor integration. For instance, SAI is
postulated to involve direct S1-M1 pathways [26,31,34],
whereas LAI is thought to involve indirect basoganglia-
thalamocortical pathways [31,33–35]. This interpretation
is further supported by evidence that SAI and LAI dis-
play unique interactions with other intracortical circuitry
[30,31,36], and are differentially affected by pathology
[34,35,37] and drug formulations [38–40]. In the present
study we show reduced SAI immediately following, and
reduced LAI 15 minutes following, an episode of acute
muscle pain. Hence, the different cortical pathways that
underpin these mechanisms are likely to explain these
differential time effects. Although it is beyond the scope
of the present study to infer causation, it is possible that
the timing of these effects may relate to the relative tem-
poral sensitivity of the cortical generators of SAI and LAI
to salient cues (i.e., the cessation of nociceptive input)
[41].
Although the functional significance of reduced SAI and
LAI in response to acute muscle pain is unclear, evi-
dence suggests that appropriate sensorimotor integra-
tion constitutes an essential component of fluid,
coordinated motor control [42]. Work performed in non-
pain conditions indicate that SAI and LAI support the
operation of ‘surround inhibition’, a mechanism that fa-
cilitates fine motor control via regulation of the inhibitory
drive to specific muscles [43]. Indeed, it has been
shown during selective movement of the index finger
that SAI/LAI to muscles necessary for movement is
decreased, whilst inhibition to redundant muscles is
increased [44,45]. One explanation for our data is that
reduced afferent inhibition (SAI and LAI) following reso-
lution of muscle pain acts to facilitate motor recovery,
promoting a return to normal motor output of the painful
part as the threat of pain and injury subsides. Indeed,
although motor output remains suppressed compared
with baseline in the post pain time period, our data
demonstrates that motor output has undergone recov-
ery of approximately 50% 15 minutes after pain has
resolved (Figure 2). Further work is necessary to deter-
mine the time course of recovery of motor output and
the relationship between motor output and afferent in-
hibition to confirm this hypothesis.
We contend that motor output in the post-pain period
may reflect a balance between the need for recovery of
motor output and protection from the threat of further
pain and injury. This is supported by evidence of altered
activity in the cortical circuits thought to support each of
these functions. For instance, although SAI and LAI are
reduced (less inhibition) in the post-pain period, possibly
to facilitate motor recovery, other inhibitory mechanisms
are increased. Short-interval intracortical inhibition (SICI),
an index of M1 intracortical activity mediated via GABAA
receptors on inhibitory interneurons [46,47], is increased
immediately following the resolution of muscle pain and
this is thought to maintain a protective motor strategy in
the post-pain period by continuing to limit motor output
[12]. As SICI is known to inhibit the expression of SAI
[36,48], and interacts in an additive manner with LAI
when activated concurrently [31], it is possible that SICI
is the dominant mechanism during this early post-pain
time period, ensuring a protective strategy persists until
the threat of pain is completely removed. Once all threat
has dissipated, SICI may reduce, and mechanisms such
as SAI and LAI may become dominant, facilitating re-
covery of motor output. However, SICI has only been
investigated in the period immediately following the
resolution of acute pain [12], and it is unknown how the
temporal profile of this mechanism is altered in relation
to SAI, LAI and motor output over an extend time frame.
Future work should seek to examine the interaction of
these mechanisms over a prolonged time period once
pain has resolved.
Our observation that LICI remains unchanged in re-
sponse to pain is further evidence that the response to
pain varies across different inhibitory networks. Unlike
SICI, the effects of LICI are mediated via GABAB recep-
tors located on M1 interneurons [49,50], therefore the
results of the present study suggest that the effect of
pain differs among GABA receptor subtypes. Although it
is unclear why GABAA, but not GABAB mediated inhib-
ition is affected by pain, one possible explanation may
be that LICI is more robust than SICI and less sensitive
to transient changes in afferent input. Indeed, since re-
ductions in LICI have been observed in chronic pain
conditions such as fibromyalgia and rheumatoid arthritis
[51], it is likely that the effect of pain on LICI may de-
pend upon symptom duration. Alternatively, as LAI has
been demonstrated to interact with LICI in an intensity
dependent manner [31], it is possible that LICI remained
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unaffected during or immediately post pain due to the
stability of LAI at these time points. However, since LAI
was reduced 15 minutes post pain but LICI was un-
changed, further work is needed to determine whether
LICI/LAI interactions are relevant during and/or following
a painful episode.
A vehicle control was not included in the current study
for several reasons. First, use of such a control is com-
mon in both animal and human studies of experimental
pain and rarely, if ever, shows an effect [52,53]. Indeed,
previous studies of similar methodology have demon-
strated no effect of intramuscular isotonic saline solution
on the amplitude or latency of MEPs to muscles of the
upper limb [14,15]. Second, numerous studies demon-
strate that measures of M1 organization and function
are stable and reliable over time [54–56]. For example,
corticomotor output has been shown to be stable dur-
ing 30 minutes of controlled, quiet sitting [16] and is reli-
able over short (0-4 days) and long (0-14 days, 0-1
months) intersession intervals [54,55]. Similarly, LICI and
SAI have been shown to be stable over testing intervals
of 1 and 7 days, respectively [27,57]. Taken together,
these observations indicate that the measures used in
this study are not sensitive to time effects and our find-
ings are unlikely to be replicated in a no pain control
condition.
This study has several limitations that should be
acknowledged. First, we did not collect data from
muscles other than FDI and thus, this study is not able
to determine whether reductions in SAI and LAI are
muscle specific. However, results from previous studies
suggest a non-specific, but localised, effect of hand
pain on corticomotor output. For example, muscle pain
induced in FDI has been shown to reduce corticomotor
output of distant hand muscles (abductor digiti minimi)
[12,14], but not of proximal forearm muscles (flexor
carpi ulnaris) [16]. Further research is required to deter-
mine whether reductions in SAI and LAI are confined to
the muscle in pain, or extend to other local hand and
forearm muscles. Second, SAI, LAI, and LICI were not
tested using a range of ISIs. In early studies of SAI, the
ISIs tested were based on calculations of the specific la-
tency of the N20 component of the somatosensory
evoked potential observed following median nerve
stimulation for each participant [26]. Following ulnar
nerve stimulation, the latency of this component is
known to occur within the range of 19.9361.1 ms [27]
to 20.76 0.7ms [36]. As inter-individual variability for
SAI has been shown to be high within the optimal test
range [27,58] and SAI is decreased or absent if afferent
stimulation fails to correspond with the latency of N20, it
is possible that that the stimulus parameters used in
this present study may have been suboptimal for some
participants. As this limitation necessitated the exclusion
of six participants from SAI and LAI analysis, future re-
search should seek to use stimulus parameters specific
to induce inhibition in each individual participant. Two
participants who responded with MEP facilitation to the
LICI protocol were also excluded as there is evidence
that such facilitation is due to the interference of intra-
cortical facilitatory mechanisms [59]. Future work con-
cerning LICI should seek to investigate the effect of pain
at intervals <160 ms as recent evidence suggests that
LICI evoked using early (100ms) and late (150 ms)
test intervals [60,61] may differentially reflect pre- and
postsynaptic inhibitory processes [62].
Conclusions
This study is the first to provide evidence of reduced
SAI and LAI following acute muscle pain. We hypothe-
size that these responses may reflect the early activation
of mechanisms that restore normal motor function after
the resolution of pain. It is possible that a protective
motor strategy (reduced corticomotor output) prevails
early after the resolution of pain, despite reductions in
SAI and LAI, due to the existence of competitive inter-
actions between SAI/LAI and other inhibitory networks.
Further studies are required to confirm this hypothesis.
If confirmed, these data may have relevance for the de-
sign of clinical interventions that aim to restore motor
output in musculoskeletal pain conditions.
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Abstract
Background: Lateral epicondylalgia (LE) is a musculotendinous
condition characterized by persistent pain, sensorimotor dysfunction and
motor cortex reorganization. Although there is evidence linking cortical
reorganization with clinical symptoms in LE, the mechanisms
underpinning these changes are unknown. Here we investigated activity
in motor cortical (M1) intracortical inhibitory and facilitatory networks
in individuals with chronic LE and healthy controls.
Methods: Surface electromyography was recorded bilaterally from the
extensor carpi radialis brevis (ECRB) muscle of 14 LE (4 men,
41.5  9.9 years) and 14 control participants (4 men,
42.1  11.1 years). Transcranial magnetic stimulation of M1 was used
to evaluate resting and active motor threshold, corticomotor output,
short- (SICI) and long-latency intracortical inhibition (LICI) and
intracortical facilitation (ICF) of both hemispheres.
Results: In individuals with LE, SICI (p = 0.005), ICF (p = 0.026) and LICI
(p = 0.046) were less in the M1 contralateral to the affected ECRB muscle
compared with healthy controls. Motor cortical threshold (rest: p = 0.57,
active: p = 0.97) and corticomotor output (p = 0.15) were similar between
groups. No differences were observed between individuals with LE and
healthy controls for the M1 contralateral to the unaffected ECRB muscle.
Conclusions: These data provide evidence of less intracortical inhibition
mediated by both GABAA and GABAB receptors, and less intracortical
facilitation in the M1 contralateral to the affected ECRB in individuals
with LE compared with healthy controls. Similar changes were not
present in the M1 contralateral to the unaffected ECRB. These changes
may provide the substrate for M1 reorganization in chronic LE and
could provide a target for future therapy.
What does this study add: Lateral epicondylalgia (LE) is a common
musculoskeletal condition characterized by elbow pain and sensorimotor
dysfunction. The excitability and organization of the motor cortical
representation of the wrist extensor muscles is altered in LE, but the
mechanisms that underpin these changes are unknown. evidence of less
intracortical inhibition mediated by both GABAA and GABAB receptors,
and less intracortical facilitation mediated by NMDA receptors, in the
M1 contralateral to the affected extensor carpi radialis brevis muscle in
chronic LE compared with healthy controls. Altered activity in
intracortical networks may contribute to altered motor cortex
organization in LE and could provide a potential target for future
treatments.
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1. Introduction
Lateral epicondylalgia (LE), commonly termed ‘ten-
nis elbow’, is a disabling condition affecting the mus-
culotendinous structures at the lateral epicondyle,
characterized by symptoms of persistent pain and
sensorimotor dysfunction (Bisset et al., 2006; Skin-
ner and Curwin, 2007; Juul-Kristensen et al., 2008;
Coombes et al., 2012). Thought to be triggered by
repetitive, forceful use of the forearm extensor mus-
cles (Fan et al., 2009), LE affects 1–3 per cent of the
general population and 15% of workers, with high
rates of symptom persistence and recurrence (Shiri
et al., 2006). Recent evidence suggests that altered
primary motor cortex (M1) organization could con-
tribute to symptoms of pain and motor dysfunction
in this condition. For instance, increased excitability,
greater overlap and a reduced number of discrete
cortical peaks have been demonstrated in the repre-
sentations of the elbow extensor muscles in chronic
LE, and these changes are associated with pain
severity (Schabrun et al., 2014). As M1 representa-
tions are known to be maintained and adjusted by
intracortical inhibitory (ICI) and facilitatory (ICF)
networks (Liepert et al., 1998a), altered activity in
these networks could underpin altered M1 organiza-
tion in LE.
Intracortical networks can be probed in the
human M1 using paired-pulse transcranial magnetic
stimulation protocols. ICI measured at short (SICI)
and long (LICI) latencies is thought to reflect activity
in GABAA and GABAB receptor systems, respec-
tively, while ICF is thought to reflect activity in the
glutamatergic (NMDA receptor) system, with a rela-
tive spinal contribution (Ziemann et al., 1998; Wer-
hahn et al., 1999; McDonnell et al., 2006). Studies
have shown increased ICI, and reduced ICF, in
response to acute muscle pain, and these findings
are hypothesized to underpin reduced M1 excitabil-
ity and restriction of motor output observed in acute
pain (Hodges and Tucker, 2011; Schabrun and
Hodges, 2012). Conversely, in persistent neuropathic
pain, complex regional pain syndrome and low back
pain, ICI is reduced, a finding that may underpin
increased excitability and altered organization of M1
in these conditions (Schwenkreis et al., 2003, 2010;
Eisenberg et al., 2005; Masse-Alarie et al., 2012).
Similar alterations in intracortical networks could be
present in LE, yet no study has investigated these
mechanisms in this condition.
Understanding the mechanisms that contribute to
chronic LE has the potential to provide new targets
for therapy. Indeed, use of repetitive transcranial
magnetic stimulation to restore ICI in chronic neuro-
pathic pain is associated with a reduction in pain
severity, suggesting that therapies designed to target
intracortical networks may be effective in ameliorat-
ing persistent pain (Lefaucheur et al., 2006). Here
we aimed to investigate the function of M1 intracor-
tical networks mediated by GABAA (short-interval
intracortical inhibition, SICI), GABAB (long-interval
intracortical inhibition; LICI) and NMDA receptors
(ICF) in individuals with persistent LE and healthy
controls. Consistent with findings in other persistent
pain conditions, we hypothesized a reduction in
intracortical inhibition in individuals with LE.
2. Method
2.1 Participants
Fourteen individuals with LE (mean  standard
deviation; 4 men, aged 41.5  9.9 years) and 14
age- and gender-matched healthy controls (4 men,
aged matched  5 years: 42.1  11.1) participated.
As M1 intracortical mechanisms are yet to be inves-
tigated in LE, sample size calculations were based on
effect sizes from a previous study examining cortical
excitability (motor evoked potential amplitude) in
LE (Schabrun et al., 2014). Based on these data (dif-
ference of means between patients and controls:
0.59 mV, standard deviation: 0.625 mV), it was cal-
culated that a minimum sample size of nine partici-
pants in each group were needed to observe a
statistically significant difference (80% power, alpha
0.05) should one exist (Kadam and Bhalerao, 2010).
Individuals with LE were included if they had expe-
rienced elbow pain over the lateral epicondyle for
greater than 6 weeks that was provoked by palpa-
tion, gripping, resisted wrist and/or middle finger
extension (Linaker et al., 1999). Exclusion criteria
included: (1) use of oral or topical pain-relief medi-
cation in the preceding 48 h; (2) concomitant neck
or arm pain that prevented participation in usual
work or recreational activities; (3) corticosteroid
injections in the last 6 months; and (4) evidence of
sensory disturbances, history of fractures, elbow sur-
gery, arthritic or inflammatory disorders or pain
localized to the radiohumeral joint (Coombes et al.,
2009, 2013). In addition, participants completed a
transcranial magnetic stimulation (TMS) safety
screening questionnaire and were excluded from
enrolment if they had a personal or family history of
epilepsy, major neurological, respiratory, orthopaedic
or circulatory disorders, if they were pregnant, had
© 2016 European Pain Federation - EFIC Eur J Pain 20 (2016) 1166--1175 1167
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metal in their head or jaw or were taking central
nervous system acting medications (Keel et al.,
2001). The study was approved by the institutional
human medical research ethical committee and per-
formed in accordance with the Declaration of Hel-
sinki. All participants provided written, informed
consent.
2.2 Clinical measures of LE
2.2.1 Pain and disability
The Patient Rated Tennis Elbow Evaluation (PRTEE)
was used to assess pain and disability for the week
preceding the experiment (Macdermid, 2005). Scores
for pain (sum of five items out of 50) and function
(sum of 10 items, divided by 2, out of 50) were com-
bined to give a total score ranging from 0 (no pain
and no functional impairment) to 100 (worst pain
imaginable with significant functional impairment).
Current pain intensity was recorded using an 11-
point numerical rating scale (NRS) anchored with ‘0’
as no pain and ‘10’ as worst pain imaginable.
2.2.2 Pressure pain thresholds (PPT)
A hand-held pressure algometer (Commander probe
size 1 cm2, JTECH Medical, Midvale, Utah, USA)
was applied perpendicular to the extensor carpi radi-
alis brevis (ECRB) muscle at a steadily increasing
rate of pressure. ECRB was located via palpation
during resisted middle finger and wrist extension.
The location of the muscle belly was marked on the
skin with an oily-tipped pen to ensure accurate
probe placement between trials. Participants were
instructed to vocalize at the exact moment they per-
ceived the sensation of pressure first turn to pain.
Pressure pain threshold (N) was assessed for each
arm and defined as the average of five consecutive
trials (rate of 1 trial every 10 s).
2.2.3 Pain-free grip strength and maximum grip
strength
Pain-free and maximum grip strength were assessed
using a hand-held dynamometer (Baseline Digital
Hand dynamometer, Chattanooga Group, Chatta-
nooga, Tennessee, USA). Participants assumed a
seated position and were assisted in placing their
arm in 90° shoulder flexion, full elbow extension
and neutral forearm pronation (De Smet et al.,
1998). For pain-free grip strength, participants were
instructed to squeeze the dynamometer, but to cease
immediately at the onset of pain. To assess maximal
grip strength, participants were instructed to squeeze
the dynamometer as hard as possible, regardless of
pain. Grip strength (kg) of each arm was determined
based on the average of three consecutive trials (rate
1 trial every 30 s).
2.3 Neurophysiological measures
2.3.1 Electromyographic recordings
Surface electromyography (EMG) was recorded from
ECRB using dual silver–silver chloride disposable
electrodes (spacing 2.0 cm). Electrode position was
determined following palpation of ECRB during
resisted wrist and middle finger extension. The
ground electrode was positioned over the olecranon.
EMG signals were amplified 91000 (NL844, Dig-
itimer Ltd, Welwyn Garden City, UK), band-pass fil-
tered: 20–1000 Hz and sampled at 2000 Hz using a
Micro3 1401 Data Acquisition System and Signal 5
software (Cambridge Electronic Design, Cambridge,
UK).
2.3.2 Motor threshold and corticomotor output
Transcranial magnetic stimulation (TMS) was deliv-
ered to the primary motor cortex using a Magstim
200 stimulator (Magstim Co. Ltd., Dyfed, UK) con-
nected to a circular coil (90 mm diameter) and all
procedures adhered to the TMS checklist for
methodological quality (Chipchase et al., 2012). The
coil was oriented to induce posterior–anterior cur-
rent flow (left hemisphere: anticlockwise current
direction; right hemisphere: clockwise current direc-
tion), and positioned over the optimal scalp position
for ECRB (Groppa et al., 2012). This position was
determined by systematic application of TMS to the
scalp until the site that produced the largest motor
evoked potential (MEP) was identified. A Brainsight
neuronavigation system (Rogue Resolutions Ltd.,
Cardiff, UK) ensured accurate coil placement
throughout each experiment. Resting and active
motor threshold were determined at the optimal
position via the maximum-likelihood protocol
(Motor threshold Assessment Tool, version 2.0:
http://www.clinicalresearcher.org/software.htm)
(Awiszus, 2003). Resting motor threshold (RMT) was
defined as the minimum stimulus intensity that
evoked a MEP greater than 50 lV in the target mus-
cle at rest (Rossini et al., 1994). Active motor thresh-
old (AMT) was defined as the minimum stimulus
intensity that evoked a MEP greater than 200 lV
during isometric contraction of ECRB [10% maxi-
1168 Eur J Pain 20 (2016) 1166--1175 © 2016 European Pain Federation - EFIC
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mum voluntary contraction (MVC)] (Rossini et al.,
1994). Thirty MEPs were recorded from resting
ECRB at 120% RMT to assess corticomotor output
(rate of 1 pulse every 6 s). Trials containing muscle
activity within 50 ms preceding the TMS pulse were
discarded (Groppa et al., 2012).
2.3.3 Short-interval intracortical inhibition (SICI)
and intracortical facilitation (ICF)
A standard paired-pulse TMS protocol that consisted
of a sub-threshold conditioning stimulus delivered 2
or 10 ms before a supra-threshold test stimulus, was
used to evaluate SICI and ICF, respectively (Kujirai
et al., 1993). Magnetic stimulation was delivered at
the optimal scalp site to evoke a response in ECRB
with the muscle at rest. Conditioning intensity was
based on a percentage of AMT to decrease the likeli-
hood of SICI and ICF measurements being influ-
enced by other intracortical mechanisms, such as
short-interval intracortical facilitation (sICF) (Ortu
et al., 2008; Peurala et al., 2008). However, as indi-
vidual variability for SICI thresholds is known to be
high (Orth et al., 2003), testing SICI at a single con-
ditioning intensity is unlikely to reflect the true
maximum inhibition for all individuals. Thus, to
account for between-subject variability to paired-
pulse TMS (Boroojerdi et al., 2000; Maeda et al.,
2002; Wassermann, 2002) and to investigate the
stimulus–response profile of SICI and ICF, three con-
ditioning intensities were used in this experiment.
The intensities 70, 80, 90% of AMT were selected as
these are known to elicit reliable SICI and ICF in
healthy individuals (Ortu et al., 2008; Peurala et al.,
2008). As MEPs from proximal upper limb muscles
are typically smaller and less defined than those
evoked from distal muscles (Chen et al., 1998;
Groppa et al., 2012), test stimulus intensity was set
to evoke a test MEP with a peak-to-peak amplitude
of approximately 0.3–0.5 mV in all subjects (Perez
and Cohen, 2008; Schwenkreis et al., 2011). Twelve
trials were recorded in pseudorandom order at each
interstimulus interval (ISI; 2 ms, 10 ms) and for the
test stimulus alone (rate of 1 every 6 s; total of 36
trials per conditioning intensity).
2.3.4 Long-interval intracortical inhibition (LICI)
Long-interval intracortical inhibition (LICI) was eval-
uated using a supra-threshold conditioning stimulus
delivered 160 ms before a supra-threshold test stim-
ulus (Claus et al., 1992). Stimulations were per-
formed at the optimal scalp site to evoke a response
in ECRB at rest. The test and conditioning intensities
were equal and set to evoke a peak-to-peak response
of approximately 0.3–0.5 mV in ECRB. Twelve trials
were recorded in pseudorandom order at ISI 160 ms
and for the test stimulus alone (rate of 1 every 6 s;
total of 24 trials).
2.4 Experimental protocol
All experimental procedures were conducted in a
single test session. Data collection was performed in
the following order: (1) clinical outcome measures
(LE participants only); (2) resting and active motor
threshold; (3) corticomotor output (MEPs); (4) SICI
and ICF (three conditioning intensities: 70, 80, 90%
of AMT); and (5) LICI. TMS measures were repeated
over both hemispheres for consenting participants.
Rest intervals of at least 2 min were provided
between each measure.
2.5 Data and statistical analysis
2.5.1 Clinical measures of LE
Measures of PPT, maximum grip strength and pain-
free grip strength were compared between sides (af-
fected vs. unaffected arm) for individuals with LE.
Pearson correlation coefficients were used to evalu-
ate relationships between (1) pain (NRS) and disabil-
ity (PRTEE), sensorimotor function (PPT, max grip
strength, pain-free grip strength); and (2) SICI, ICF
and LICI of the corresponding hemisphere.
2.5.2 Neurophysiological measures
MEP data were measured as peak-to-peak ampli-
tudes and averaged for each trial. Intracortical inhi-
bition (SICI, LICI) and facilitation (ICF) were
calculated by expressing the mean peak-to-peak con-
ditioned MEP amplitudes as a percentage of the
unconditioned (test) response.
All neurophysiological outcomes (RMT, AMT,
MEP, SICI, ICF and LICI) were assessed for normal-
ity via the Shapiro–Wilk test, transformed if neces-
sary, and compared between groups (LE vs. control)
for each hemisphere using separate one-way ANO-
VAs. To account for the influence of the amplitude
of the unconditioned (test) MEP on the magnitude
of SICI, ICF and LICI (Chen et al., 1998; Udupa
et al., 2010), test MEP amplitude was also compared
between groups with one-way ANOVAs. One-way
repeated measures ANOVA were used to compare
contralateral and ipsilateral data within the LE
group. Post hoc analyses were corrected for multiple
© 2016 European Pain Federation - EFIC Eur J Pain 20 (2016) 1166--1175 1169
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comparisons using the Holm–Sidak method. Statisti-
cal significance was set at p < 0.05. Data in text are
expressed as mean  standard deviation unless sta-
ted otherwise.
3. Results
3.1 Clinical measures of LE
Patient characteristics are summarized in Table 1.
Average current pain intensity was 3.5  2.8 on the
NRS and the average combined score for the pain
and function subscale of the PRTEE was
38.4  19.0. Individuals with LE demonstrated
reduced strength for the affected arm compared to
the unaffected arm in the pain-free (affected:
18.6  18.2 kg; unaffected: 32.1  12.8 kg; main
effect, p = 0.004) and maximal grip strength tasks;
however, results for the latter failed to reach statisti-
cal significance (affected: 30.3  15.0 kg; unaffected:
34.7  11.2 kg; main effect, p = 0.075). Pressure
pain thresholds were less for ECRB of the affected
arm compared to the unaffected arm (affected:
17.8  8.7 kg; unaffected: 21.4  7.4 kg; main
effect, p = 0.017), suggesting increased sensitivity to
mechanical stimuli in the affected limb.
3.2 Neurophysiological measures
3.2.1 TMS of the hemisphere contralateral to the
‘affected’ arm in LE and the matched hemisphere
in healthy controls
There was no difference in resting motor threshold
(LE: 48.6  8.5; Control: 50.7  10.4; main effect,
p = 0.57), active motor threshold (LE: 45.6  9.3;
Control: 45.4  8.9; main effect, p = 0.97) or MEP
amplitude (LE: 0.30  0.14 mV; Control:
0.53  0.46 mV; main effect, p = 0.15) between
individuals with LE and healthy controls.
The magnitude of SICI and ICF observed for ECRB
of healthy controls was consistent with previous
investigations of similar methodology (circular coil,
2 ms, 10 ms ISI) (Shimizu et al., 1999). SICI was less
in individuals with LE compared to healthy controls
at a conditioning intensity of 90% AMT (main effect,
p = 0.005), but was similar between groups at condi-
tioning intensities of 70% and 80% AMT (70%:
main effect, p = 0.24; 80%: main effect, p = 0.50;
Fig. 1A). Similarly, LICI was less in individuals with
LE when compared with controls (main effect,
p = 0.046; Fig. 2A). Intracortical facilitation was less
in LE participants compared with healthy controls at
a conditioning intensity of 80% AMT (main effect,
p = 0.026; Fig. 1C), but not at 70% (main effect,
p = 0.95) or 90% AMT (main effect, p = 0.43). Test
MEP amplitudes were comparable between groups
for LICI (main effect, p = 0.30) and for each SICI
and ICF conditioning intensity (70% AMT: main
effect, p = 0.30; 80% AMT: main effect, p = 0.96;
90% AMT: main effect, p = 0.58). The magnitude of
SICI, ICF and LICI did not correlate with pain, dis-
ability or sensorimotor function in the affected arm
(all p > 0.16).
3.2.2 TMS of the hemisphere ipsilateral to the
‘affected’ arm in LE and the matched hemisphere
in the healthy controls
Ten LE (3 men, aged 40.2  11.8 years) and 10 con-
trol participants (3 men, aged 42.0  12.3 years)
consented to TMS of the ipsilateral hemisphere. Of
Table 1 Demographic and clinical characteristics for individuals with lateral epicondylalgia (n = 14).
Subject Gender Age (years) Symptom duration (months) Dominant arm Affected arm PRTEE (/100) NRS (/10)
1 F 52 288 R R 35 2
2 F 38 3 R R 79 7
3 M 44 12 R R 14 0.5
4 F 45 7 R R 45 6
5 F 48 7 R R 31.5 2
6 F 43 3 R R 17 0
7 F 50 24 L R 24 0.5
8 M 46 60 R R 22 2
9 F 45 3 R R 67 7.5
10 M 20 3 R R 32.5 1
11 M 37 4 R R 34.5 6
12 F 21 24 R L 56 7
13 F 50 60 R L 30 3
14 F 42 24 R R 50.5 5
PRTEE, patient rated tennis elbow evaluation (pain and disability); NRS, numerical rating scale.
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the participants who chose to withdraw from this part
of the study, all cited poor tolerability to TMS as the
reason for their decision. Similar to data obtained
from the contralateral hemisphere, there was no dif-
ference in resting motor threshold (LE: 47.8  10.7;
Control: 49.5  13.7; main effect, p = 0.76), active
motor threshold (LE: 45.6  10.0; Control:
46.0  9.9; main effect, p = 0.93) or MEP amplitude
(LE: 0.28  0.14 mV; Control: 0.33  0.22 mV; main
effect, p = 0.54) between groups.
The magnitude of SICI was similar between those
with and without LE under all test conditions (70%:
main effect, p = 0.91; 80%: main effect, p = 0.95;
90%: main effect p = 0.89; Fig. 1B), and this was the
same for measures of LICI (main effect, p = 0.14;
Fig. 2B) and ICF (70% AMT: main effect, p = 0.99;
80%: main effect, p = 0.71; 90%: main effect,
p = 0.43; Fig. 1D). The amplitude of the test MEP was
comparable between groups for LICI (main effect,
p = 0.15) and for each SICI and ICF conditioning
Figure 1 Group data (mean  standard error) for SICI and ICF over the hemisphere contralateral (LE, n = 14; control, n = 14) and ipsilateral (LE,
n = 10; control, n = 10) to the affected arm of LE participants (black bars) and the matched arm of healthy controls (grey bars). Trials were per-
formed using conditioning stimulus (CS) intensities 70%, 80% and 90% of AMT. SICI and ICF were determined by expressing the conditioned MEP as
a percentage of the unconditioned test MEP (percentage of test MEP). LE participants displayed less SICI (less inhibition, higher percentage of the
test MEP) for the contralateral hemisphere compared to healthy controls at CS 90% AMT (A). There was no difference in SICI between groups for
the ipsilateral hemisphere (B). LE participants displayed less ICF (less facilitation, lower percentage of the test MEP) for the contralateral hemi-
sphere compared to healthy controls at CS 80% AMT (C). There was no difference in ICF between groups for the ipsilateral hemisphere (D).
*p < 0.05. AMT, active motor threshold; ICF, intracortical facilitation; LE, lateral epicondylalgia; MEP, motor evoked potential; SICI, short-interval
intracortical inhibition.
Figure 2 Group data (mean  standard error) for LICI over the hemisphere contralateral (LE, n = 14; control, n = 14) and ipsilateral (LE, n = 10;
control, n = 10) to the affected arm of LE participants (black bars) and the matched arm of healthy controls (grey bars). LICI was determined by
expressing the conditioned MEP as a percentage of the unconditioned test MEP (percentage of test MEP). LE participants displayed less LICI (less
inhibition, higher percentage of the test MEP) for the contralateral hemisphere compared to healthy controls (A), however no difference was
detected between groups for the ipsilateral hemisphere (B). *p < 0.05. LE, lateral epicondylalgia; LICI, long-interval intracortical inhibition; MEP,
motor evoked potential.
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intensity (70% AMT: main effect, p = 0.37; 80%
AMT: main effect, p = 0.07; 90% AMT: main effect,
p = 0.19).
3.2.3 Comparison of TMS of the hemisphere
contralateral and ipsilateral to the ‘affected’ arm
in LE
There was no difference in resting motor threshold
(p = 0.78), active motor threshold (p = 0.47) or MEP
amplitude (p = 0.50) between the motor representa-
tions of ECRB of the affected or unaffected arm for
individuals with LE consenting to TMS of both
hemispheres (n = 10). Similarly, there was no differ-
ence in SICI (70%: p = 0.21, 80%: p = 0.99, 90%:
p = 0.80) or ICF (70%: p = 0.40, 80%: p = 0.15,
90%: p = 0.16) at any conditioning intensity. LICI
was also comparable between hemispheres
(p = 0.86) as were test MEP amplitudes for the
paired-pulse protocols (SICI/ICF 70%: p = 0.93,
80%: p = 0.11, 90%: p = 0.68; LICI: p = 0.81).
4. Discussion
This study is the first to investigate M1 intracortical
networks in individuals with chronic LE. We demon-
strate less intracortical inhibition mediated by both
GABAA and GABAB receptors, and less intracortical
facilitation, in the M1 contralateral to the affected
ECRB in individuals with LE compared with healthy
controls. Similar changes were not present in the
M1 contralateral to the unaffected ECRB. These
changes may provide the substrate for altered M1
organization in chronic LE and could provide a tar-
get for future therapy.
Individuals with LE displayed on average, 27%
less inhibition in networks mediated by GABAA
(SICI) and 50% less inhibition in networks mediated
by GABAB (LICI) for the motor representation of the
affected ECRB muscle compared with healthy con-
trols. These data are suggestive of cortical disinhibi-
tion (shift towards greater excitability) in LE.
However, individuals with LE also displayed 26%
less ICF than healthy controls, suggesting that ICI
and ICF are differentially affected by the presence of
chronic elbow pain. This finding is not surprising
given that ICI and ICF are mediated by different
receptor systems and are thought to act indepen-
dently (Ziemann et al., 1996a, 1998; Werhahn et al.,
1999; Ilic et al., 2002; McDonnell et al., 2006; Di
Lazzaro et al., 2007). Indeed, despite similar condi-
tioning requirements, ICI and ICF are differentially
affected by current direction and intensity (Ziemann
et al., 1996b), and evoke different patterns of cere-
bral blood flow (Strafella and Paus, 2001).
Previous studies investigating intracortical net-
works in chronic musculoskeletal pain have pro-
duced mixed findings. Although some studies report
less SICI in fibromyalgia (Mhalla et al., 2010; Sch-
wenkreis et al., 2011), low back pain (Masse-Alarie
et al., 2012) and complex regional pain syndrome
(Schwenkreis et al., 2003; Eisenberg et al., 2005)
compared with healthy controls, others report nor-
mal levels of inhibition (Salerno et al., 2000). Simi-
larly, less ICF has been demonstrated in fibromyalgia
(Salerno et al., 2000; Mhalla et al., 2010) compared
with controls, whereas studies of people with
osteoarthritis and complex regional pain syndrome
report no difference (Schwenkreis et al., 2003, 2010;
Eisenberg et al., 2005). Only one study has exam-
ined the effect of musculoskeletal pain on LICI. That
study reported less inhibition in individuals with
fibromyalgia than controls (Salerno et al., 2000).
Since M1 disinhibition has been demonstrated in
conditions characterized by pain of neuropathic
(neuralgia), but not nociceptive (osteoarthritis) ori-
gin (Schwenkreis et al., 2010), it has been suggested
that discrepancies between studies might reflect dif-
ferences in the pathological process of different
chronic conditions. Alternatively, it is possible that
symptom duration is a significant determinant of the
direction and extent of M1 cortical change. Indeed,
although there is currently little data detailing the
progression of cortical change during the transition
from the acute to the chronic pain state, there is evi-
dence to suggest that the direction of these effects
differ for acute experimental pain (e.g. SICI
increased), compared to clinical chronic pain (e.g.
SICI decreased or unchanged) (Schabrun and
Hodges, 2012). In addition to differences in patient
characteristics, discrepancies between studies in
identical pain conditions may also relate to method-
ological factors. For example, in fibromyalgia, ICI is
reduced when TMS pulses are separated by 2 ms
(Mhalla et al., 2010; Schwenkreis et al., 2011), but
not at intervals of 4 ms (Salerno et al., 2000) and in
the present study, between-group differences were
only detected using a conditioning intensity of 90%
active motor threshold for SICI and 80% active
motor threshold for ICF. These data indicate that
studies investigating M1 intracortical networks
should use a range of conditioning stimulus intensi-
ties and interstimulus intervals.
The conditioning stimulus intensity required to
observe differences between people with LE and
healthy controls provides further information on the
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integrity of intracortical networks in this condition.
Data from healthy individuals indicate that SICI is
strongest at a conditioning intensity of 90% active
motor threshold and ICF is strongest at a condition-
ing intensity of 80% active motor threshold (Ortu
et al., 2008). However, individuals with LE displayed
the strongest SICI and ICF at 80% and 90% active
motor threshold, respectively. As the threshold for
evoking ICI/ICF is hypothesized to reflect the thresh-
old for stimulating axons belonging to GABAergic
and glutamatergic interneurons, respectively (Zie-
mann et al., 1998; Ilic et al., 2002; Orth et al.,
2003), these findings suggest that the electrophysio-
logical properties of circuits involving these popula-
tions may be altered in LE (Di Lazzaro et al., 1998,
2006; Hanajima et al., 1998). Changes to the struc-
ture of these circuits, such as the proximity of each
population to the stimulating coil and the orienta-
tion of their axons with respect to the induced cur-
rent, may also contribute to altered ICI/ICF
thresholds in this condition (Orth et al., 2003).
The results of the present study provide insight
into mechanisms that may contribute to the devel-
opment of altered M1 organization and motor dys-
function in LE. Rapid reorganization of M1 is
thought to depend on changes in synaptic efficacy
that rely on GABAergic disinhibition and NMDA
receptor-dependent long-term potentiation-like
mechanisms (Liepert et al., 1998a). Altered function
of intracortical networks is therefore a plausible
mechanism to explain increased map volume,
greater MEP amplitude and less separation in the
cortical representations of the ED and ECRB muscles
in LE (Schabrun et al., 2014). In addition, a key
function of intracortical networks is to facilitate con-
traction of muscles required for a motor task while
preventing unwanted movements, muscle overflow
and co-contraction of surrounding muscles (Liepert
et al., 1998b). Motor dysfunction characterized by
altered muscle synergies between ECRB and other
extensor/flexor muscles of the wrist (Alizadeh-
khaiyat et al., 2007), adoption of a flexed wrist pos-
ture (Bisset et al., 2006), diminished ability to
generate force (De Smet and Fabry, 1997; Slater
et al., 2005) and reduced fine motor performance
(Skinner and Curwin, 2007) have been reported in
LE. Finally, LE is common in people who perform
manual tasks with repeated, rapid movements of the
wrist and forearm (Fan et al., 2009; Descatha et al.,
2013) and repetitive movement training has been
shown to reduce expression of SICI and ICF (Nord-
strom and Butler, 2002; Cirillo et al., 2011). One
possibility is that repetitive movements drive intra-
cortical changes (reduced ICI and reduced ICF as
observed in the present study) leading to altered M1
organization, motor dysfunction and pain persistence
in LE. However, as this study was exploratory in
nature and not designed to determine causality, fur-
ther work using longitudinal study designs are
needed to confirm this hypothesis. Studies investi-
gating larger cohorts of participants and studies
including individuals in the acute (<6 weeks) and
chronic (>3 months) stage of disease are required to
determine the time-course of altered cortical organi-
zation and function in LE.
We did not observe a relationship between ICI/ICF
and measures of pain or disability. However, previ-
ous studies of M1 organization in LE have shown a
relationship between the degree of cortical reorgani-
zation (specifically the degree of overlap between
the representations of ED and ECRB) and pain
severity in the last 6 months (Schabrun et al., 2014).
It is conceivable that any relationship between ICI/
ICF and outcomes of pain and disability is non-lin-
ear, and depends on the relative contribution of
changes in ICI and ICF to M1 organization. This
hypothesis would explain why features of altered
M1 organization are associated with pain severity in
LE while intracortical mechanisms are not. Further-
more, although SICI has been shown to correlate
with pain measures in myofascial pain syndrome
(Volz et al., 2013) and complex regional pain syn-
drome (Schwenkreis et al., 2003), similar findings
have not been reported for other conditions such as
low back pain or fibromyalgia (Mhalla et al., 2010;
Schwenkreis et al., 2011; Masse-Alarie et al., 2012).
Despite these findings, it remains possible that thera-
pies that normalize activity in intracortical networks
could have a role in the treatment of LE and other
chronic pain conditions by preventing maladaptive
reorganization of M1. Future studies should seek to
investigate whether therapies capable of targeting
intracortical networks, such as repetitive TMS, are of
benefit in persistent LE and whether normalization
of these networks is associated with improved M1
organization.
Finally, there are several limitations of the present
study that should be acknowledged. First, it is
unclear whether the present findings are typical of
the general LE population as data were collected
from a small sample of convenience. Studies involv-
ing a larger number of participants are required to
confirm our results and to further examine potential
relationships between neurophysiological outcomes
and clinical characteristics. Larger trials would also
be better able to control for confounding variables
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such as ‘handedness’ – a factor not accounted for in
the in the present study due to the small proportion
of LE participants (n = 3) experiencing symptoms in
the non-dominant arm. Second, since we did not
assess muscle representations other than ECRB, it is
not clear whether the observed changes are
restricted to the ‘painful’ muscle. Indeed, since the
M1 representation of a muscle adjacent to ECRB
(extensor digitorum) has been found to be similarly
altered in LE in a previous study (Schabrun et al.,
2014), it may be anticipated that altered inhibitory
and/or facilitatory network activity may extend to
other local muscles. Further research is required
to determine whether M1 cortical change is confined
to muscles located within the immediate vicinity of
pain in LE or whether these effects also extend to
muscles distal and/or proximal to ECRB.
5. Conclusion
This study is the first to provide evidence of reduced
intracortical activity mediated by GABAA (SICI),
GABAB (LICI) and NMDA (ICF) receptors in individ-
uals with chronic LE. We hypothesize that these
mechanisms may drive altered M1 organization and
aspects of motor dysfunction in this condition. How-
ever, longitudinal trials on larger subject numbers
are required to confirm this relationship. If con-
firmed, therapies that restore intracortical function
may have the potential to normalize cortical abnor-
malities and improve outcomes in LE.
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ABSTRACT
Purpose/aim: Recently, a novel measure of cortical disinhibition was identified using transcranial
magnetic stimulation (TMS). This measure, described as post-silent period electromyographic
(EMG) bursting, may inform on the corticomotor control of movement in health and disease;
however, it has not been investigated for muscles outside the hand or in musculoskeletal
conditions. Thus, the aim of this study was to investigate the temporal and spatial characteristics of
“EMG bursting” in individuals with and without low back pain (LBP).
Materials and Methods: TMS was used to map the motor cortical representation of paraspinal
muscles in 11 individuals with LBP and 11 pain-free controls. The latency, duration and magnitude
of bursting, number of active burst sites, map volume and coordinates of the burst “hotspot” were
compared between the groups.
Results: In pain-free controls, the latency, duration and magnitude of bursts were similar to the
hand; however, bursts occurred earlier and were of smaller magnitude in LBP. Bursting was
widespread throughout the cortical representation in both groups; however, there was a trend
towards smaller mean EMG burst and map volume in LBP.
Conclusions: We confirm the presence of EMG bursting in back muscles and provide a description
of the spatial profile of this mechanism. Our observations in LBP suggest that cortical disinhibition
may be altered in this condition.
KEYWORDS
Transcranial magnetic
stimulation; low back pain;
cortical disinhibition; primary
motor cortex; brain mapping
Introduction
Transcranial magnetic stimulation (TMS) can be used to
assess features of the corticomotor control of movement
in health and disease. In particular, paired pulse para-
digms have been used to investigate inhibitory activity
mediated by gamma-aminobutyric acid (GABA) in
healthy individuals and in a range of pathological condi-
tions. In low back pain (LBP), for example, there is evi-
dence of reduced inhibition in networks mediated by
GABAA receptors, suggesting changes in these networks
might be involved in this condition. Recently, a novel sin-
gle-pulse measure of intracortical activity has been iden-
tified. This response, described as post-silent period
“electromyographic (EMG) bursting”, has been hypothes-
ised to reflect the activation of GABAB receptors on
inhibitory interneurons and represent a measure of
corticomotor disinhibition [1]. However, despite recur-
rent observations [2–5], few studies have specifically
examined this measure in healthy individuals and
there have been no studies in musculoskeletal pain
conditions.
EMG burst responses following the cortical silent
period have been demonstrated following magnetic
stimulation of the cortical territory devoted to the hand
[1,5]. In a recent investigation, TMS delivered over the
motor hotspot during volitional contraction consistently
evoked transient (»60 ms) but distinct bursts of muscle
activity up to three times the amplitude of the back-
ground EMG. A GABAergic origin for this response was
proposed since bursts were the largest following longer
cortical silent periods (GABAB-mediated) and occurred at
latencies corresponding with a known period of reduced
corticomotor inhibition (also GABAB-mediated) [6].
Hence, measurement of EMG bursting may provide fur-
ther insight into cortical processes involving GABA-medi-
ated networks in pathological conditions such as LBP.
However, the temporal characteristics and the cortical
distribution of EMG bursts have yet to be investigated
for muscles outside the hand. It is also unknown whether
EMG bursting differs between healthy individuals and
those with musculoskeletal pain. Thus, the aims of the
present study were to (1) confirm the presence of post-
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silent period EMG bursting in low back muscles and (2)
examine the spatial and temporal profile of EMG bursting
using TMS mapping, in persons with and without LBP.
We hypothesised that the examination of burst character-
istics in individuals with LBP would reveal further evi-
dence of reduced cortical inhibition in this condition.
Methods
Participants
Eleven right-handed individuals with a history of recur-
ring episodes of non-specific LBP (6 males, aged 29 §
7 years) and 11 age- and gender-matched pain-free con-
trols (6 males, 27 § 5 years) participated. Individuals
with LBP were recruited during an active episode of LBP
(with or without buttock pain). To be eligible for inclu-
sion, the average pain intensity was required to be
greater than 3 on an 11-point numerical rating scale
(NRS) anchored with “no pain” at 0 and “worst pain
imaginable” at 10, and of sufficient intensity to interfere
with at least three important activities of daily living
(assessed via a Patient-Specific Functional Scale) [7]. All
participants completed a TMS safety screening question-
naire and were excluded from enrolment if they had a
personal or family history of epilepsy, major neurologi-
cal, respiratory, orthopaedic or circulatory disorders, if
they were pregnant, had metal in their head or jaw or
were taking central-nervous-system-acting medications
[8]. Additional exclusion criteria for LBP participants
included previous spinal surgery, the use of analgesic or
anti-inflammatory medication in the last month or the
receipt of treatment from a health professional in the
last month. The study was approved by the institutional
human medical research ethical committee and per-
formed in accordance with the Declaration of Helsinki.
All participants provided written, informed consent.
Electromyography (EMG)
Surface electromyography (EMG) was recorded bilater-
ally from the paraspinal muscles 3 cm lateral to the spi-
nous process of L3 and 1 cm lateral to the spinous
process of L5 via dual silver–silver chloride disposable
electrodes (spacing 2.0 cm, Noraxon USA Inc, Scottsdale,
AZ, USA). These sites record EMG from deep and superfi-
cial back muscles including the multifidus and erector
spinae [9]. Ground electrodes were positioned over the
anterior superior iliac spine of the same side. EMG signals
were amplified x1000 (NL844, Digitimer Ltd., Welwyn
Garden City, UK), band-pass filtered: 20–1000 Hz and
sampled at 2000 Hz using a Micro1401 data acquisition
system and Spike2 software (Cambridge Electronic
Design, Cambridge, UK).
Transcranial magnetic stimulation (TMS)
TMS mapping of the cortical representation of the lum-
bar paraspinal muscles was performed according to the
procedures outlined previously [10–12]. In brief, TMS
was delivered to the primary motor cortex contralateral
to the side of worst pain (or the matched side for pain-
free controls) using a Magstim 200 stimulator (Magstim
Co. Ltd., Dyfed, UK) connected to a figure-of-eight coil
(70 mm wing diameter), oriented with the handle facing
posteriorly with respect to the midline. The location of
the vertex (Cz) was determined using the 10/20 Interna-
tional EEG Electrode Placement system and registered
using a Brainsight neuronavigation system (Rogue
Research Inc., Quebec, Canada). Starting at the vertex,
five magnetic stimuli were delivered at 1-cm intervals
on a 6 cm £ 7 cm grid with the aid of the neuronaviga-
tion instrument. The stimuli were applied at 100% of the
stimulation output with an inter-stimulus interval of 6 s,
while participants performed a low-level voluntary con-
traction (20% maximum) of the paraspinal muscles. The
target amplitude was determined based on the largest
root mean square (RMS) EMG achieved during three 3-s
maximal trunk extension efforts performed against man-
ual resistance in sitting [11]. During testing, the partici-
pants maintained the appropriate level of muscle
contraction by sitting forward with the back straight
[11,13]. Visual feedback was provided on a computer
monitor to ensure symmetrical pre-activation. To ensure
that the prolonged sitting and high TMS stimulator out-
put required during the mapping procedure did not
exacerbate LBP symptoms, the pain severity was moni-
tored verbally throughout, and evaluated on completion
of TMS mapping using an 11-point numerical rating
scale (NRS). All procedures adhered to the TMS checklist
for methodological quality [14].
Data analyses
Analysis of TMS map data was performed using MATLAB
7 (The Mathsworks, Natick, MA). EMG was full-wave-recti-
fied and trials (five) at each scalp site were averaged. Five
parameters were extracted from these data: (1) motor-
evoked potential (MEP) amplitude, (2) cortical silent
period, (3) percentage burst ratio (PBR), (4) burst
duration and (5) burst silent period. To account for pre-
activation, the MEP amplitude (uV) was calculated by
subtracting the RMS EMG recorded 55–5 ms prior to
stimulation (background EMG) from the RMS EMG
between MEP onset and offset [15–18]. The duration of
the cortical silent period (ms) was determined as the
time between MEP offset and the resumption of EMG
equivalent to or greater than that present pre-stimulus.
If a clear burst in EMG activity was identified following
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the cortical silent period, the RMS of the burst was calcu-
lated by manually cursoring burst onset and offset.
Where a burst was not apparent in a trial, but could be
identified in other trials within the set of five, the mean
of those bursts was used to calculate the RMS EMG for
that map site [1]. If no bursts were identified within the
set of five trials, the RMS EMG for that map site was cal-
culated from the background EMG 0–50 ms after the cor-
tical silent period. The PBR (%) was calculated by
expressing the mean burst RMS EMG as a percentage of
the mean background EMG [1]. The duration of the burst
silent period (ms) was determined to be the period
between burst offset and the resumption of RMS EMG
equivalent to or greater than that observed pre-stimulus.
To examine the spatial profile of EMG bursting in M1,
the PBR was superimposed over the respective scalp
sites to generate a “PBR map” for each participant. The
number of active burst sites, the mean PBR of the map
(%), the PBR map volume, and the anterior–posterior
and the medial–lateral location (cm) of the largest MEP
(the “motor hotspot”) and the PBR (“burst hotspot”) were
identified for each map. For a map site to be considered
“active”, at least one trial out of five was required to dis-
play the evidence of EMG bursting. The mean PBR of the
map (%) and the PBR map volume were calculated as
the average or the sum of the PBRs recorded at each
active site, respectively.
Statistical analyses
Data for MEP amplitude, cortical silent period, PBR,
map volume, burst duration and burst silent period
were assessed for normality via the Shapiro–Wilk test
and compared between the groups (Control vs. LBP)
using separate one-way analyses of variance (ANOVA).
To ensure that pre-activation during TMS testing did
not aggravate pain in the LBP group, pain intensity
before and after TMS were compared using one-way
repeated measures ANOVA. Separate two-way ANOVA
was used to compare map hotspots (MEP vs. PBR)
between the groups (Control vs. LBP) in the anterior–
posterior and the medial–lateral directions. Post hoc
analyses were corrected for multiple comparisons
using the Holm–Sidak method. Eta-squared was calcu-
lated as a measure of the effect size for each outcome.
Pearson correlation analyses were performed to exam-
ine the relationship between (1) the cortical silent
period duration and PBR in both groups and (2) the
pain severity and neurophysiological outcomes in LBP.
Statistical significance was set at P < 0.05. Data in text
are expressed as mean § standard deviation unless
stated otherwise.
Results
As there was no difference between the responses at L3
and L5 within the LBP or pain-free groups (P > 0.42),
data generated from both recording sites were pooled
and compared between the groups. Normative data and
data from individuals with LBP are presented in Table 1.
EMG bursting is present in the low back muscles of
pain-free individuals
Burst characteristics of the map in pain-free
individuals
The present data indicate that EMG bursting can be eli-
cited by stimulating multiple scalp sites overlying the
cortical territory of the low back muscles. Example traces
of EMG bursting are presented in Figure 1 and average
PBR maps are presented in Figure 2. In pain-free controls,
approximately 92% of map sites showed evidence of
EMG bursting. In this group, the largest burst was more
than double the amplitude of the background RMS EMG
(PBR »229%) and was located 1.3 § 1.8 cm anterior and
1.7 § 1.7 cm lateral to Cz. The mean PBR of the map was
140% § 13% and the map volume was 5406% § 734%.
Burst characteristics at the motor hotspot
in pain-free individuals
At the motor hotspot, normative data indicated that the
burst amplitude was approximately 1.5 times larger than
that of the background RMS EMG. On average, the burst
activity commenced 123 § 54 ms following magnetic
stimulation and lasted 57 § 33 ms. This was immediately
followed by a period of EMG silence in 10 out of 11 con-
trol participants (Figure 1(b)). In these participants, the
duration of the burst silent period was 54 § 34 ms. A
positive correlation between the PBR and the duration
of the cortical silent period was detected at the motor
hotspot (r = 0.54, P = 0.0096).
Table 1. Group data (mean § SD) for controls and individuals
with LBP.
Control
(n = 11)
LBP
(n = 11)
Active burst sites (n/42) 38.6§ 3.5 36.5 § 7.6
Map volume (%) 5406§ 734 4794§ 1327
Mean PBR of map (%) 140§ 13 131 § 18
Max PBR of map (%) 229§ 59 209 § 77
MEP at motor hotspot (mV) 0.019 § 0.013 0.010 § 0.009
Cortical silent period at motor
hotspot (ms)
81.4§ 49.3 53.7 § 21.3
PBR at motor hotspot (%) 150§ 62 117 § 46
Burst onset at motor hotspot (ms) 123§ 54 88 § 23
Burst duration at motor hotspot (ms) 57.0 § 33.6 61.2 § 25.4
Burst silent period duration at motor
hotspot (ms)
54.3§ 34.2 54.7 § 33.1
P < 0.05.
Abbreviations: PBR: Percentage burst ratio; MEP: motor-evoked
potential.
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Burst characteristics differ for individuals with low
back pain compared to pain-free controls
Patient characteristics are summarised in Table 2. The
average pain intensity on the day of testing was 4.0 §
2.0 on the NRS and the time elapsed since the first pain
episode was 56 § 40 months. The procedure of TMS
mapping did not alter the pain intensity (F(1,10) = 2.41,
P = 0.15, h2 = 0.028). At the motor hotspot, EMG bursts
occurred earlier (F(1,42) = 7.62, P = 0.009, h
2 = 0.15) and
were of smaller magnitude in individuals with LBP com-
pared to controls (F(1,42) = 4.09, P = 0.050, h
2 = 0.091).
There was, however, no detectable correlation between
pain severity and PBR (r = 0.27, P = 0.22) or pain severity
and burst onset (r = 0.26, P = 0.24). Other characteristics
including the duration of the burst (F(1,42) = 0.23, P =
0.64, h2 = 0.005) and the burst silent period did not differ
(F(1,30) = 0.001, P = 0.97, h
2 < 0.001) between the groups.
The number of active burst sites was also similar for
Figure 1. Representative waveforms demonstrating EMG bursting in the lumbar paraspinal muscles of two pain-free subjects (a,b) and
one LBP subject (c) during sustained 20% maximum voluntary contraction (MVC). Note that two types of responses were typically
observed: (a) the cortical silent period is terminated by a burst of EMG activity, or (b,c) the cortical silent period is interrupted by a burst
of EMG activity. The MEP amplitudes were typically smaller and bursts occurred earlier in persons with LBP compared to controls.  indi-
cates the position of the burst.
Figure 2. Averaged and normalised PBR maps obtained from the lumbar paraspinal muscles of (a) pain-free individuals and (b) individuals
with LBP. The horizontal dashed line represents the inter-aural line and the vertical dashed line represents the line from the nasion to the
inion. Cz is located at the coordinate (0,0). Note the difference in the magnitude and distribution of EMG bursting between the groups.
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individuals with and without LBP (F(1,42) = 1.43, P = 0.24,
h2 = 0.033; Figure 2(a,b)), as was the maximum PBR of
the map (F(1,42) = 1.03, P = 0.32, h
2 = 0.024). A trend
towards smaller mean PBR and map volume was
detected for LBP but failed to reach significance (mean:
F(1,42) = 3.48, P = 0.069, h
2 = 0.076; volume: F(1,42) = 3.58,
P = 0.065, h2 = 0.079). The PBR hotspot was located
1.2 § 1.7 cm anterior and 1.8 § 1.7 cm lateral to Cz.
Two-way ANOVA revealed that the burst hotspot was
located significantly closer to the midline compared to
the MEP hotspot in both groups (Figure 3; post hoc: P =
0.007), however, did not identify an interaction between
groups (medial–lateral: F(1,84) = 0.38, P = 0.54, h
2 = 0.004).
MEP amplitude and the duration of the cortical
silent period are less in LBP compared
to pain-free controls
At the motor hotspot, MEP amplitudes were smaller
(F(1,42) = 5.90, P = 0.019, h
2 = 0.12) and the cortical silent
period was shorter (F(1,42) = 5.87, P = 0.02, h
2 = 0.12) for
individuals with LBP compared to controls. In contrast to
pain-free controls, there was no correlation between PBR
and cortical silent period duration at this site for individ-
uals with LBP (r = 0.21, P = 0.34). There was also no signif-
icant correlation between pain severity and MEP
amplitude (r = ¡0.20, P = 0.37) or pain severity and corti-
cal silent period duration (r = 0.074, P = 0.75) in this
group.
Discussion
The results of the present study confirm the presence of
post-silent period EMG bursting in muscles of the low
back. We also provide a description of the spatial distri-
bution of bursting in M1, and the first account of differ-
ences between healthy individuals and those with
musculoskeletal pain.
Spatial and temporal characteristics of EMG
bursting in the back
This study utilised TMS mapping techniques to examine
the spatial profile of post-silent period EMG bursting in
M1. Our findings show that, like MEPs, EMG bursts may
be elicited from a number of scalp sites overlying the
cortical representation of the lumbar paraspinal muscles
in individuals with and without LBP. While the magni-
tude of bursting varied across sites, we found the largest
responses to be distributed within the posterior half of
the map. Here, we observed a clear peak in PBR approxi-
mately 2 cm medial to the location of the motor hotspot
(Figure 3). In pain-free individuals, PBR at the burst hot-
spot was 53% greater than that recorded at the motor
hotspot. Interestingly, this difference was more pro-
nounced in LBP (»77%). Differences in PBR at the burst
and motor hotspots could be evidence that the burst
and MEP responses are generated by independent corti-
cal networks and may explain previous accounts of
bursting in the absence of an evoked potential [2,5].
These findings also suggest that the motor hotspot may
not be the optimal location to assess EMG bursting, par-
ticularly in patient populations.
Table 2. Demographic and clinical characteristics for individuals
with LBP (n = 11).
Subject Gender
Age
(years)
Side of
pain
Current pain
(NRS/10)
Pain duration
(months)
1 F 27 L 1 84
2 M 36 R 7.5 60
3 M 39 R 4 100
4 F 19 R 2 60
5 M 27 R 6 18
6 M 41 L 3 60
7 F 31 R 5 6
8 M 31 R 6 108
9 M 24 L 5 6
10 F 27 L 2 100
11 F 19 R 3 17
Abbreviation: NRS: numerical rating scale.
Figure 3. Topographical location (mean § standard error) of
MEP hotspot (open markers) and PBR hotspot (filled markers) for
LBP (squares) and pain-free controls (circles). The horizontal
dashed line represents the inter-aural line and the vertical
dashed line represents the line from the nasion to the inion. Cz is
located at the coordinate (0,0). Each grid square represents 1 cm
£ 1 cm. Note that the PBR hotspot is positioned medially to the
MEP hotspot in both groups.
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In pain-free individuals, EMG bursts at the motor hot-
spot demonstrated a similar latency, duration and mag-
nitude to those reported in the hand under similar test
conditions [1]. Similarly, a positive correlation between
the cortical silent period and PBR was detected in the
present study. Taken together, these findings suggest
that the burst characteristics may be similar across the
distal and axial muscles. If confirmed, responses
recorded from the hand could be used to provide a
global estimate of EMG bursting in M1. This method
would be particularly advantageous in patient studies
where the cortical representation of the affected muscle
is positioned deep in the cortex and is difficult to target
with TMS (e.g. low back or leg muscles) or where voli-
tional contraction aggravates pain. However, as we only
investigated EMG bursting at the site of pain in LBP, fur-
ther work is needed to determine whether the burst
characteristics are identical for painful and pain-free
muscles in this and other musculoskeletal pain
conditions.
By confirming the latency and duration of the burst
and its affiliation with the cortical silent period, our data
further support the hypothesis that the post-silent
period EMG bursting represents a measure of the depth
and magnitude of disinhibition in M1 [1]. As was the
case in the hand, the latency (»120 ms) and duration
(»50 ms) of bursting in the back muscles are consistent
with that of a recently described period of late cortical
disinhibition [6]. In that study, a period of raised cortico-
motor excitability was noted following the evocation of
a form of GABAB-mediated inhibition known as long-
interval intracortical inhibition (LICI). This effect was
attributed to the action of pre-synaptic GABAB receptors
which function to negatively regulate GABA release and
facilitate excitatory post-synaptic potentials [19,20]. This,
taken together with the evidence linking the EMG bursts
with the cortical silent period (also GABAB-mediated),
suggests that this mechanism may reflect the depth and
magnitude of disinhibition in M1. However, as LICI and
late cortical disinhibition have yet to be investigated in
muscles of the trunk, further work is necessary to deter-
mine whether these mechanisms are present in the low
back and whether this hypothesis also holds for our
results.
A novel outcome of the present study was identifica-
tion of the “burst silent period”. While previous studies
show the evidence of EMG bursts terminating the corti-
cal silent period or trains of bursts interspersed with low-
level EMG in a proportion of test subjects, the EMG
bursts in the present study were followed by a clear
period of EMG silence in 20 of 22 participants [1,2]. In
pain-free individuals, this episode appeared 200 ms
post-stimulus and persisted for »50 ms. Since cortical
silent periods longer than 85 ms have yet to be demon-
strated in muscles of the low back [2,16], we suggest
that this response represents a separate entity, rather
than a continuation of the cortical silent period. It is pos-
sible that this “burst silent period” may signify a return
of post-synaptic GABAergic activity following the conclu-
sion of the EMG burst; however, further work is neces-
sary to establish the causation and identify the
mechanisms involved.
EMG bursting in low back pain
At the location of the motor hotspot, bursts occurred
earlier and were smaller in magnitude in individuals with
LBP compared to pain-free controls. In keeping with cur-
rent hypotheses, we interpret smaller bursts in LBP as an
evidence of reduced cortical disinhibition in this condi-
tion. Previous estimates of disinhibition in LBP have
been based on chance observations in paired pulse stud-
ies investigating inhibitory networks in M1. In contrast to
the present study, those studies cite lower levels of short
interval intracortical inhibition (SICI) in the abdominal
and paravertebral muscles in LBP as evidence of
increased disinhibition in this condition [21,22].
Although it is common to interpret a reduction in SICI as
a form of disinhibition, pharmacological evidence indi-
cates that this mechanism reflects inhibitory processes
mediated by post-synaptic GABAA receptors [23,24],
which, unlike the pre-synaptic GABAB receptors pro-
posed to underlie EMG bursting [1], do not have the
innate capacity to negatively regulate GABAergic trans-
mission. Furthermore, a number of competitive interac-
tions have been documented between SICI and other
inhibitory and excitatory mechanisms in M1 [25–28].
Therefore, we suggest that the present findings may pro-
vide a more accurate account of the depth and duration
of M1 disinhibition in LBP. However, as we found no evi-
dence of a relationship between the burst characteristics
and pain, the clinical significance of these findings
remains unclear.
Despite no statistical difference between the location
of hotspots between the groups, there was a trend
towards smaller mean PBR and smaller map volume in
individuals with LBP. These findings are further evidence
that the topography and mean excitability of the motor
representation of low back muscles are altered com-
pared to the controls [11,12,15]. As these changes are
hypothesised to underpin the altered trunk muscle coor-
dination and postural control in LBP, it is possible that an
abnormal burst mechanism may similarly contribute to
motor dysfunction in this condition [15].
In addition to the altered burst characteristics, we also
report reduced MEP amplitudes and shorter cortical
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silent periods at the motor hotspot in LBP. While these
findings complement previous observations of
decreased corticomotor excitability [11,16,29] and dys-
functional GABAergic disinhibition in LBP [21,22], they
are not entirely compatible with our conclusion of
reduced cortical disinhibition. Discrepant responses to
TMS are not uncommon in observational studies and
serve to highlight the intricate nature of M1; however,
methodological factors also have the potential to affect
the study outcomes. For example, in the present study,
TMS mapping was performed with maximum stimulator
output (100% intensity) in all the participants. While in
line with previous studies using surface EMG over
muscles of the low back during volitional contraction
[2,10–12], this methodology may give rise to erroneous
results if differences in corticomotor excitability exist
between the groups. Indeed, since the magnitude of the
MEP, the cortical silent period and EMG burst are report-
edly intensity-dependent [1,30], it is possible that our
observation of smaller MEPs, smaller bursts, shorter
silent periods and earlier burst onset in LBP may be a
consequence of raised motor threshold. However, as
motor threshold was not an outcome of the present
study and there is a lack of consensus regarding this
aspect of cortical excitability for low back muscles in LBP
[16,21], the impact of this factor on our results remains
unclear. To prevent such ambiguity in the future, we rec-
ommend that future studies, requiring maximum stimu-
lator output to generate M1 maps, include a measure of
active motor threshold to validate their findings, espe-
cially if abnormal motor threshold is suspected.
Conclusion
This study confirms the presence of post-silent period
EMG bursting in low back muscles. We found that the
latency, duration and magnitude of bursting in healthy
persons were similar to that reported previously in the
hand; however, our novel observation of a “burst silent
period” suggests that this feature may be specific to the
back. TMS mapping revealed a graded distribution of
EMG bursting throughout M1, culminating in one defini-
tive “hotspot”. Our observation of spatial and temporal
differences between individuals with and without LBP
may be evidence of altered cortical disinhibition in this
condition; however, further work is necessary to confirm
this hypothesis.
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